<SEC-DOCUMENT>0001104659-17-071865.txt : 20171205
<SEC-HEADER>0001104659-17-071865.hdr.sgml : 20171205
<ACCEPTANCE-DATETIME>20171205125339
ACCESSION NUMBER:		0001104659-17-071865
CONFORMED SUBMISSION TYPE:	N-CSR
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20170930
FILED AS OF DATE:		20171205
DATE AS OF CHANGE:		20171205
EFFECTIVENESS DATE:		20171205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA HEALTHCARE INVESTORS
		CENTRAL INDEX KEY:			0000805267
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CSR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-04889
		FILM NUMBER:		171239164

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q HEALTHCARE INVESTORS
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSR
<SEQUENCE>1
<FILENAME>a17-24476_1ncsr.htm
<DESCRIPTION>CERTIFIED ANNUAL SHAREHOLDER REPORT
<TEXT>


<html>
<head>






  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="25%" colspan="2" valign="top" style="border:solid windowtext 1.0pt;border-left:none;padding:0in 0in 0in 0in;width:25.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">OMB   APPROVAL</font></p>    </td>   </tr>
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:12.5%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">OMB Number:</font></p>    </td>
<td width="12%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">3235-0570</font></p>    </td>   </tr>
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:12.5%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">Expires:</font></p>    </td>
<td width="12%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">August   31, 2020</font></p>    </td>   </tr>
<tr height="1" style="height:1.0pt;">
<td width="24%" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" height="1" valign="bottom" style="border:none;border-right:solid windowtext 1.0pt;height:1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">UNITED   STATES</font></p>    </td>
<td width="25%" colspan="2" height="1" valign="top" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:solid windowtext 1.0pt;border-top:none;height:1.0pt;padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">Estimated average burden hours   per response. . . . . . . . . . . . . . .20.6</font></p>    </td>   </tr>
<tr height="1" style="height:1.0pt;">
<td width="24%" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">SECURITIES   AND EXCHANGE COMMISSION</font></p>    </td>
<td width="25%" colspan="2" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:25.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:2.0pt 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:2.0pt 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">Washington, D.C. 20549</font></p>    </td>
<td width="25%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p align="center" style="margin:2.0pt 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">FORM N-CSR</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CERTIFIED SHAREHOLDER REPORT OF REGISTERED<br> MANAGEMENT INVESTMENT COMPANIES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="29%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:29.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment Company Act file number</font></p>    </td>
<td width="70%" colspan="7" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:70.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">811-04889</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Healthcare Investors</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as   specified in charter)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="66%" colspan="8" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:66.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&nbsp;Floor, Boston, MA </p>    </td>
<td width="2%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">02110</font></p>    </td>   </tr>
<tr>
<td width="66%" colspan="8" valign="top" style="padding:0in 0in 0in 0in;width:66.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive   offices)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip code)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura Woodward, Chief Compliance Officer   and Vice President of Fund Administration<br>   100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&nbsp;Floor, Boston, MA&nbsp; 02110</p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name and address of agent for   service)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:39.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including   area code:</font></p>    </td>
<td width="22%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.82%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500</font></p>    </td>
<td width="37%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:37.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="18%" valign="top" style="padding:0in 0in 0in 0in;width:18.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of fiscal year end:</font></p>    </td>
<td width="19%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">September 30</font></p>    </td>
<td width="62%" colspan="6" valign="top" style="padding:0in 0in 0in 0in;width:62.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of reporting period:</font></p>    </td>
<td width="34%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:34.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">October 1,   2016 to September 30, 2017</font></p>    </td>
<td width="45%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="128" style="border:none;"></td>
<td width="9" style="border:none;"></td>
<td width="69" style="border:none;"></td>
<td width="56" style="border:none;"></td>
<td width="20" style="border:none;"></td>
<td width="102" style="border:none;"></td>
<td width="60" style="border:none;"></td>
<td width="24" style="border:none;"></td>
<td width="14" style="border:none;"></td>
<td width="227" style="border:none;"></td>   </tr> </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-ba.htm',USER='105348',CD='Dec  2 06:43 2017' -->


<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 1. REPORTS TO STOCKHOLDERS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106406\14-22610-1\task7089019\22610-1-bg.htm',USER='106406',CD='Nov 25 14:29 2014' -->


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.aa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
</div>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j17244762_aa001.jpg"></p>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:30pt;"><b><i>Annual Report</i></b></font></p>
<p style="margin:11pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:13pt;">&nbsp;&nbsp;2&nbsp;&nbsp;0&nbsp;&nbsp;1&nbsp;&nbsp;7</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=1,FOLIO='',FILE='17-24476-2.aa',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Distribution policy:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund has implemented a managed distribution policy (the Policy) that provides for quarterly distributions at a rate set by the Board of Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Policy would result in a return of capital to shareholders, if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income."</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The amounts and sources of distributions reported in the Fund's notices pursuant to Section 19(a) of the Investment Company Act of 1940 are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that tells you how to report distributions for federal income tax purposes.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">You should not draw any conclusions about the Fund's investment performance from the amount of distributions pursuant to the Policy or from the terms of the Policy. The Policy has been established by the Trustees and may be changed or terminated by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distributions considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions. The suspension or termination of the Policy could have the effect of creating a trading discount or widening an existing trading discount. At this time there are no reasonably foreseeable circumstances that might cause the Trustees to terminate the Policy.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Consider these risks before investing:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> As with any investment company that invests in equity securities, the Fund is subject to market risk&#151;the possibility that the prices of equity securities will decline over short or extended periods of time. As a result, the value of an investment in the Fund's shares will fluctuate with the market generally and market sectors in particular. You could lose money over short or long periods of time. Political and economic news can influence market wide trends and can cause disruptions in the U.S. or world financial markets. Other factors may be ignored by the market as a whole but may cause movements in the price of one company's stock or the stock of companies in one or more industries. All of these factors may have a greater impact on initial public offerings and emerging company shares. Different types of equity securities tend to shift into and out of favor with investors, depending on market and economic conditions. The performance of funds that invest in equity securities of Healthcare Companies may at times be better or worse than the performance of funds that focus on other types of securities or that have a broader investment style.</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=2,FOLIO='',FILE='17-24476-2.aa',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.ba-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dear Shareholders,</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In the last ten to fifteen year period, the performance of the healthcare sector, and that of the biotechnology sub-sector in particular, has been impressive. Note in the following graph that both the S&amp;P Composite 1500<sup>&reg;</sup> Health Care Index* ("S15HLTH") and the NASDAQ Biotechnology Index<sup>&reg;</sup>* ("NBI") materially outperformed the broad S&amp;P 500<sup>&reg;</sup> Index* ("SPX") in the fifteen year period ending September 30, 2017.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Biotechnology, Healthcare, and S&amp;P 500 Performance<BR>2002 &#150; 2017</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244762_ba002.jpg">
</p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We believe that a consistent record of discovery, development and commercialization of new drugs and products that improve quality of life, address medical need and ultimately save lives is the basis for this performance. Nearly everyone has heard of the remarkable genetic engineering and related technologies that are the basis of these new medical products. Moreover, just about everyone we know has a friend or relative who has benefitted from these products and technologies. We think that the combination of accomplishment and positive sentiment has driven healthcare/biotech sector performance.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We also feel that, despite the long history of fundamental progress, angst over drug industry profitability in general, and over drug pricing in particular, has had a negative effect on sector sentiment as of late. These issues were front and center during the recently concluded presidential election cycle and have remained a controversial topic since then as Congress debated the potential repeal and/or replacement of Obamacare. In particular, we think that outrage over drug pricing, justified or (maybe) not, has hurt sentiment for the healthcare/biotech sector.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>1</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=3,FOLIO='1',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Despite these challenges, recent sector performance has been quite positive. In fact, the broad SPX was up approximately 20% in calendar 2017 while the healthcare and biotech indices we track were up closer to 30%. As the quarter ended, we were quite upbeat.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">However, third quarter 2017 healthcare/biotech sector company reports (made in the month or so after the September 30, 2017 end of the Fund's fiscal year) were mediocre overall, particularly for the large bellwether biotech and pharma companies. This has caused a pullback of approximately 10% in the healthcare sector. As of this writing in early November 2017, both the broad SPX and the healthcare and biotech indices are up approximately 20% in calendar 2017. Such a move in the markets in a ten-month period would always be welcome. However, given both the apparent sentiment and a weak quarter, we have taken a step back to review our thoughts on the healthcare/biotech sector.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">More detail is provided later in this note, but in summary, we remain optimistic about the sector. Overall, we expect a continuation of the impressive innovation we have seen. In just the last few years, there have been remarkable developments in immuno-oncology, gene therapy and other areas. In addition, the FDA (while remaining formidable) appears to have become incrementally more accommodative. The IPO market continues to produce new public companies. Our aggregate view is that, in combination with the broad creation and funding of a new generation of public companies, this continued innovation will lead to the discovery and development of many new and novel medical products that will propel the healthcare and biotech sectors forward. We expect these newly formed companies to either be acquired by or to replace the current industry leaders forming the next generation of healthcare/biotech growth. Although we may see some volatility as this renewal process sorts itself out, this makes us optimistic about the medium- and<BR>long-term.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">As always, we thank you for your consideration of the Tekla Funds. Please call us if you have any questions.</font></p>
<p style="margin:6pt 0pt 1pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Respectfully yours,</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" align="right" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<img src="j17244762_ba003.jpg">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> </font></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="8" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><img src="j17244762_ba004.jpg">
</p></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D.<BR>President and Portfolio Manager</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>2</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=4,FOLIO='2',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Perspective on the Biotechnology and Healthcare Sectors</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">For some time, Tekla has been positive about the long-term prospects for the healthcare/biotech sector. Over any reasonable multi-year timeframe, we are bullish. As we and others have noted, this sector continues to be a large portion of the US GDP. Healthcare spending is expected to reach 20% of the US economy within the next decade. While the sector comprises a smaller portion of the GDP of other countries, spending is considerable and expected to grow meaningfully in many developed countries. Furthermore, it is reported that overall US Medicare health spending is expected to grow at 5.8% for at least the next decade. In particular, prescription drug spending is expected to grow at 6.7% per year in this same timeframe. We think these projections make the sector attractive.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Actual and Projected Net Medicare Spending<BR>2010 &#150; 2027</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244762_ba005.jpg">
</p>
<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Long-term sector fundamentals are also attractive when we consider healthcare spending on an individual basis. As seen in the figure below and the citation above, the population of the largest countries is expected to age in the coming years. Since more is spent on healthcare as individuals get older, overall healthcare spending should grow. This suggests that, over the long-term, demand for healthcare products and services should continue to grow, likely at an attractive rate.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Population 65 to 84 and 85 Years and Over in the World's<BR>Four Largest Countries: 2012, 2030, and 2050</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244762_ba006.jpg">
</p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>3</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=5,FOLIO='3',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In the intermediate term, we see the continued creation of new and differentiated medical products that are safer and/or more efficacious than existing products and that address currently unmet medical needs in the US and non-US population. These products will be the basis for continued growth in the sector.</font></p>
<p style="margin:9pt 0pt 3pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The creation of new and novel products depends on the advancement of science in key areas, the identification and clinical testing of newly discovered drugs, and the regulatory approval of such drugs. We see evidence of these accomplishments. The following three charts present favorable trends in the publication of new NIH papers, in the number of registered clinical trials and in the approval of new drugs. For additional data and information, visit fda.gov, clintrials.gov and i2.wp.com.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>National Institute of Health (NIH) <BR>Funded Papers Per Year</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244762_ba007.jpg">
</p>
<p style="margin:6pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Number of Registered Clinical Trials</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244762_ba008.jpg">
</p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>4</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=6,FOLIO='4',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>New Molecular Entity (NME) and New Biologic License <BR>Application (BLA) Approvals by Calendar Year</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244762_ba009.jpg">
</p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">These data suggest that the pipeline of new drugs should continue to grow over time. As previously reported, an entirely new generation of public companies has been created and funded in the last several years. For example, note that Bloomberg reports that since 2014, there have been 839 IPOs and follow-on financings which raised an aggregate of $49.21 billion.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In combination with existing corporations, this new generation of well-funded companies will sponsor the new and novel products we anticipate. We continue to see encouraging technological and clinical results. As an example, we point to the coming of age of cell, gene and RNAi therapies. These technologies have been in development for many years; each of these somewhat related approaches have accomplished major milestones. For example, we have seen the approval of an antisense product (Biogen's SPINRAZA<sup>TM</sup>) which treats an otherwise lethal pediatric condition called Spinal Muscular Atrophy, the approval of two T cell based therapies (Novartis AG's KYMRIAH<sup>TM</sup> and Gilead Sciences, Inc./Kite's Yescarta) that are remarkably effective in certain hematologic cancers, and clear proof of principle by an RNAi based product (Alnylam Pharmaceuticals, Inc.'s patisiran) in the treatment of a form of amyloidosis, and finally, a positive FDA panel recommendation for Spark Therapeutic's Luxturna to treat a rare genetic form of blindness.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">These are just a few examples of the encouraging developments we are seeing. There are certainly many challenges to overcome but, in aggregate, these and other developments are an important part of our underlying optimism toward the healthcare/biotech sector.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>5</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=7,FOLIO='5',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Fund Essentials</b></font></p>
<p style="margin:18pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Objective of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, the Fund seeks to provide regular distribution of realized capital gains.</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Description of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Healthcare Investors ("HQH") is a non-diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQH. HQH primarily invests in healthcare industries and will emphasize both large established companies and smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Philosophy</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Capital Management LLC, the Investment Adviser to the Fund, believes that:</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Aging demographics and adoption of new medical products and services can provide long-term tailwinds for healthcare companies</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Late stage biotechnology product pipeline could lead to significant increases in biotechnology sales</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Robust M&amp;A activity in healthcare may create additional investment opportunities</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Overview and Characteristics</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> as of 9/30/17</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="90" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Market Price<sup>1</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>25.23</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV<sup>2</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="72" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>26.02</b></font></p></td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Premium/(Discount)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>-3.04</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>%</b></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Average 30 Day<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Volume</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="72" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>80,169</b></font></p></td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Net Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>1,057,640,494</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Ticker</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="114" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQH</b></font></p></td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV Ticker</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="0" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="114" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>XHQHX</b></font></p></td>
<td colspan="1" width="0" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Commencement of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Operations Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="114" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>4/22/87</b></font></p></td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="90" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Fiscal Year to Date<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Distributions<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">per Share</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>1.96</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>1</sup></i><i> The closing price at which the Fund's shares were traded on the exchange.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>2</sup></i><i> Per-share dollar value of the Fund, calculated by dividing the total value of all the securities in its portfolio, plus any other assets and less liabilities, by the number of Fund shares outstanding.</i></font></p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Holdings of the Fund</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Data is based on net assets)</i></font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Asset Allocation as of 9/30/17</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j17244762_ba010.jpg">
</p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Sub-Sector Allocation as of 9/30/17</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j17244762_ba011.jpg">
</p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><i>This data is subject to change on a daily basis.</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=8,FOLIO='6',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Largest Holdings by Issuer</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>(Excludes Short-Term Investments)</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>As of September 30, 2017</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Issuer &#150; </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Sector</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>% of Net<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Assets</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Celgene Corporation</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9.2</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Gilead Sciences, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">8.8</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Biogen Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">8.1</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Amgen Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6.3</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Regeneron Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5.1</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Vertex Pharmaceuticals Incorporated</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.7</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Alexion Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.6</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Incyte Corporation</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.0</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Illumina, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3.8</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>BioMarin Pharmaceutical Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3.0</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Mylan NV</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.8</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Jazz Pharmaceuticals plc</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.8</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Shire plc</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.2</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Thermo Fisher Scientific Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.1</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Neurocrine Biosciences, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.5</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Merck &amp; Co., Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.4</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Teva Pharmaceutical Industries Ltd.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.2</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Allergan plc</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.2</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Abbott Laboratories</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Health Care Equipment &amp; Supplies</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.2</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>IDEXX Laboratories, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Health Care Equipment &amp; Supplies</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.1</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Fund Performance</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQH is a closed-end fund which invests predominantly in healthcare companies. Subject to regular consideration, the Trustees of HQH have instituted a policy of making quarterly distributions to shareholders. The Fund seeks to make such distributions in the form of long-term capital gains.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund considers investments in companies of all sizes and in all healthcare subsectors, including but not limited to, biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, healthcare technology, and healthcare facilities. The Fund emphasizes innovation, investing both in public and pre-public venture companies. The Fund considers its venture investments to be a differentiating characteristic. Among the various healthcare subsectors, HQH has considered the </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=9,FOLIO='7',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">biotechnology subsector, including both pre-public and public companies, to be a key contributor to the healthcare sector. The Fund holds biotech assets, including both public and pre-public, often representing 50-60% of net assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">There is no commonly published index which matches the investment strategy of HQH. The S15HLTH consists of more than 160 companies representing most or all of the healthcare subsectors in which HQH typically invests; biotechnology often represents 15-20% of this index. By contrast, the NBI, which contains approximately 160 securities, is much more narrowly constructed. The vast majority of this index is comprised of biotechnology, pharmaceutical and life science tools companies. In recent years, biotechnology has often represented 72-82% of the NBI. Neither the S15HLTH nor NBI indices contain any material amount of pre-public company assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We present both NAV and stock returns for the Fund in comparison to several commonly published indices. One index, the SPX, is a commonly considered broad based index comprised of companies in many areas of the economy, including, but not limited to healthcare. As described above, the NBI is a healthcare index mostly focused in three healthcare sectors with a uniquely high level of biotechnology comparison. The S15HLTH contains a wider representation of healthcare subsectors, but typically contains a much lower biotechnology composition.</font></p>
<p style="margin:9pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQH generally invests in a combination of large cap growth-oriented and earlier stage innovative healthcare companies with a focus on the biotechnology sector. Generally, HQH targets biotechnology exposure below that of the NBI and targets a higher biotechnology exposure than does the S15HLTH. We note that in recent periods, biotechnology has been a significant contributor to returns (both positive and negative) associated with those indices. We believe this sector continues to have significant potential for growth in the future.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>8</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=10,FOLIO='8',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244762_ba012.jpg">
</p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i>All performance over one-year has been annualized.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i>Performance data quoted represents past performance, which is no guarantee of future results, and current performance may be lower or higher than the figures shown. The NAV total return takes into account the Fund's total annual expenses and does not reflect transaction charges. If transaction charges were reflected, NAV total return would be reduced. All distributions are assumed to be reinvested either in accordance with the dividend reinvestment plan (DRIP) for market price returns or NAV for NAV returns. The market price returns reflect the reinvestment at the closing market price on the last business day of the month.</i></font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Portfolio Highlights as of September 30, 2017</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other investments, HQH's performance benefitted in the past year by the following:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Vertex Pharmaceuticals Inc. (VRTX)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is developing small molecules for the treatment of Cystic Fibrosis. The excitement now surrounds upcoming full phase 2 datasets for their triple combinations in heterozygous CF patients, which is expected in early 2018. The company proposes that these triple combination treatments could treat up to 90% of CF patients with a disease-modifying therapy. Sales on existing products continue to be strong as additional countries gain reimbursement outside U.S. We expect this trend to continue into 2018. We also anticipate the company to start sharing more data around their non-CF franchise going into 2018.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pieris Pharmaceuticals, Inc. (PIRS).</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> A global deal with Astra-Zeneca on the company's second asset has drawn the market's attention to Pieris Pharmaceuticals and the stock has performed well. The growing immuno-oncology pipeline based on their novel modular anticalin platform has advanced to the clinic and the market has begun to give it credit.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Paratek Pharmaceuticals, Inc. (PRTK)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a development-stage antibiotics company that has outperformed this fiscal year following two successful Phase 3 trials for its lead program, omadacycline, a novel antibiotic for treating severe pneumonia and skin infections.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>9</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=11,FOLIO='9',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other examples, HQH's performance was negatively impacted by the following:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">While we view </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Teva Pharmaceuticals Industries Ltd. (TEVA)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> as a leading specialty pharmaceuticals company, the stock under-performed due to sector wide pricing pressures in the generic space, and company-specific concerns about their high margin branded products business and their debt burden. We see TEVA as having the potential to turn around, but that may prove difficult. Teva will need to make significant structural changes to their business to effect a turnaround. Furthermore, the new CEO did not come on board until November 1st.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund was underweight in </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Kite Pharma, Inc.</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>(KITE)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> a mid cap biopharmaceutical company. We have largely avoided the CAR T-cell platform companies that utilize a patient's own cells as product material except for selectively investing in particular clinical trial events. This has been due to concerns with competitive technologies that use more "off-the-shelf" products that could enter the market in the mid-term. For that reason, we did not have exposure to Kite Pharma when Gilead purchased them for a high multiple after a large run up in stock price.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">**The trademarks NASDAQ Biotechnology Index<sup>&reg;</sup>, S&amp;P Composite 1500 Healthcare Index<sup>&reg;</sup>, S&amp;P 500 Index<sup>&reg;</sup>, S&amp;P 500 Health Care Corporate Bond Index<sup>&reg;</sup> and FTSE NAREIT Health Care Property Sector Index<sup>&reg;</sup> referenced in this report are the property of their respective owners. These trademarks are not owned by or associated with the Fund or its service providers, including Tekla Capital Management LLC.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>10</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=12,FOLIO='10',FILE='17-24476-2.ba',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.ca-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONVERTIBLE PREFERRED AND WARRANTS </b><b><sup>(a) (b)</sup></b><b> -<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>2.3% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 1.1%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,266,667</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amphivena Therapeutics, Inc. Series B <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Restricted)<sup> (c)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,900,001</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,692,309</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioClin Therapeutics, Inc. Series A (Restricted)<sup> (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,750,001</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,039,811</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioClin Therapeutics, Inc. Series B (Restricted)<sup> (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">777,779</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,696,765</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">EBI Life Sciences, Inc. Series A (Restricted)<sup> (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">18,854</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,266,666</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">GenomeDx Biosciences, Inc. Series C <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Restricted)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,399,999</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">210,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trillium Therapeutics, Inc. Series II<sup> (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,081,500</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,928,134</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies <BR></i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>(Restricted) - 0.5%</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="116" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,364,723</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AlterG, Inc. Series C</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,244,948</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">114,158</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series C</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">205,167</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series D</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">632,211</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series E</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">692,715</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series F</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 12/11/19)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 6/03/20)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,695</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 8/15/24)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">951,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Series AA</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">895,848</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Junior Preferred</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">71,324</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 3/31/27)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,720,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Series B</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 10/30/17)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 11/28/17)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,750,143</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Veniti, Inc. Series A<sup> (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,250,086</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,881,048</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Veniti, Inc. Series B<sup> (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,185,060</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,031,378</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Veniti, Inc. Series C<sup> (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">763,220</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,443,314</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="373" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Life Sciences Tools &amp; Services (Restricted) - 0.5%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,669,024</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Labcyte, Inc. Series C</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,622,970</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">160,767</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Labcyte, Inc. Series D</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">221,858</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">122,220</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Labcyte, Inc. Series E</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">196,774</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,041,602</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>11</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=13,FOLIO='11',FILE='17-24476-2.ca',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals (Restricted) - 0.2%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,118,954</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Euthymics Biosciences, Inc. Series A <sup>(c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,538,235</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone Pharmaceuticals, Inc. Series C <sup>(d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,099,998</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,099,998</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE PREFERRED <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>AND WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $41,234,084)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,513,048</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>PRINCIPAL <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONVERTIBLE AND NON-CONVERTIBLE<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>NOTES - 0.1% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Convertible Notes (Restricted) </b><b><sup>(a)</sup></b><b> - 0.0%</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 0.0%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">17,751</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AlterG, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6.00%, due 9/8/18<sup> </sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">17,751</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">74,456</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5.00%, due 7/31/18 <sup>(b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">285,294</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8.00%, due 3/31/18</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">142,647</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">160,398</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="373" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 0.0%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">38,745</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Euthymics Biosciences, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8.00%, due 5/31/18 <sup>(b) (c)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,915</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Euthymics Biosciences, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1.00%, due 5/31/18 <sup>(b) (c)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE NOTES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">160,398</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Non-Convertible Notes (Restricted) </b><b><sup>(a) (b)</sup></b><b> - 0.0%</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 0.0%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">342,899</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Non-Cvt. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0.00%, due 12/31/18<sup> </sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">40,596</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Non-Cvt. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6.00%, due 04/17/18<sup> </sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL NON-CONVERTIBLE NOTES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE AND <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>NON-CONVERTIBLE NOTES<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $813,075)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">160,398</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>12</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=14,FOLIO='12',FILE='17-24476-2.ca',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>COMMON STOCKS AND WARRANTS - 93.9% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 66.2%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">28,233</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AC Immune SA <sup>(b) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">319,033</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">207,053</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Adverum Biotechnologies, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">755,743</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">348,916</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alexion Pharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">48,949,426</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">80,940</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alnylam Pharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,509,641</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">664,303</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amarin Corporation plc <sup>(b) (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,325,061</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">358,742</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amgen Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">66,887,446</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">114,764</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amicus Therapeutics, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,730,641</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">272,374</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Biogen Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">85,285,747</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">341,175</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioMarin Pharmaceutical Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">31,753,157</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">313,191</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cascadian Therapeutics, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,280,951</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">669,410</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Celgene Corporation <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">97,613,366</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">52,600</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Clovis Oncology, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,334,240</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">90,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Coherus BioSciences, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,201,500</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">371,065</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CytomX Therapeutics, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,742,251</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">279,101</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dermira, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,535,727</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">21,409</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Eiger BioPharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">235,499</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">733</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Eiger BioPharmaceuticals, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 10/10/18) <sup>(a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">320,750</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Epizyme, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,110,287</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">272,948</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Exelixis, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,613,530</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,142,842</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Gilead Sciences, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">92,593,059</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">359,901</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Incyte Corporation <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">42,014,843</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">174,191</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Innoviva, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,459,577</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">85,600</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Intercept Pharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,968,224</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">336,567</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Merus B.V. <sup>(b) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,687,586</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">280,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Myovant Sciences Ltd. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,331,600</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">208,876</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Natera, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,692,412</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">261,836</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Neurocrine Biosciences, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">16,045,310</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">113,776</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ovid Therapeutics Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">975,060</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">261,301</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ovid Therapeutics Inc. (Restricted) <sup>(a) (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,015,418</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,907,141</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,985,132</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">54,790</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc., Series A <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Warrants (expiration 6/8/21) <sup>(a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">156,699</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,394</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc., Series B <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Warrants (expiration 6/8/21) <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">91,770</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,397</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Protagonist Therapeutics, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">95,365</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">275,873</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ra Pharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,027,746</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">121,134</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Regeneron Pharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">54,161,434</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">116,450</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Sarepta Therapeutics, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,282,172</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">156,590</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Seattle Genetics, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,520,062</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">40,018</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">TESARO, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,166,324</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">350,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trillium Therapeutics Inc. <sup>(b) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,802,500</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>13</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=15,FOLIO='13',FILE='17-24476-2.ca',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - continued</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">102,919</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ultragenyx Pharmaceutical Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,481,466</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">329,549</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Vertex Pharmaceuticals Incorporated <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">50,104,630</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">699,841,635</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="373" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 3.4%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">229,600</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Abbott Laboratories</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,251,456</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,155,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alliqua BioMedical, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">421,691</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">160,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cercacor Laboratories, Inc. (Restricted) <sup>(a) (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">349,910</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">107,900</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">DexCom, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,279,008</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">77,194</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IDEXX Laboratories, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,002,895</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">52,990</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Nevro Corp. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,815,731</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">82,014</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Quotient Limited <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">404,329</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,735</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">TherOx, Inc. (Restricted) <sup>(a) (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">215</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,525,235</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="373" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Providers &amp; Services - 4.7%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">109,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Acadia Healthcare Company, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,205,840</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">120,880</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AmerisourceBergen Corporation</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,002,820</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">70,300</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cardinal Health, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,704,476</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">55,158</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Centene Corporation <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,337,640</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">66,650</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Charles River Laboratories International, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,199,533</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">62,800</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Henry Schein, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,148,972</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">222,222</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">InnovaCare Health, Inc. (Restricted) <sup>(a) (b) (g)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">484,444</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">34,977</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">UnitedHealth Group Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,850,245</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">48,076</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Universal Health Services, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,333,551</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">50,267,521</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Technology - 0.2%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">122,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Evolent Health, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,180,500</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Life Sciences Tools &amp; Services - 6.6%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">199,517</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Illumina, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">39,743,786</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">102,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">PRA Health Sciences, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,769,340</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">116,197</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Thermo Fisher Scientific Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">21,984,472</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">69,497,598</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="373" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 12.8%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,643</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Acceleron Pharma Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">135,957</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">61,992</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Allergan plc</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,705,260</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">542,153</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Auris Medical Holding AG <sup>(b) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">444,565</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">637,200</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Endo International plc <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,457,618</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">289,660</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Foamix Pharmaceuticals Ltd. <sup>(b) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,607,613</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">88,386</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Impax Laboratories, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,794,236</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">200,099</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Jazz Pharmaceuticals plc <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">29,264,479</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">230,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Merck &amp; Co., Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">14,758,915</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">941,720</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Mylan NV <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">29,541,756</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">149,585</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shire plc <sup>(f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,907,447</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>14</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=16,FOLIO='14',FILE='17-24476-2.ca',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - continued</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">574,944</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tetraphase Pharmaceuticals, Inc. <sup>(b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,932,617</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">734,158</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Teva Pharmaceutical Industries Ltd. <sup>(f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,921,181</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">135,471,644</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL COMMON STOCKS AND WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $689,282,726)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">992,784,133</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>EXCHANGE TRADED FUND - 0.9% of Net Assets</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">105,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">SPDR S&amp;P Biotech ETF</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,089,850</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL EXCHANGE TRADED FUND<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $7,403,543)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,089,850</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>SHORT-TERM INVESTMENT - 2.4% of<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>N</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>et Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><sup> </sup></b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">25,235,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Repurchase Agreement, Fixed Income Clearing <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Corp., repurchase value $25,235,000, 0.12%, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">dated 09/29/17, due 10/02/17 (collateralized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">by U.S. Treasury Notes 1.50%, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">due 08/15/26, market value $25,743,232)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">25,235,000</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL SHORT-TERM INVESTMENT<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $25,235,000)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">25,235,000</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL INVESTMENTS BEFORE <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>MILESTONE INTERESTS - 99.5%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $763,968,428)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,051,782,429</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>INTEREST</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="249" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>MILESTONE INTERESTS (Restricted) </b><b><sup>(a) (b)</sup></b><b> - 0.7% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="116" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="98" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="373" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 0.7%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,605,603</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,902,572</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">TargeGen Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">197,790</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL MILESTONE INTERESTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $11,734,486)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,705,965</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL INVESTMENTS - 100.2%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $775,702,914)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,059,488,394</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>OTHER LIABILITIES IN EXCESS <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>OF ASSETS - (0.2)%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(1,847,900</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="69" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>NET ASSETS - 100%</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,057,640,494</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>15</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=17,FOLIO='15',FILE='17-24476-2.ca',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(a)&nbsp;&nbsp;Security fair valued. See Investment Valuation and Fair Value Measurements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(b)&nbsp;&nbsp;Non-income producing security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(c)&nbsp;&nbsp;Affiliated issuers in which the Fund holds 5% or more of the voting securities (total market value of $11,645,001).</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(d)&nbsp;&nbsp;Foreign security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(e)&nbsp;&nbsp;Number of warrants to be determined at a future date.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(f)&nbsp;&nbsp;American Depository Receipt</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(g)&nbsp;&nbsp;Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>16</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=18,FOLIO='16',FILE='17-24476-2.ca',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.da-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF ASSETS AND LIABILITIES</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in unaffiliated issuers, at value <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(cost $746,488,096)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,040,137,428</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in affiliated issuers, at value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(cost $17,480,332)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,645,001</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests, at value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(cost $11,734,486)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,705,965</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investments</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,059,488,394</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cash</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,456,250</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dividends and interest receivable</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">184,618</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Prepaid expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">46,863</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other assets (see Note 1)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,226,178</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,067,402,303</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">LIABILITIES:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Payable for investments purchased</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,620,431</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued advisory fee</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">789,186</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued investor support service fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">43,279</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued shareholder reporting fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">53,967</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued trustee fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">225</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued other</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">254,721</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total liabilities</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,761,809</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Commitments and Contingencies (see Note 1)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:7pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:7pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,057,640,494</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:7pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">SOURCES OF NET ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shares of beneficial interest, par value $.01 per share, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">unlimited number of shares authorized, amount paid <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">in on 40,648,724 shares issued and outstanding</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">749,587,673</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accumulated net investment loss</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(52,500</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accumulated net realized gain on investments <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">and milestone interests</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,319,841</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net unrealized gain on investments and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">milestone interests</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">283,785,480</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:9pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total net assets (equivalent to $26.02 per <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">share based on 40,648,724 shares outstanding)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,057,640,494</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>17</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=19,FOLIO='17',FILE='17-24476-2.da',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF OPERATIONS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>YEAR ENDED SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">INVESTMENT INCOME:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dividend income (net of foreign tax of $71,382)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,514,835</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Interest and other income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">104,178</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investment income</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,619,013</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">EXPENSES:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Advisory fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,005,761</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investor support service fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">486,573</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Legal fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">235,272</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Administration fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">202,677</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholder reporting</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">192,096</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Custodian fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">159,857</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Auditing fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">100,221</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trustees' fees and expenses</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">131,971</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Transfer agent fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">56,199</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other (see Note 2)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">212,790</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,783,417</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(5,164,404</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">REALIZED AND UNREALIZED GAIN (LOSS):</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain (loss) on:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in unaffiliated issuers</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">83,909,163</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in affiliated issuers</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(2,844,521</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">81,064,642</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="371" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in unrealized appreciation (depreciation)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in unaffiliated issuers</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,758,179</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in affiliated issuers</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,457,661</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">166,473</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in unrealized appreciation (depreciation)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">45,382,313</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">126,446,955</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase in net assets resulting<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">121,282,551</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>18</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=20,FOLIO='18',FILE='17-24476-2.da',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENTS OF CHANGES IN NET ASSETS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="190" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="139" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Year ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="139" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Year ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2016</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="476" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET INCREASE (DECREASE) IN <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS RESULTING FROM <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">OPERATIONS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,164,404</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,283,079</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">81,064,642</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">50,259,045</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in net unrealized appreciation <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">45,382,313</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(99,995,160</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase (decrease) in net<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">assets resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">121,282,551</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(56,019,194</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="476" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">DISTRIBUTIONS TO SHAREHOLDERS<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">FROM:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized capital gains</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(77,681,147</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(116,918,005</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total distributions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(77,681,147</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(116,918,005</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="476" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CAPITAL SHARE TRANSACTIONS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Reinvestment of distributions<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(1,693,901 and 1,705,651 shares, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">respectively)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">40,294,549</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">43,362,911</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Fund shares repurchased (48,775 <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">and 0 shares, respectively)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(see Note 1)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(1,038,493</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">&#151;</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total capital share transactions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">39,256,056</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">43,362,911</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase (decrease) in net<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">assets</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">82,857,460</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(129,574,288</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="476" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Beginning of year</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">974,783,034</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,104,357,322</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">End of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,057,640,494</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="78" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">974,783,034</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accumulated net investment loss <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">included in net assets at end of year</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">52,500</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) <sup>(a)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="78" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,437,021</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) <sup>(a)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(a)&nbsp;&nbsp;Reflects reclassifications to the Fund's capital accounts to reflect income and gains available for distribution under income tax regulations.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>19</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=21,FOLIO='19',FILE='17-24476-2.da',USER='pvangb',CD='Nov 24 08:22 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.ea-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>FINANCIAL HIGHLIGHTS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="158" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="19" width="436" align="center" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">For the years ended September 30,</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="85" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2015</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="83" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2014</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2013</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="594" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>OPERATING PERFORMANCE FOR A <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>SHARE OUTSTANDING THROUGHOUT <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>EACH YEAR</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, beginning of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.99</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">29.61</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">29.40</font></p></td>
<td colspan="1" width="31" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.90</font></p></td>
<td colspan="1" width="29" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19.20</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss <sup>(1)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.13</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.17</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.22</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.24</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.20</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.12</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.35</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.04</font></p></td>
<td colspan="1" width="31" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7.66</font></p></td>
<td colspan="1" width="29" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7.51</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total increase (decrease) from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">investment operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.99</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.52</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.82</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7.42</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7.31</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="594" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions to shareholders from:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized capital gains</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.96</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.10</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.61</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.13</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.61</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total distributions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.96</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.10</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.61</font></p></td>
<td colspan="1" width="31" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.13</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.61</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Increase resulting from shares repurchased <sup>(1)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><sup>(2)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change due to rights offering</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="31" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.79</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(3)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Short term gain due to trading error</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><sup>(2)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, end of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">26.02</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.99</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">29.61</font></p></td>
<td colspan="1" width="31" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">29.40</font></p></td>
<td colspan="1" width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.90</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Per share market value, end of year</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">25.23</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.81</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">27.60</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">28.40</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.97</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return at market value</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">14.95</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.19</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4.94</font></p></td>
<td colspan="1" width="31" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">28.08</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">41.12</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return at net asset value</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12.95</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(5.29</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8.76</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%<sup>(4)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">27.64</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">40.18</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="594" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>RATIOS</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Expenses to average net assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.10</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.10</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.03</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.15</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.26</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Expenses to average net assets with waiver</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.00</font></p></td>
<td colspan="1" width="31" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.13</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss to average net assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.53</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.62</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.65</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.87</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.92</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="594" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>SUPPLEMENTAL DATA</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net assets at end of year (in millions)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,058</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">975</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,104</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,053</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">690</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Portfolio turnover rate</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">29.21</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">29.44</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">37.43</font></p></td>
<td colspan="1" width="31" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">28.96</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">35.41</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1)&nbsp;&nbsp;Computed using average shares outstanding.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2)&nbsp;&nbsp;Rounds to less than $0.005 per share.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3)&nbsp;&nbsp;These rights offering shares were issued at a subscription price of $25.037 which was less than the Fund's net asset value per share of $29.01 on June 27, 2014 thus creating a dilution effect on the net asset value.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(4)&nbsp;&nbsp;Total return includes payment by the Adviser. Excluding this payment, total return would have been 8.68% at net asset value.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>20</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=22,FOLIO='20',FILE='17-24476-2.ea',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.fa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(1)&nbsp;&nbsp;Organization and Significant Accounting Policies</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Healthcare Investors (the Fund) is a Massachusetts business trust formed on October 31, 1986 and registered under the Investment Company Act of 1940 as a non-diversified closed-end management investment company. The Fund commenced operations on April 22, 1987. The Fund's investment objective is long-term capital appreciation through investment in U.S. and foreign companies in the healthcare industry. The Fund invests primarily in securities of public and private companies that are believed by the Fund's Investment Adviser, Tekla Capital Management LLC (the Adviser), to have significant potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of U.S. issuers that are traded primarily in foreign markets.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The preparation of these financial statements requires the use of certain estimates by management in determining the Fund's assets, liabilities, revenues and expenses. Actual results could differ from these estimates and such differences could be material. The following is a summary of significant accounting policies followed by the Fund, which are in conformity with accounting principles generally accepted in the United States of America (GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board Accounting Standards Codification 946. Events or transactions occurring after September 30, 2017, through the date that the financial statements were issued, have been evaluated in the preparation of these financial statements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Investment Valuation</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Shares of publicly traded companies listed on national securities exchanges or trading in the over-the-counter market are typically valued at the last sale price, as of the close of trading, generally 4 p.m., Eastern time. The Board of Trustees of the Fund (the Trustees) has established and approved fair valuation policies and procedures with respect to securities for which quoted prices may not be available or which do not reflect fair value. Convertible bonds, corporate and government bonds are valued using a third-party pricing service. Convertible bonds are valued using this pricing service only on days when there is no sale reported. Restricted securities of companies that are publicly traded are typically valued based on the closing market quote on the valuation date adjusted for the impact of the restriction as determined in good faith by the Adviser also using fair valuation policies and procedures approved by the Trustees described below. Non-exchange traded warrants of publicly traded companies are generally valued using the Black-Scholes model, which incorporates both observable and unobservable inputs. Short-term investments with a maturity of 60 days or less are generally valued at amortized cost, which approximates fair value.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Convertible preferred shares, warrants or convertible note interests in private companies, milestone interests, and other restricted securities, as well as shares of publicly traded companies for which market quotations are not readily available, such as stocks for which trading has been halted or for which there are no current day sales, or which do not reflect fair value, are typically valued in good faith, based upon the recommendations made by the Adviser pursuant to fair valuation policies and procedures approved by the Trustees.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Adviser has a Valuation Sub-Committee comprised of senior management which reports to the Valuation Committee of the Board at least quarterly. Each fair value determination is based on a consideration of relevant factors, including both observable and unobservable inputs. Observable and unobservable inputs the Adviser considers may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>21</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=23,FOLIO='21',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">the company, which may include an analysis of the company's financial statements, the company's products or intended markets or the company's technologies; (iii) the price of the same or similar security negotiated at arm's length in an issuer's completed subsequent round of financing; (iv) the price and extent of public trading in similar securities of the issuer or of comparable companies; or (v) a probability and time value adjusted analysis of contractual terms. Where available and appropriate, multiple valuation methodologies are applied to confirm fair value. Significant unobservable inputs identified by the Adviser are often used in the fair value determination. A significant change in any of these inputs may result in a significant change in the fair value measurement. Due to the uncertainty inherent in the valuation process, such estimates of fair value may differ significantly from the values that would have been used had a ready market for the investments existed, and differences could be material. Additionally, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the valuations used at the date of these financial statements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Milestone Interests</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund holds financial instruments which reflects the current value of future milestone payments the Fund may receive as a result of contractual obligations from other parties. The value of such payments are adjusted to reflect the estimated risk based on the relative uncertainty of both the timing and the achievement of individual milestones. A risk to the Fund is that the milestones will not be achieved and no payment will be received by the Fund. The milestone interests were received as part of the proceeds from the sale of three private companies. Any payments received are treated as a reduction of the cost basis of the milestone interest with payments received in excess of the cost basis treated as a realized gain. The contractual obligations with respect to the Afferent Milestone Interest, Neurovance Milestone Interest and the TargeGen Milestone Interest provide for payments at various stages of the development of Afferent's, Neurovance's and TargeGen's principal product candidate as of the date of the sale.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a summary of the impact of the milestone interests on the financial statements as of and for the year ended September 30, 2017:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="272" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, Milestone interests, at value</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">7,705,965</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="272" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, Net unrealized loss on <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">milestone interests</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4,028,521</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="272" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Operations, Change in unrealized appreciation (depreciation)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">on milestone interests</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">166,473</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Other Assets</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Other assets in the Statement of Assets and Liabilities consists of amounts due to the Fund at various times in the future in connection with the sale of investments in four private companies.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Investment Transactions and Income</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Investment transactions are recorded on a trade date basis. Gains and losses from sales of investments are recorded using the "identified cost" method. Interest income is recorded on the accrual basis, adjusted for amortization of premiums and accretion of discounts. Dividend income is recorded on the ex-dividend date, less any foreign taxes withheld. Upon notification from issuers, some of the dividend income received may be redesignated as a reduction of cost of the related investment if it represents a return of capital.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>22</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=24,FOLIO='22',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The aggregate cost of purchases and proceeds from sales of investment securities (other than short-term investments) for the year ended September 30, 2017 totaled $277,098,801 and $318,456,650, respectively.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Repurchase Agreements</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">In managing short-term investments the Fund may from time to time enter into transactions in repurchase agreements. In a repurchase agreement, the Fund's custodian takes possession of the underlying collateral securities from the counterparty, the market value of which is at least equal to the principal, including accrued interest, of the repurchase transaction at all times. In the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral by the Fund may be delayed. The Fund may enter into repurchase transactions with any broker, dealer, registered clearing agency or bank. Repurchase agreement transactions are not counted for purposes of the limitations imposed on the Fund's investment in debt securities.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Distribution Policy</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Pursuant to a Securities and Exchange Commission exemptive order, the Fund may make periodic distributions that include capital gains as frequently as 12 times in any one taxable year in respect of its common shares, and the Fund has implemented a managed distribution policy (the Policy) providing for quarterly distributions at a rate set by the Board of Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Fund intends to use net realized capital gains when making quarterly distributions, if available, but the Policy would result in a return of capital to shareholders if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. If taxable income and net long-term realized gains exceed the amount required to be distributed under the Policy, the Fund will at a minimum make distributions necessary to comply with the requirements of the Internal Revenue Code. The Policy has been established by the Trustees and may be changed by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distribution considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's policy is to declare quarterly distributions in stock. The distributions are automatically paid in newly-issued full shares of the Fund unless otherwise instructed by the shareholder. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts of the Fund's transfer agent who will have whole and fractional shares added to their accounts. The Fund's transfer agent delivers an election card and instructions to each registered shareholder in connection with each distribution. The number of shares issued will be determined by dividing the dollar amount of the distribution by the lower of net asset value or market price on the pricing date. If a shareholder elects to receive a distribution in cash, rather than in shares, the shareholder's relative ownership in the Fund will be reduced. The shares reinvested will be valued at the lower of the net asset value or market price on the pricing date. Distributions in stock will not relieve shareholders of any federal, state or local income taxes that may be payable on such distributions. Additional distributions, if any, made to satisfy requirements of the Internal Revenue Code may be paid in stock, as described above, or in cash.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>23</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=25,FOLIO='23',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Share Repurchase Program</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">In March 2017, the Trustees approved the renewal of the repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July 14, 2018. Prior to this renewal, in March 2016, the Trustees approved the renewal of the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one year period ending July 10, 2017. The share repurchase program is intended to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the Fund's net asset value.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">During the year ended September 30, 2017 the Fund repurchased 48,775 shares at a total cost of $1,038,493. The weighted average discount per share between the cost of repurchase and net asset value applicable to such shares at the date of repurchase was 7.56%. During the year ended September 30, 2016, the Fund did not repurchase any shares through the repurchase program.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Federal Taxes</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">It is the Fund's policy to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute to its shareholders substantially all of its taxable income and its net realized capital gains, if any. Therefore, no Federal income or excise tax provision is required.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">As of September 30, 2017, the Fund had no uncertain tax positions that would require financial statement recognition or disclosure. The Fund's federal tax returns are subject to examination by the Internal Revenue Service for a period of three years.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Distributions</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund records all distributions to shareholders on the ex-dividend date. Such distributions are determined in conformity with income tax regulations, which may differ from GAAP. These differences include temporary and permanent differences from losses on wash sale transactions, installment sale adjustments and ordinary loss netting to reduce short term capital gains. Reclassifications are made to the Fund's capital accounts to reflect income and gains available for distribution under income tax regulations. At September 30, 2017, the Fund reclassified $7,374,029 from accumulated net realized gain on investment and $9,548,925 to undistributed net investment income to paid in capital, with a net impact of $2,174,896, to adjust for current period book/tax differences.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The tax basis components of distributable earnings and the tax cost as of September 30, 2017 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="162" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of investments for tax purposes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">771,497,965</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="162" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gross tax unrealized appreciation</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">390,061,277</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="162" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gross tax unrealized depreciation</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">102,070,848</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="162" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net tax unrealized depreciation on investments</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">287,990,429</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="162" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Undistributed long-term capital gains</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20,062,392</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>24</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=26,FOLIO='24',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has designated the distributions for its taxable years ended September 30, 2017 and 2016 as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="88" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions paid from:</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="84" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="88" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Long-term capital gain</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">77,681,147</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">116,918,005</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Commitments and Contingencies</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Under the Fund's organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund's maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>&nbsp;&nbsp;Investor Support Services</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has retained Destra Capital Investment LLC (Destra) to provide investor support services in connection with the ongoing operation of the Fund. The Fund pays Destra a fee in an annual amount equal to 0.05% of the average aggregate daily value of the Fund's Managed Assets from January 1, 2017 through the remaining term of the investor support services agreement.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(2)&nbsp;&nbsp;Investment Advisory and Other Affiliated Fees</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has entered into an Investment Advisory Agreement (the Advisory Agreement) with the Adviser. Pursuant to the terms of the Advisory Agreement, the Fund pays the Adviser a monthly fee at the rate when annualized of (i) 2.50% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for all other net assets, 0.98% of the average net assets up to $250 million, 0.88% of the average net assets for the next $250 million, 0.80% of the average net assets for the next $500 million and 0.70% of the average net assets thereafter. The aggregate fee would not exceed a rate when annualized of 1.36%.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has entered into a Services Agreement (the Agreement) with the Adviser. Pursuant to the terms of the Agreement, the Fund reimburses the Adviser for certain services related to a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the year ended September 30, 2017, these payments amounted to $86,846 and are included in the Other category of expenses in the Statement of Operations, together with insurance and other expenses incurred to unaffiliated entities. Expenses incurred pursuant to the Agreement as well as certain expenses paid for by the Adviser are allocated to the Fund in an equitable fashion as approved by the Trustees of the Fund who are also officers of the Adviser.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund pays compensation to Independent Trustees in the form of a retainer, attendance fees, and additional compensation to Board and Committee chairpersons. The Fund does not pay compensation directly to Trustees or officers of the Fund who are also officers of the Adviser.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>25</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=27,FOLIO='25',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(3)&nbsp;&nbsp;Other Transactions with Affiliates</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">An affiliate company is a company in which the Fund holds 5% or more of the voting securities. Transactions involving such companies during the year ended September 30, 2017 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated Companies</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="99" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Begining<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="81" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Purchases at<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from Sales</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net Realized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gain/(Loss)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">on sale of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Comapnies</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="99" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Unrealized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Appreciation/<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Depreciation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ending Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Amphivena <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Therapeutics, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">*</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,900,001</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="97" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="97" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,900,001</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">BioClin <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Therapeutics, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,009,616</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">*</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,518,656</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="97" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">492</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,527,780</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">EBI Life Sciences, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">18,854</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="97" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="97" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">18,854</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Euthymics <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biosciences, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,119</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">54,114</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="97" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(58,233</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Insightra Medical, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20,071</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">26,794</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,900,026</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,906,749</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">**</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,260,018</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">828,984</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(16,453,054</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,926,377</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">437,675</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="20" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">**</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Palyon Medical <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(4,870,872</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,870,872</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">**</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Veniti, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,885,704</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,913</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(4,698,251</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,198,366</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">14,198,382</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,312,668</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16,479,848</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,844,521</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,458,320</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11,645,001</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">* Not an affiliate at September 30, 2016.</font></p>
<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">** Not an affiliate at September 30, 2017.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated Companies</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="77" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Shares as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Dividend<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Income<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Companies</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Capital Gain<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from Affiliated<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Companies</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Amphivena <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Therapeutics, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,266,667</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="78" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">BioClin Therapeutics, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,732,120</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="78" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">EBI Life Sciences, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,696,765</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="78" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Euthymics Biosciences, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,118,954</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="78" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Insightra Medical, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16,560</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="87" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Palyon Medical Corporation</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Veniti, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,662,569</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="87" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21,477,075</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16,560</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(4)&nbsp;&nbsp;Fair Value Measurements</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund uses a three-tier hierarchy to prioritize the assumptions, referred to as inputs, used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels. Level 1 includes quoted prices in active markets for identical </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>26</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=28,FOLIO='26',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">investments. Level 2 includes prices determined using other significant observable inputs (including quoted prices for similar investments, interest rates, credit risk, etc.). The independent pricing vendor may value bank loans and debt securities at an evaluated bid price by employing methodologies that utilize actual market transactions, broker-supplied valuations, and/or other methodologies designed to identify the market value for such securities and such securities are considered Level 2 in the fair value hierarchy. Level 3 includes prices determined using significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). These inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For the year ended September 30, 2017, there was a transfer between Level 3 and 2 and no other transfers between Levels. The amount of transfers between Level 3 and Level 2 was $5,273,598. The investment was transferred from Level 3 to Level 2 due to an initial public offering. The Fund accounts for transfers between levels at the beginning of the period.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a summary of the levels used as of September 30, 2017 to value the Fund's net assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Assets at Value</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="84" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 1</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 2</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="480" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,081,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="80" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,846,634</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11,928,134</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,443,314</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,443,314</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences Tools &amp; Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="80" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,041,602</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,041,602</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,099,998</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,099,998</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="480" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible and Non-Convertible Notes</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">160,398</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">160,398</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="80" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="480" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">697,577,748</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,015,418</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">248,469</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">699,841,635</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">35,175,110</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">350,125</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">35,525,235</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Providers &amp; Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">49,783,077</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">484,444</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">50,267,521</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Technology</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,180,500</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,180,500</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences Tools &amp; Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">69,497,598</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">69,497,598</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">135,471,644</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">135,471,644</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Exchange Traded Fund</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,089,850</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,089,850</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Short-term Investment</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">25,235,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">25,235,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="480" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,705,965</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,705,965</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,226,178</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,226,178</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">999,857,027</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">27,250,418</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">33,607,127</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,060,714,572</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>27</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=29,FOLIO='27',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3 Assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="89" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="104" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">gain (loss) and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">change in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">unrealized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="81" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">purchases<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from sales<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">transfers<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(out of)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="103" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="687" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and Warrants</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,428,469</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,889</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,420,054</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,846,634</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16,436,992</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(11,399,651</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">406,414</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">441</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,443,314</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences Tools &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Services</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,896,989</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(192,447</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">107,506</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1,770,446</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,041,602</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,730,001</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,138,181</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,112,530</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(16,880,714</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,099,998</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="687" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Non-Convertible Notes</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(184,002</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">377,766</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(33,366</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">160,398</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">807,734</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,566,970</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">59,096</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2,433,800</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="687" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30,134</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">217,574</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,274,359</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,273,598</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">248,469</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">263,608</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">86,517</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">350,125</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Providers &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Services</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">190,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">294,444</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">484,444</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="687" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interests</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,620,804</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">166,473</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,918,688</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,705,965</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">776,205</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">843,687</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(393,714</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,226,178</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">41,180,936</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="62" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,307,830</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20,520,100</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21,512,481</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,273,598</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">33,607,127</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="576" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net change in unrealized appreciation (depreciation) from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">investments still held as of September 30, 2017</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11,293,492</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a quantitative disclosure about significant unobservable inputs used in the determination of the fair value of Level 3 assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="112" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="107" align="center" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Fair Value at<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="180" align="center" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Valuation Technique</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="179" align="center" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Unobservable Input</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="190" align="center" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Range<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(Weighted Average)</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="112" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Private Companies and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Restricted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Securities</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="26" bgcolor="#cceeff" align="right" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">598,379<BR></font></td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="top" style="padding:0pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Income approach,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Black-Scholes</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="179" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount for lack <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">of marketability</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20% (20%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="112" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="26" valign="top" style="padding:3pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" align="right" valign="top" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16,430,446<BR></font></td>
<td colspan="1" width="14" valign="top" style="padding:3pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="180" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability-weighed<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">expected return model</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="179" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount rate<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Price to sales multiple</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15.39%-60.56% (23.82%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 1.31x-10.90x (3.96x)</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="112" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,359,505<BR></font></td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market approach, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">recent transaction</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="179" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="112" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="26" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">484,444<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font></td>
<td colspan="1" width="14" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="180" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market comparable<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="179" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount for lack <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">of marketability<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Price to earnings<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">multiple</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">50%<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.00x<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="112" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,734,353<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="179" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10%-98% (61.66%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 0.25-7.50 (2.33) years</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="112" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="26" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">33,607,127</font></p></td>
<td colspan="1" width="14" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="180" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="179" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="190" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>28</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=30,FOLIO='28',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)&nbsp;&nbsp;The valuation technique used as a basis to approximate fair value of these investments is based upon subsequent financing rounds. There is no quantitative information to provide as these methods of measure are investment specific.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(5)&nbsp;&nbsp;Private Companies and Other Restricted Securities</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund may invest in private companies and other restricted securities if these securities would currently comprise 40% or less of net assets. The value of these securities represented 3% of the Fund's net assets at September 30, 2017.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">At September 30, 2017, the Fund had a commitment of $2,099,998 relating to additional investments in one private company.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's private companies and other restricted securities at September 30, 2017. The Fund on its own does not have the right to demand that such securities be registered.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Security (#)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Acquisition<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Carrying Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/27/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,621,781</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,605,603.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,605,603</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">AlterG, Inc. </font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4/12/13</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,053,934</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.37</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,244,948</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9/8/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17,751</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">100.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17,751</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Amphivena Therapeutics, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/17/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,900,001</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.50</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,900,001</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">BioClin Therapeutics, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1/19/16, 10/24/16</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,751,154</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.65</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,750,001</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/3/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">777,779</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.75</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">777,779</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">CardioKinetix, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5/22/08</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,379,300</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series D Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/10/10</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">785,862</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series E Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9/14/11</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,804,729</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series F Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/04/14</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,367,910</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6/20/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">74,456</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 12/11/19)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/10/09, 2/11/10</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">177</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 6/03/20)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6/03/10, 9/01/10</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">177</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 8/15/24)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8/15/14</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">196</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cercacor Laboratories, Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/31/98</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.19</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">349,910</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">EBI Life Sciences, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/29/11&dagger;</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19,566</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.01</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">18,854</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Euthymics Biosciences, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/14/10 - 5/21/12</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,795,063</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/17/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12,915</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5/22/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">38,768</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">GenomeDx Biosciences, Inc. Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2/22/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,403,860</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.50</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,399,999</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">IlluminOss Medical, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series AA Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1/21/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">956,841</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Junior Preferred Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1/21/16</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,463,505</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/28/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">285,386</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">50.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">142,647</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 3/31/27)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/28/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">46</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">InnovaCare Health, Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/21/12&dagger;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">965,291</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.18</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">484,444</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>29</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=31,FOLIO='29',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Security (#)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Acquisition<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Carrying Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Labcyte, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/18/05</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,927,151</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.26</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,622,970</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series D Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/21/12</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">102,965</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.38</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">221,858</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series E Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/27/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">106,240</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.61</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">196,774</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Pharmaceuticals, Inc. Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/17/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,099,998</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.37</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,099,998</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/20/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,913,269</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,902,572.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,902,572</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ovid Therapeutics Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8/7/15</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,501,977</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7.71</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,015,418</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">TargeGen Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/20/10</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,199,436</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">197,790.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">197,790</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">TherOx, Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9/11/00, 7/8/05</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,582,705</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.02</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">215</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Tibion Corporation</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2/23/11</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,302,544</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Non-Cvt. Promissory Note</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/12/12</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">343,202</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Non-Cvt. Promissory Note</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4/12/13</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">40,597</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 10/30/17)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10/30/12</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 11/28/17)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11/28/12</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="504" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Veniti, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2/28/11</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,276,497</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.60</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,250,086</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5/24/13</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,726,666</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.63</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,185,060</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/12/14</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,181,924</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.74</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">763,220</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="164" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">60,781,619</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="88" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">34,147,898</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;(#)&nbsp;&nbsp;See Schedule of Investments and corresponding footnotes for more information on each issuer.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;&dagger;&nbsp;&nbsp;Interest received as part of a corporate action for a previously owned security.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>30</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=32,FOLIO='30',FILE='17-24476-2.fa',USER='pvangb',CD='Nov 24 11:23 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.ga-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>To the Board of Trustees and Shareholders of Tekla Healthcare Investors:</i></font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We have audited the accompanying statement of assets and liabilities of Tekla Healthcare Investors (the "Fund"), including the schedule of investments, as of September 30, 2017, the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended. These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of September 30, 2017, by correspondence with the custodian and brokers; where replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In our opinion, such financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of Tekla Healthcare Investors as of September 30, 2017, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">DELOITTE &amp; TOUCHE LLP<BR>Boston, Massachusetts<BR>November 20, 2017</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>31</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=33,FOLIO='31',FILE='17-24476-2.ga',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>TRUSTEES</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="120" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s)<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other Directorship(s) Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolios in Fund<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Complex Overseen<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b><i>Independent Trustees:</i></b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Michael W. Bonney<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">8/1958</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2011)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Executive Officer and Chairman of the Board of Trustees, Kaleido Biosciences (since 2017); Partner, Third Rock Ventures (2016); Chief Executive Officer and Director, Cubist Pharmaceuticals, Inc. (2012-2015); President, Chief Executive Officer and Director, Cubist Pharmaceuticals, Inc. (2002-2012); Director, Magenta Therapeutics (since 2016); Director, Global Blood Therapeutics (since 2016); Director, Revolution Medicine (since 2016); Director, Celgene Corporation (since 2015); Director, Whitehead Institute (since 2015); Director, Alnylam Pharmaceuticals, Inc. (since 2014); Director, Gulf of Maine Research Institute (since 2015); Director, NPS Pharmaceuticals, Inc. (2012-2015); Chairman of the Board of Trustees, Bates College (since 2010); Board member of Pharmaceutical Research and Manufacturers of America (PhRMA) (2009-2014) Trustee, Bates College (since 2002).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Rakesh K. Jain, Ph.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">12/1950</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2007)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Tumor Biology (Radiation Oncology) at Harvard Medical School (since 1991); Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotech companies (various times since 2002); Ad hoc Consultant, Gershon Lehman Group (since 2004); Director, Co-Founder, XTuit Pharmaceuticals, Inc. (since 2012).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>32</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=34,FOLIO='32',FILE='17-24476-2.ga',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>TRUSTEES</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="120" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s)<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other Directorship(s) Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolios in Fund<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Complex Overseen<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Oleg M. Pohotsky, M.B.A., J.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">3/1947</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2000)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chairman (since 2012)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Consultant and Managing Partner, Right Bank Partners (since 2002); Adviser, Board Advisers, Kaufman &amp; Co. LLC (since 2008); Director, AvangardCo Investment Holdings (since 2011); Director, The New America High Income Fund, Inc. (since 2013).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:7pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:7pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">William S. Reardon<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">6/1946</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2010)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Certified Public Accountant (until 2017); Independent Consultant (since 2002); Director, Idera Pharmaceuticals, Inc (since 2002); Director, Synta Pharmaceuticals, Inc. (2004-2016).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Uwe E. Reinhardt, Ph.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">9/1937 (deceased 11/2017)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 1988)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Professor of Economics, Princeton University (since 1968); Director, Boston Scientific Corporation (2002-2015); Director, Amerigroup, Inc. (2002-2012).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Lucinda H. Stebbins, CPA<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">11/1945</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2006)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Independent Consultant, Deutsche Bank (2004-2015); Director, Bald Peak Land Company, Inc. (2008-2014); Director, Solstice Home Care, Inc. (since 2014).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>33</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=35,FOLIO='33',FILE='17-24476-2.ga',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>TRUSTEES</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="120" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s)<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other Directorship(s) Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolios in Fund<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Complex Overseen<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b><i>Interested Trustee:</i></b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Daniel R. Omstead, Ph.D.<sup>3<BR></sup></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">7/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President (since 2001);<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2003)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President of the Fund, Tekla Life Sciences Investors (HQL) (since 2001),Tekla Healthcare Opportunities Fund (THQ) (since 2014), Tekla World Healthcare Fund (THW) (since 2015); President, Chief Executive Officer and Managing Member of Tekla Capital Management LLC (since 2002); Director: IlluminOss Medical, Inc. (since 2012); Magellan Diagnostics, Inc.(since 2006); Dynex Corporation (since 2012); Insightra Medical, Inc. (since 2015); Neurovance, Inc. (since 2015); EBI Life Sciences, Inc. (since 2015); Euthymics Biosciences, Inc. (since 2015); Veniti, Inc. (since 2015).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>1</sup>&nbsp;&nbsp;The Address for each Trustee is: Tekla Healthcare Investors Fund, 100 Federal Street, 19th Floor, Boston, Massachusetts, 02110, 617-772-8500.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>2</sup>&nbsp;&nbsp;Each Trustee currently is serving a three year term.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>3</sup>&nbsp;&nbsp;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with the Adviser.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>34</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=36,FOLIO='34',FILE='17-24476-2.ga',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>OFFICERS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="104" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="140" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1693" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s) During Past 5 Years</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="104" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Daniel R. Omstead, Ph.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">7/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="140" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President (since 2001);<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2003)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1693" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President of the Fund and HQL (since 2001), THQ (since 2014) and THW (since 2015); President, Chief Executive Officer and Managing Member of Tekla Capital Management LLC (since 2002); Director: IlluminOss Medical, Inc. (since 2012); Magellan Diagnostics, Inc. (since 2006); Dynex Corporation (since 2012); Insightra Medical, Inc. (since 2015); Neurovance, Inc. (since 2015); EBI Life Sciences, Inc. (since 2015); Euthymics Biosciences, Inc. (since 2015); Veniti, Inc. (since 2015).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="104" align="left" valign="top" style="padding:0pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Laura Woodward, CPA<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">11/1968</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="140" align="left" valign="top" style="padding:0pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Compliance Officer, Secretary<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">and Treasurer (since 2009)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1693" align="left" valign="top" style="padding:0pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Compliance Officer, Secretary and Treasurer, the Fund and HQL (since 2009), THQ (since 2014) and THW (Since 2015); Chief Compliance Officer and Vice President of Fund Administration, Tekla Capital Management LLC (Since 2009); Senior Manager, PricewaterhouseCoopers LLP (1990-2009).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>1</sup>&nbsp;&nbsp;The Address for each officer is: Tekla Healthcare Investors Fund; 100 Federal Street, 19th Floor, Boston, Massachusetts, 02110, 617-772-8500.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>2</sup>&nbsp;&nbsp;Each officer serves in such capacity for an indefinite period of time at the pleasure of the Trustees.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">The Fund's Statement of Additional Information includes additional information about the Fund's Trustees and is available without charge, upon request by calling (617) 772-8500 or writing to Tekla Capital Management LLC at 100 Federal Street, 19th Floor, Boston, MA 02110.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>35</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=37,FOLIO='35',FILE='17-24476-2.ga',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>ANNUAL MEETING REPORT: </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">An Annual Meeting of Shareholders was held on June 15, 2017. Shareholders voted to elect Trustees of the Fund to hold office for a term of three years or until their respective successors shall have been duly elected and qualified. The following votes were cast with respect to each of the nominees:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="102" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="64" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Withheld</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Rakesh K. Jain. Ph. D.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">34,569,567</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">1,036,327</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="102" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Lucinda H. Stebbins, CPA</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">34,619,434</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">986,460</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Rakesh K. Jain, Ph.D., and Lucinda H. Stebbins, CPA were elected to serve until the 2020 Annual Meeting.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustees serving until the 2018 Annual Meeting are Daniel R. Omstead, Ph.D. and Uwe E. Reinhardt, Ph. D.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustees serving until the 2019 Annual Meeting are Michael W. Bonney, Oleg Pohotsky, MBA, J.D. and William S. Reardon.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Shareholders ratified the appointment of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2017 by the following votes:</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" width="35" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="58" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Against</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="58" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Abstain</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">34,858,572</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="42" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">402,314</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="42" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">345,008</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>FOR MORE INFORMATION:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> A description of the Fund's proxy voting policies and procedures and information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request by calling 1-800-451-2597; (ii) by writing to Tekla Capital Management LLC at 100 Federal Street, 19th Floor, Boston, MA 02110; (iii) on the Fund's website at www.teklacap.com; and (iv) on the SEC's website at http://www.sec.gov.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's complete Schedule of Investments for the first and third quarters of its fiscal year will be filed quarterly with the SEC on Form N-Q. This Schedule of Investments will also be available on the Fund's website at www.teklacap.com, or the SEC's website at http://www.sec.gov. The Fund's Form N-Q may be reviewed and copied at the SEC's Public Reference Room in Washington, DC or by calling 1-800-SEC-0330.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">You can find information regarding the Fund at the Fund's website, www.teklacap.com. The Fund regularly posts information to its website, including information regarding daily share pricing and distributions and press releases, and maintains links to the Fund's SEC filings. The Fund currently publishes and distributes quarterly fact cards, including performance, portfolio holdings and sector information for each fiscal quarter. These fact cards will be available on the Fund's website and by request from the Fund's marketing and investor support services agent, Destra Capital Investments, at 1-877-855-3434.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>36</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=38,FOLIO='36',FILE='17-24476-2.ga',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>FEDERAL TAX INFORMATION (unaudited):</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Certain information for the Fund is required to be provided to shareholders based on the Fund's income and distributions for the taxable year ended December 31, 2017. In February 2018, shareholders will receive Form 1099-DIV, which will include their share of qualified dividends and capital gains and return of capital distributed during the calendar year 2017. Shareholders are advised to check with their tax advisors for information on the treatment of these amounts on their individual tax returns.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For corporate shareholders, 0.00% of ordinary income dividends paid by the Fund qualified for the dividends received deduction during the period July 31, 2017 to September 30, 2017.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Under Section 854(b)(2) of the Code, the Fund designated $5,586,217 as qualified dividends for the year ended September 30, 2017.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>DISTRIBUTION POLICY:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund has a fixed distribution policy as described in the Notes to Financial Statements. For more information contact your financial adviser.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>SHARE REPURCHASE PROGRAM:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> In March 2017, the Trustees approved the renewal of the repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July 14, 2018.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>PORTFOLIO MANAGEMENT:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Daniel R. Omstead, Ph.D., Jason C. Akus, M.D./M.B.A., Timothy Gasperoni, M.B.A, Ph.D., Christian M. Richard, M.B.A, M.S., Henry Skinner, Ph.D., Christopher Abbott, Robert Benson, CFA, CAIA, Amanda Birdsey-Benson, Ph.D. and Alan Kwan, M.B.A, Ph.D. are members of a team that analyzes investments on behalf of the Fund. Dr. Omstead exercises ultimate decision making authority with respect to investments.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>37</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=39,FOLIO='37',FILE='17-24476-2.ga',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24476-2.za-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:16pt;"><b>TEKLA HEALTHCARE INVESTORS</b></font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">New York Stock Exchange Symbol: HQH<BR>NAV Symbol: XHQHX</font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">100 Federal Street, 19th Floor<BR>Boston, Massachusetts 02110<BR>(617) 772-8500<BR>www.teklacap.com</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Officers</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D., President<BR>Laura Woodward, CPA, Chief Compliance Officer,<BR>Secretary and Treasurer</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Trustees</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Michael W. Bonney<BR>Rakesh K. Jain, Ph.D.<BR>Daniel R. Omstead, Ph.D.<BR>Oleg M. Pohotsky, M.B.A., J.D.<BR>William S. Reardon<BR>Uwe E. Reinhardt, Ph.D.<BR>Lucinda H. Stebbins, CPA</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Adviser</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tekla Capital Management LLC</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Administrator &amp; Custodian</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">State Street Bank and Trust Company</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Transfer Agent</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Computershare, Inc.</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Legal Counsel</b></font></p>
<p style="margin:0pt 0pt 11pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dechert LLP</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders with questions regarding share transfers may call</font></p>
<p style="margin:0pt 0pt 7pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>1-800-426-5523</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daily net asset value may be obtained from<BR>our website (</font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>www.teklacap.com</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) or by calling</font></p>
<p style="margin:0pt 0pt 7pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>617-772-8500</b></font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=40,FOLIO='',FILE='17-24476-2.za',USER='bjonesc',CD='Nov 23 01:44 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 2.&#160; CODE OF ETHICS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">As of the end of the period covered by this report, the Registrant has adopted a code of ethics that applies to the Registrant&#146;s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the Registrant or a third party.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No disclosures are required by this Item.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">During the period covered by this report, the Registrant did not make any substantive amendment to the code of ethics.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">During the period covered by this report, the Registrant did not grant any waiver, including any implicit waiver, from any provision of the code of ethics.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Not applicable.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">A copy of the Registrant&#146;s code is filed as Exhibit&nbsp;1 to this Form&nbsp;N-CSR.&#160; Copies of the Code will also be made available, free of charge, upon request, by writing or calling Tekla Capital Management LLC at 100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font><font size="2" style="font-size:10.0pt;">&#160;Floor, Boston, MA&#160; 02110, 617-772-8500.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant&#146;s Board of Trustees has determined that the Registrant has at least one audit committee financial expert serving on its audit committee.&#160; The audit committee financial expert is Oleg M. Pohotsky.&#160; He is &#147;independent&#148; for the purposes of Item 3.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.</font></b></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Audit Fees.&#160; The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for the audit of the Registrant&#146;s annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years were $111,240 for the fiscal year ended September&nbsp;30, 2017 and $108,000 for the fiscal year ended September&nbsp;30, 2016.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Audit Related Fees.&#160; The Registrant was not billed any fees in each of the last two fiscal years ended September&nbsp;30 for assurance and related services by the principal accountant that are reasonably related to the performance of the audit of the Registrant&#146;s financial statements and not otherwise included above.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Tax Fees.&#160; The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning were $5,500 for the fiscal year ended September&nbsp;30, 2017 and $4,650 for the fiscal year ended September&nbsp;30, 2016.&#160; The nature of the services comprising the fees disclosed under this category was tax compliance.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">All Other Fees.&#160; The aggregate fees billed in each of the last two fiscal years ended September&nbsp;30 for products and services provided by the principal accountant, other than the services reported in paragraphs (a)&nbsp;through (c)&nbsp;of this Item were $0 for the fiscal year ended September 30, 2017 and $0 for the fiscal year ended September 30, 2016.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">(1)&nbsp; Pre-approval Policies and Procedures.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the Registrant&#146;s Audit Committee Charter (&#147;Charter&#148;), the Audit Committee is responsible for approving in advance the firm to be employed as the Registrant&#146;s independent auditor.&#160; In addition, the Charter provides</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">that the Audit Committee is responsible for approving any and all proposals by the Registrant, its investment adviser or their affiliated persons or any entity controlling, controlled by, or under common control with the adviser that provides services to the Registrant to employ the independent auditor to render permissible non-audit services related directly to the operations and financial reporting of the Registrant.&#160; In determining whether to pre-approve non-audit services, the Audit Committee considers whether such services are consistent with the independent auditor&#146;s independence.&#160; The Charter further permits the Audit Committee to delegate to one or more of its members authority to pre-approve permissible non-audit services to the registrant, provided that any pre-approval determination of a delegate is for services with an estimated budget of less than $15,000.</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)&#160;&#160; None of the services described in each of paragraphs (b)&nbsp;through (d)&nbsp;of this Item were approved by the Audit Committee pursuant to paragraph (c)(7)(i)(C)&nbsp;of Rule&nbsp;2-01 of Regulation S-X.All services described in paragraphs (b) through (d) of the NCSR were approved in advance by the Audit Committee of each Fund.</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Not applicable.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">None.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Not applicable.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 5.&#160; AUDIT COMMITTEE OF LISTED REGISTRANTS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant has a separately-designated standing Audit Committee established in accordance with Section&nbsp;3(a)(58)(A)&nbsp;of the Exchange Act (15 U.S.C. 78c(a)(58)(A)).&#160; The members of the Audit Committee are Oleg M. Pohotsky, Uwe E. Reinhardt (deceased 11/2017), Lucinda H. Stebbins and William S. Reardon.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 6.&#160; INVESTMENTS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant&#146;s Schedule of Investments is included as part of the Report to Shareholders filed under Item 1 of this form.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 7.&#160; DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant has adopted the following proxy voting policies and procedures.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:none;">PROXY VOTING POLICIES AND PROCEDURES</font></b></p>
<p style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Policy</font></u></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following are the policies and procedures adopted and implemented by Tekla Capital Management LLC (&#147;TCM&#148;) for voting proxies with respect to portfolio securities held by Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund (each a &#147;Fund&#148; and collectively the &#147;Funds&#148;). The policies and procedures are reasonably designed to ensure that proxies are voted in the best interest of the Funds and the Funds&#146; shareholders, in accordance with TCM&#146;s fiduciary duties and Rule&nbsp;206(4)-6 under the Investment Advisers Act of 1940 (the &#147;Investment Advisers Act&#148;). TCM considers the &#147;best interests&#148; of the Funds and their shareholders to mean their best long-term economic interests.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM shall vote proxies for the exclusive benefit, and in the best economic interest, of the Funds and their shareholders. Such exercise of voting rights shall be subject to the same standard of care as is generally applicable to TCM&#146;s performance of its duties, as set forth in the advisory agreements with the Funds. The policies and procedures contained herein are designed to be guidelines, however each vote is ultimately cast on a case-by-case basis, taking into consideration the relevant facts and circumstances at the time of the vote. Any material conflicts that may arise will be resolved in the best interests of the Funds and their shareholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A proxy committee has been designated and is responsible for administering and overseeing the proxy voting process. The committee consists of the President of TCM, TCM&#146;s Chief Compliance Officer (&#147;CCO&#148;), and the analyst responsible for oversight of the company that is the subject of the proxy.&#160; The committee considers proxy questions and determines the vote on behalf of the Funds.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Procedures</font></u></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Logistics</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM&#146;s CCO shall be responsible for maintaining the proxy log, monitoring corporate actions and confirming the timely voting of proxies. The proxy log shall contain the following information, in accordance with Form&nbsp;N-PX:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the name of the issuer;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the exchange ticker symbol, if available;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the CUSIP number, if available;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">the shareholder meeting date;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">a brief identification of the matter voted on;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">whether the matter was proposed by the issuer or a security holder;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">whether TCM cast its vote on the matter;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">how TCM cast its vote on the matter (for, against, abstain; for or withhold regarding the election of directors); and</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">whether TCM cast its vote for or against management;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM&#146;s CCO shall also record whether any conflicts of interest have been identified and, if so, what action was taken to resolve the conflict with respect to each vote cast and each abstention.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Substantive Voting Decisions</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM&#146;s substantive voting decisions turn on the particular facts and circumstances of each proxy vote. The following is a list of common proxy vote issues and TCM&#146;s standard considerations when determining how to vote such proxies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Routine Matters/Corporate Administrative Items</font></i><font size="2" style="font-size:10.0pt;">. After an initial review, TCM generally votes with management on routine matters related to the operation of the issuer that are not expected to have a significant economic impact on the issuer and/or its shareholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Potential for Major Economic Impact</font></i><font size="2" style="font-size:10.0pt;">. TCM may review and analyze on a case-by-case basis, non-routine proposals that are more likely to affect the structure and operation of the issuer and to have a greater impact on the value of the investment.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Corporate Governance</font></i><font size="2" style="font-size:10.0pt;">. TCM may review and consider corporate governance issues related to proxy matters and generally supports proposals that foster good corporate governance practices.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Special Interest Issues</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;the long-term benefit to shareholders of promoting corporate accountability and responsibility on social issues; (ii)&nbsp;management&#146;s responsibility with respect to special interest issues; (iii)&nbsp;any economic costs and restrictions on management; and (iv)&nbsp;the responsibility of TCM to vote proxies for the greatest long-term shareholder value.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Limitations on Director Tenure and Retirement</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;a reasonable retirement age for directors, <i>e.g.</i> 70 or 72; (ii)&nbsp;the introduction of new perspectives on the board; and (iii)&nbsp;the arbitrary nature of such limitations and the possibility of detracting from the board&#146;s stability and continuity.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Directors&#146; Minimum Stock Ownership</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;the benefits of additional vested interest; (ii)&nbsp;the ability of a director to serve a company well regardless of the extent of his or her share ownership; and (iii)&nbsp;the impact of limiting the number of persons qualified to be directors.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">D&amp;O Indemnification and Liability Protection</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;indemnifying directors for acts conducted in the normal course of business; (ii)&nbsp;limiting liability for monetary damages for violating the duty of care; (iii)&nbsp;expanding coverage beyond legal expenses to acts that represent more serious violations of fiduciary obligation than carelessness (<i>e.g.</i> negligence); and (iv)&nbsp;providing expanded coverage in cases when a director&#146;s legal defense was unsuccessful if the director was found to have acted in good faith and in a manner that he or she reasonably believed was in the best interests of the issuer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Director Nominations in Contested Elections</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;long-term financial performance of the issuer relative to its industry; (ii)&nbsp;management&#146;s track record; (iii)&nbsp;background to proxy contest; (iv)&nbsp;qualifications of both slates of nominees; (v)&nbsp;evaluations of what each side is offering shareholders as well as the likelihood that the proposed objectives and goals can be met; and (vi)&nbsp;stock ownership positions.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Cumulative Voting</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;the ability of significant stockholders to elect a director of their choosing; (ii)&nbsp;the ability of minority shareholders to concentrate their support in favor of a director or directors of their choosing; and (iii)&nbsp;the potential to limit the ability of directors to work for all shareholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Classified Boards</font></i><font size="2" style="font-size:10.0pt;">.&#160; TCM may consider: (i)&nbsp;providing continuity; (ii)&nbsp;promoting long-term planning; and (iii)&nbsp;guarding against unwanted takeovers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Poison Pills</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;TCM&#146;s position on supporting proposals to require a shareholder vote on other shareholder rights plans; (ii)&nbsp;ratifying or redeeming a poison pill in the interest of protecting the value of the issuer; and (iii)&nbsp;other alternatives to prevent a takeover at a price demonstrably below the true value of the issuer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Fair Price Provisions</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;the vote required to approve the proposed acquisition; (ii)&nbsp;the vote required to repeal the fair price provision; (iii)&nbsp;the mechanism for determining fair price; and (iv)&nbsp;whether these provisions are bundled with other anti-takeover measures (<i>e.g.</i>, supermajority voting requirements) that may entrench management and discourage attractive tender offers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Equal Access</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;the opportunity for significant shareholders of the issuer to evaluate and propose voting recommendations on proxy proposals and director nominees, and to nominate candidates to the board; and (ii)&nbsp;the added complexity and burden.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Charitable Contributions</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;the potential benefits to shareholders; (ii)&nbsp;the potential to detract the issuer&#146;s resources from more direct uses of increasing shareholder value; and (iii)&nbsp;the responsibility of shareholders to make individual contributions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Stock Authorizations</font></i><font size="2" style="font-size:10.0pt;">: TCM may consider: (i)&nbsp;the need for the increase; (ii)&nbsp;the percentage increase with respect to the existing authorization; (iii)&nbsp;voting rights of the stock; and (iv)&nbsp;overall capitalization structures.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Preferred Stock</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;whether the new class of preferred stock has unspecified voting, conversion, dividend distribution, and other rights; (ii)&nbsp;whether the issuer expressly states that the stock will not be used as a takeover defense or carry superior voting rights; (iii)&nbsp;whether the issuer specifies the voting, dividend, conversion, and other rights of such stock and the terms of the preferred stock appear reasonable; and (iv)&nbsp;whether the stated purpose is to raise capital or make acquisitions in the normal course of business.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Director Compensation</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;whether director shares are at the same market risk as those of the shareholders; and (ii)&nbsp;how option programs for outside directors compare with the standards of internal programs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Golden and Tin Parachutes</font></i><font size="2" style="font-size:10.0pt;">. TCM may consider: (i)&nbsp;whether they will be submitted for shareholder approval; and (ii)&nbsp;the employees covered by the plan and the quality of management.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Compensation. </font></i><font size="2" style="font-size:10.0pt;">TCM</font><font size="2" style="font-size:10.0pt;"> may consider: (i) Whether the company has an independent compensation committee; (ii) whether the compensation committee engaged independent consultants; (iii) whether the compensation committee has lapsed or waived equity vesting restrictions; and (iv) whether the company has adopted or extended a Golden Parachute without shareholder approval. </font><font size="2" style="font-size:10.0pt;">TCM</font><font size="2" style="font-size:10.0pt;"> will generally support annual advisory votes on executive compensation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Limitations</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM may abstain from voting a proxy if it concludes that the effect on shareholders&#146; economic interests or the value of the portfolio holding is indeterminable or insignificant. TCM may abstain from voting a proxy if it concludes that the cost of voting is disproportionate to the economic impact the vote would have on the portfolio holdings. With respect to certain privately held companies, TCM may not have the opportunity to vote or may have a limitation on its ability to vote. For example, in certain cases a company may be permitted by its charter or other governing documents to take action without a shareholder meeting and with written consent of fewer than all shareholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conflicts of Interest</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Proxy Committee identifies any potential conflicts of interest.&#160; Each potential conflict must be addressed in a manner which will be in the best interest of the Funds and their shareholders. If any potential conflict is identified the Proxy Committee consults with the Funds&#146; counsel.&#160; Where conflicts of interest arise between clients and TCM, TCM may convene an ad-hoc committee to debate the conflict and to give a ruling on a preferred course of action. If the ad-hoc committee determines that TCM has a conflict of interest in any instance, TCM&#146;s CCO shall disclose the conflict to the Board and seek voting instructions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM may cause the proxies to be voted in accordance with the recommendations of an independent third party service provider that TCM may use to assist in voting proxies.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Disclosure</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following disclosure shall be provided in connection with these policies and procedures:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TCM shall provide a description or a copy of these policies and procedures to the Boards of Trustees of the Funds annually and upon request.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TCM shall make available to the Funds its proxy voting records, for inclusion on the Funds&#146; Form&nbsp;N-PX.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TCM shall include its proxy voting policies and procedures in its annual filing on Form&nbsp;N-CSR.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TCM shall cause the Funds&#146; shareholder reports to include a statement that a copy of these policies and procedures is available upon request (i)&nbsp;by calling a toll-free number; (ii)&nbsp;on the Funds&#146; website, (if the Funds choose); and (iii)&nbsp;on the SEC&#146;s website.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TCM shall cause the Funds&#146; annual and semi-annual reports to include a statement that information is available regarding how the Funds voted proxies during the most recent twelve-month period (i)&nbsp;without charge, upon request, either by calling a toll-free number or on or through the Funds&#146; website, or both; and (ii)&nbsp;on the SEC&#146;s website.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recordkeeping</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM shall maintain records of proxies voted in accordance with Section&nbsp;204-2 of the Advisers Act, including proxy statements, a record of each vote cast, and a copy of any document created by the Adviser that was material to making a decision of how to vote the proxy, or that memorializes the basis for the Adviser&#146;s decision on how to vote the proxy. TCM shall also maintain a copy of its policies and procedures and each written request from a client for proxy voting records and the Adviser&#146;s written response to any client request, either written or oral, for such records. Proxy statements that are filed on EDGAR shall be considered maintained by TCM. All such records shall be maintained for a period of five years in an easily accessible place, the first two years in the offices of TCM.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 8.&#160; PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(1)&#160;&#160;&#160;&#160;&#160; As of December 5, 2017, Daniel R. Omstead, Ph.D., Jason C. Akus, M.D./M.B.A.</font><font size="2" style="font-size:10.0pt;">, Timothy Gasperoni, Ph.D, M.B.A., Christian M. Richard, M.S, M.B.A, Henry Skinner, Ph.D., Amanda Birdsey-Benson, Ph.D., Alan Kwan, Ph.D, M.B.A.,</font><font size="2" style="font-size:10.0pt;"> Christopher Abbott</font><font size="2" style="font-size:10.0pt;"> and Robert Benson, CFA</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font><font size="2" style="font-size:10.0pt;">, CAIA </font><font size="2" style="font-size:10.0pt;">are members of a team that analyzes investments on behalf of the Registrant.&#160; Dr.&nbsp;Omstead exercises ultimate decision making authority with respect to investments.&#160; Dr.&nbsp;Omstead also performs other duties including management of the investment adviser and makes investments on behalf of Tekla Life Sciences Investors (&#147;HQL&#148;), Tekla Healthcare Opportunities Fund (&#147;THQ&#148;) and Tekla World Healthcare Fund (&#147;THW&#148;).&#160; The date each team member joined the portfolio management team and each team member&#146;s business experience for at least the last five years is included below.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, Ph.D. is President and Chief Executive Officer of the investment adviser and has been employed by the investment adviser of the Registrant since 2000. He is also President of the Registrant, HQL, THQ and THW.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus, M.D./M.B.A., is Senior Vice President, Research of the investment adviser and is responsible for investment research and due diligence in the biotechnology, medical device, and diagnostic areas. Dr.&nbsp;Akus joined the investment adviser of the Registrant in 2001.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Timothy Gasperoni, Ph.D., M.B.A. is Senior Vice President, Research of TCM. He&nbsp;was previously a Senior Analyst and Founding Member of Sabby Capital and was a Partner and Senior Analyst at Crosswind Investments, LLC.&nbsp; He joined TCM in 2015.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christian M. Richard, M.S., M.B.A is Senior Vice President, Research of TCM. He&nbsp;was previously a Partner/Head of Research for Merlin Biomed Private Equity/Merlin.&nbsp;He joined TCM in 2015.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Henry Skinner, Ph.D., is Senior Vice President, Venture of TCM. He was previously Vice President and Deputy Head and Managing Director of the Novartis Venture Fund. He joined TCM in October 2017. </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amanda Birdsey-Benson, Ph.D. is Senior Analyst of TCM. She was previously an analyst for R.A. Capital Management.&nbsp; She joined TCM in 2014.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Alan Kwan, Ph.D., M.B.A.is Senior Analyst of TCM. He was previously a Principal Investigator at GlaxoSmithKline, plc. He joined TCM in 2014.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher Abbott , is Senior Analyst.&#160; Previously, Mr.&nbsp;Abbott spent 8 years at Leerink Partners where he was a Vice President on the Equity Research team covering the Healthcare IT and Healthcare Supply Chain group.&#160; He joined TCM in 2016.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert Benson, CFA</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font><font size="2" style="font-size:10.0pt;">, CAIA, is Senior Analyst, Research. Previously, Mr.&nbsp;Benson spent 12 years at State Street Global Advisors (SSgA) where he performed quantitative research for asset allocation, equities, and alternatives teams.&#160; He joined TCM in 2016.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(2)&#160;&#160;&#160;&#160;&#160; The following table lists the number and types of other accounts and assets under management in those accounts advised by the Registrant&#146;s portfolio management team as of the end of the Registrant&#146;s fiscal year.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt 10.0pt;text-align:center;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">REGISTERED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt 10.0pt;text-align:center;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">INVESTMENT</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">PORTFOLIO</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">COMPANY</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">POOLED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">OTHER</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGER</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christian M. Richard</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Timothy Gasperoni</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Henry Skinner</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amanda Birdsey-Benson</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Alan Kwan</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher Abbott</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert Benson</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.7%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,167 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None of the funds or other accounts is subject to a performance-based advisory fee.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each member of the portfolio management team may perform investment management services for other accounts similar to those provided to the Registrant and the investment action for each account may differ. The portfolio management team may discover an investment opportunity that may be suitable for more than one account. However, the investment opportunity may be limited so that all accounts may not be able to fully participate or an investment opportunity or&nbsp;investment allocation&nbsp;may be allocated to just one account or may be allocated between accounts at different levels based on an investment decision made by the investment team.&nbsp; The investment team may subsequently make investment decisions that result in&nbsp;investment levels that make the accounts&nbsp;more differentiated or, conversely, more closely&nbsp;or completely aligned.&nbsp;&nbsp;Such investment decisions may occur within a day or two.&nbsp;&nbsp;In addition, the investment adviser may receive different compensation from each account. In that case, the portfolio management team may have an incentive to direct investments to an account that could result in higher fees for the investment adviser. The registrant has adopted procedures designed to allocate investments fairly across multiple accounts.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additionally, a portfolio manager may be perceived to have a conflict of interest if he has other executive management responsibilities.&#160; In addition to managing the Registrant, HQL, THQ and THW, Dr.&nbsp;Omstead is the President of the investment adviser of the Registrant.&#160; Dr.&nbsp;Omstead periodically discusses the amount of time he allocates to each of his responsibilities with the Registrant&#146;s Board of Trustees.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The portfolio management team&#146;s management of personal accounts may also present certain conflicts of interest.&#160; The Registrant has adopted a code of ethics designed to address these potential conflicts.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(3)&#160;&#160;&#160;&#160;&#160; As of September&nbsp;30, 2017, portfolio manager compensation is comprised of a base salary and discretionary compensation as described below.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Base Salary Compensation</font></i><font size="2" style="font-size:10.0pt;">.&#160; The team members receive a base salary compensation linked to individual experience and responsibilities. The amount of base salary is reviewed annually.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:41.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Compensation</font></i><font size="2" style="font-size:10.0pt;">.&#160; Discretionary Compensation is in the form of a cash bonus, paid annually, which may be up to 60% of the team member&#146;s base salary. Several factors affect discretionary compensation, which can vary by team member and circumstances. The discretionary compensation component is determined based on factors including investment performance of accounts managed by the team predominantly relative to the S&amp;P 500 Index and a blended consideration of appropriate healthcare indicies and related performance metrics during the Fund&#146;s fiscal year, performance of specific investments proposed by the individual, financial performance of the investment adviser and a qualitative assessment of the individual overall contribution to the investment team and to the investment adviser. Discretionary compensation is evaluated annually after the completion of the Registrant&#146;s fiscal year.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(4)&#160;&#160;&#160;&#160;&#160; As of September&nbsp;30, 2017, the dollar range of Registrant&#146;s shares beneficially owned by the portfolio managers are as follows as of the end of the Registrant&#146;s fiscal year:</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="93%" style="border-collapse:collapse;">
<tr>
<td width="38%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">PORTFOLIO   MANAGER</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.52%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="56%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:56.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">DOLLAR RANGE OF SHARES   BENEFICIALLY OWNED</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="bottom" style="padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">over $1,000,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="bottom" style="padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christian M. Richard</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Timothy Gasperoni</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$10,001 &#150; $50,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Henry Skinner</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amanda Birdsey-Benson</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Alan Kwan</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher Abbott</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.58%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert Benson</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.52%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="56%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:56.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&nbsp;N/A.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 9.&#160; PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="37%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Period</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(a)&nbsp;Total&nbsp;No.<br>   of&nbsp;Shares<br>   Purchased&nbsp;(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(b)&nbsp;Average<br>   Price&nbsp;Paid&nbsp;per<br>   Share</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(c)&nbsp;Total&nbsp;No.<br>   of&nbsp;Shares<br>   Purchased&nbsp;as<br>   Part&nbsp;of<br>   Publicly<br>   Announced&nbsp;Plans<br>   or&nbsp;Programs</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(d)&nbsp;Maximum&nbsp;No.<br>   of&nbsp;Shares&nbsp;that<br>   May&nbsp;Yet&nbsp;Be<br>   Purchased&nbsp;Under<br>   the&nbsp;Plans&nbsp;or<br>   Programs</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #1 (Oct.&nbsp;1,   2016-Oct.&nbsp;31, 2016)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,680,432</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #2 (Nov.&nbsp;1,   2016 &#150; Nov.&nbsp;30, 2016)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">48,775</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">21.27</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">48,775</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #3 (Dec.&nbsp;1,   2016&#150; Dec.&nbsp;31, 2016)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #4 (Jan.&nbsp;1,   2017 &#150; Jan.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #5 (Feb.&nbsp;1,   2017 &#150; Feb.&nbsp;28, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #6 (Mar.&nbsp;1,   2017 &#150; Mar.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #7 (Apri. 1, 2017   &#150; Apri. 30, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #8 (May&nbsp;1,   2017 &#150; May&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #9 (June&nbsp;1,   2017 &#150; June&nbsp;30, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,631,657</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #10 (Jul.&nbsp;1,   2017 &#150; Jul.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,828,177</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #11 (Aug.&nbsp;1,   2017 &#150; Aug.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,828,177</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #12 (Sep.&nbsp;1,   2017 &#150; Sep.&nbsp;30, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4,828,177</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="37%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:37.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">48,775</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">21.27</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">48,775</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">On June&nbsp;30, 2011, the share repurchase program was announced, </font><font size="2" style="font-size:10.0pt;">which has been subsequently reviewed and approved by the Board of Trustees.</font><font size="2" style="font-size:10.0pt;">&nbsp;On March&nbsp;24, 2016, the Trustees approved the renewal of the share repurchase program, allowing the Registrant to repurchase up to 12% of its outstanding shares &#160;in the open market for a one year period ending July&nbsp;10, 2017. On March&nbsp;23, 2017, the Trustees approved the renewal of the share repurchase program, &#160;allowing the Registrant to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July&nbsp;14, 2018.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There have been no material changes, to the procedures by which the shareholders may recommend nominees to the Registrant&#146;s Board of Trustees, where those changes were implemented after the Registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv)&nbsp;of Regulation S-K (17 CFR229.407)(as required by Item 22(b)(15) of Schedule 14A (17 CFR240.14a-101)), or this Item.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 11. CONTROLS AND PROCEDURES.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 57.0pt;text-indent:-21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">In the opinion of the principal executive officer and principal financial officer, based on their evaluation which took place within 90 days of this filing, the Registrant&#146;s disclosure controls and procedures are adequately designed and are operating effectively to ensure (i)&nbsp;that material information relating to the Registrant, including its consolidated subsidiaries, is made known to them by others within those entities, particularly during the period in which this report is being prepared; and (ii)&nbsp;that information required to be disclosed by the registrant on Form&nbsp;N-CSR is recorded, processed, summarized and reported within the time period specified in the Securities and Exchange Commission&#146;s rules&nbsp;and forms.</font></p>
<p style="margin:0in 0in .0001pt 57.0pt;text-indent:-21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 57.0pt;text-indent:-21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">There were no changes in the Registrant&#146;s internal control over financial reporting that occurred during the Registrant&#146;s most recent fiscal half-year that have materially affected or that are reasonably likely to materially affect the Registrant&#146;s internal control over financial reporting.</font></p>
<p style="margin:0in 0in .0001pt 58.5pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 12. EXHIBITS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(1)&nbsp;The Code of Ethics that is the subject of the disclosure required by Item 2 is attached hereto (Exhibit&nbsp;1).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(2)&nbsp;Separate certifications of the Principal Executive and Financial Officers as required by Rule&nbsp;30a-2(a)&nbsp;under the 1940 Act and Section&nbsp;302 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;2 and 3).</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(3)&nbsp; Notice to Fund&#146;s shareholders in accordance with Investment Company Act Section 19(a) and Rule 19a-1(Exhibit 4).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Certifications pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;5).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108736\17-24476-1\task8659799\24476-1-ga.htm',USER='108736',CD='Dec  5 20:41 2017' -->


<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:48.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="10%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:10.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant)</font></p>    </td>
<td width="89%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:89.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TEKLA HEALTHCARE INVESTORS</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="20%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:20.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By   (Signature and Title)*</font></p>    </td>
<td width="79%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:79.16%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>    </td>   </tr>
<tr>
<td width="20%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:20.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="79%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:79.16%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, President</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="44%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;12/5/17</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="40" style="border:none;"></td>
<td width="36" style="border:none;"></td>
<td width="72" style="border:none;"></td>
<td width="205" style="border:none;"></td>
<td width="356" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:48.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="20%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:20.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By   (Signature and Title)*</font></p>    </td>
<td width="79%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:79.16%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Laura Woodward</font></p>    </td>   </tr>
<tr>
<td width="20%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:20.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="79%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:79.16%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura Woodward, Treasurer</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="44%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;12/5/17</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="39" style="border:none;"></td>
<td width="108" style="border:none;"></td>
<td width="203" style="border:none;"></td>
<td width="357" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">* Print the name and title of each signing officer under his or her signature.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105733\17-24476-1\task8658856\24476-1-jc.htm',USER='105733',CD='Dec  5 03:21 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CODEETH
<SEQUENCE>2
<FILENAME>a17-24476_1ex99dcodeeth.htm
<DESCRIPTION>EX-99.CODEETH
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit 99.CODEETH</font></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;1</font></u></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sarbanes-Oxley Code of Ethics</font></u></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Introduction</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Trustees of Tekla Life Sciences Investors, Tekla Healthcare Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund (each a &#147;Fund&#148;) has established this Code of Ethics (&#147;Code&#148;) in accordance with the Sarbanes-Oxley Act of 2002 and the rules&nbsp;promulgated thereunder. This Code does not supersede or otherwise affect the separate code of ethics that the Fund and its investment adviser have adopted pursuant to Rule&nbsp;17j-1 under the Investment Company Act of 1940, as amended (&#147;1940 Act&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Code is designed to deter wrongdoing and promote: (i)&nbsp;honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; (ii)&nbsp;full, fair, accurate, timely, and understandable disclosure in reports and documents that the Fund files with, or submits to, the Securities and Exchange Commission (&#147;SEC&#148;) and in other public communications made by the Fund; (iii)&nbsp;compliance with applicable governmental laws, rules, and regulations; (iv)&nbsp;the prompt internal reporting of violations of the Code to an appropriate person or persons; and (v)&nbsp;accountability for adherence to the Code. The Code applies to the Funds&#146; President, Treasurer, Secretary and Assistant Treasurer (collectively, &#147;Covered Officers,&#148; each of whom is set forth in Exhibit&nbsp;A).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">A.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Principles of Honest and Ethical Conduct</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1<i>. </i>General Objectives</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund expects all Covered Officers to adhere to the highest possible standards of honest and ethical conduct. All Covered Officers are expected to handle actual or apparent conflicts of interest between personal and professional relationships in a manner that is above reproach, and to place the interests of the Fund above their own personal interests.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2. Conflicts of Interest</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All Covered Officers should be scrupulous in avoiding a conflict of interest with regard to the Fund&#146;s interests. A conflict of interest occurs when an individual&#146;s private interest interferes in any way with the interests of the Fund. This includes any specific situation or transaction that the Trustees of the Fund who are not interested persons as defined in the 1940 Act, would consider to create the appearance of a conflict of interest. A conflict situation can arise when a Covered Officer takes actions or has interests that may make it difficult to perform his or her work for the Fund objectively and effectively.&#160; Conflicts of interest also arise when a Covered Officer, or a member of his or her family, receives improper benefits as a result of his or her position with the Fund, whether such benefits are received from the Fund or a third party.&#160; Any conflict of interest that arises in a specific situation or transaction must be disclosed by the Covered Officer and resolved before taking any action.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conflicts of interest may not always be evident, and Covered Officers should consult with the Funds&#146; Chief Compliance Officer or the Funds&#146; legal counsel if they are uncertain about any situation.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Examples of possible conflicts of interest include:</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">Outside Employment or Activities</font></i><font size="2" style="font-size:10.0pt;">.&#160; Covered Officers may not engage in any outside employment or activity that interferes with their performance or responsibilities to the </font></h5>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fund or is otherwise in conflict with or prejudicial to the Fund.&#160; A Covered Officer must disclose to the Funds&#146; Chief Compliance Officer any outside employment or activity that may constitute a conflict of interest and obtain the Funds&#146; Chief Compliance Officer&#146;s approval before engaging in any such employment or activity.</font></h5>
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">Gifts.</font></i><font size="2" style="font-size:10.0pt;">Covered Officers may not accept gifts or other items of more than small value, consistent with industry standards from any person or entity that does business with or on behalf of the Fund.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii)</font><i><font size="1" style="font-size:3.0pt;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></i><i><font size="2" style="font-size:10.0pt;font-style:italic;">Other Situations.</font></i><font size="2" style="font-size:10.0pt;">&#160; Because other conflicts of interest may arise, it would be impractical to attempt to list all possible situations in this Code. If a proposed transaction or situation raises questions or doubts, a Covered Officer should consult with the Funds&#146; Chief Compliance Officer before engaging in the transaction or activity.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Corporate Opportunities</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers may not exploit for their own personal gain, or for the personal gain or their family members or relatives, opportunities that are discovered through the use of Fund property, information, or position, unless the opportunity is first disclosed fully in writing to the Board of Trustees and the Board of Trustees declines to pursue such opportunity.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">B.</font></b><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Full, Fair, Accurate, Timely, and Understandable Disclosure in Fund Disclosure and Reporting Documents</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As registered investment companies, it is of critical importance that the Funds&#146; public communications, reports, and filings contain full, fair, accurate, timely, and understandable disclosure. Accordingly, Covered Officers are expected to consider it central to their roles as officers of the Funds to promote full, fair, accurate, timely, and understandable disclosure in the Funds&#146; public communications and reports, and in the documents that the Funds file with, or submits to, the Securities and Exchange Commission (the &#147;SEC&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Depending on his or her position with the Funds, a Covered Officer may be called upon to provide necessary information to make the Funds&#146; public reports, communications, and SEC filings and submissions complete, fair, and understandable. The Funds expect Covered Officers to take this responsibility very seriously and to provide prompt and accurate answers to inquiries related to the Funds&#146; public disclosure requirements. Covered Officers may be asked to certify the accuracy of all responses and information provided for inclusion in the Funds&#146; public reports, communications, and SEC filings and submissions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">C.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Compliance with Applicable Governmental Rules&nbsp;and Regulations</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As registered investment companies, the Funds are subject to regulation by the SEC and must comply with Federal securities laws and regulations, as well as other applicable laws.&#160; The Funds insist on strict compliance with the spirit and the letter of these laws and regulations. Each Covered Officer shall cooperate with Fund counsel, the Funds&#146; independent accountants, and the Funds&#146; other service providers with the goal of maintaining the Funds&#146; material compliance with applicable governmental rules&nbsp;and regulations.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds expect their Covered Officers to comply with all laws, rules, and regulations applicable to the Funds&#146; operations and business. Covered Officers should seek guidance whenever they are in doubt as to the applicability of any law, rule, or regulation, or regarding any </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">contemplated course of action. Covered Officers should also make use of the various guidelines which the Funds and their service providers have prepared on specific laws and regulations.&#160; If in doubt on a course of action, a good guideline is &#147;always ask first, act later&#148; &#151; if you are unsure of what to do in any situation, seek guidance before you act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers are encouraged to attend courses and seminars for the purpose of keeping themselves apprised of developments relating to those governmental statutes, rules, and regulations applicable to the Funds.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Upon obtaining knowledge of any material violation of any applicable law, rule, or regulation by the Funds or a person acting with or on behalf of the Fund, a Covered Officer shall report such violation to the Funds&#146; Chief Compliance Officer, Fund counsel, or both. (See Section&nbsp;VI of the Code for a discussion of reporting Code violations.) Each Covered Officer shall cooperate or take such steps as may be necessary or appropriate to remedy any such material violation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">D.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Confidentiality</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers must maintain the confidentiality of information entrusted to them by the Funds, except when disclosure is authorized by Fund counsel or required by laws or regulations. Whenever possible, Covered Officers should consult with Fund counsel if they believe they have a legal obligation to disclose confidential information. Confidential information includes all non-public information that might be of use to competitors, or harmful to the Funds or their shareholders, if disclosed. The obligation to preserve confidential information continues even after employment as a Covered Officer ends.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">E.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Prompt Internal Reporting of Violations of the Code; Evaluation of Possible Violations; Determination of Sanctions</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Reporting to the Funds&#146; Chief Compliance Officer</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Covered Officer shall promptly report knowledge of, or information concerning, any material violation of this Code to the Funds&#146; Chief Compliance Officer. Any such report shall preferably be in writing, and shall describe in reasonable detail the conduct that such Covered Officer believes to have violated this Code. The Funds&#146; Chief Compliance Officer shall also have the authority to draft a report of a suspected material violation of the Code, if no written report is made by a Covered Officer.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Evaluation of Reports</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds&#146; Chief Compliance Officer shall then consult with Fund counsel to the extent necessary to determine whether the reported conduct actually violates the Code. If it is determined that there has been a violation of the Code, the Funds&#146; Chief Compliance Officer will determine (in consultation with Fund counsel) whether the violation has had or may have, in the reasonable judgment of the Funds&#146; Chief Compliance Officer, a material adverse impact upon the Fund.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">No Material Adverse Impact on the Funds.</font></i><font size="2" style="font-size:10.0pt;">&#160; If the Funds&#146; Chief Compliance Officer determines that the violation has not caused a material adverse impact upon the Fund, the Funds&#146; Chief Compliance Officer shall determine what sanctions, if any, may be appropriate for the violation. (See G of this Code for a discussion of possible sanctions.)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">Material Adverse Impact on the Funds</font></i><font size="2" style="font-size:10.0pt;">.&#160; If the Funds&#146; Chief Compliance Officer determines that the violation has caused a material adverse impact upon the Fund, the Funds&#146; Chief Compliance Officer shall promptly notify the Board of such violation. The Board shall be entitled to consult with independent legal counsel to determine whether the violation actually has had a material adverse impact upon the Fund; to formulate sanctions, if any, appropriate for the violation; or for any other purpose that the Board, in its business judgment, determines to be necessary or advisable. (See G of this Code for a discussion of possible sanctions.)</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Periodic Reports by the Funds&#146; Chief Compliance Officer to Board of Trustees.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds&#146; Chief Compliance Officer shall report to the Board at each regularly scheduled Board meeting all violations of this Code (whether or not they caused a material adverse impact upon the Fund) and all sanctions imposed.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">F.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Waivers of Provisions of the Code</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Waivers.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Covered Officer may request a waiver of a provision of this Code if there is a reasonable likelihood that a contemplated action would be a material departure from a provision of the Code. Waivers will not be granted except under extraordinary or special circumstances.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The process of requesting a waiver shall consist of the following steps:</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Covered Officer shall set forth a request for waiver in writing and submit such request to the Funds&#146; Chief Compliance Officer. The request shall describe the conduct, activity, or transaction for which the Covered Officer seeks a waiver, and shall briefly explain the reason for engaging in the conduct, activity, or transaction.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The determination with respect to the waiver shall be made in a timely fashion by the Funds&#146; Chief Compliance Officer, in consultation with Fund counsel, and submitted to the Board for ratification.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The decision with respect to the waiver request shall be documented and kept in the Fund&#146;s records for the appropriate period mandated by applicable law or regulation.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Disclosure of Waivers.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To the extent required by applicable law, waivers (including &#147;implicit waivers&#148;) shall be publicly disclosed on a timely basis. An &#147;implicit waiver&#148; is defined as the Fund&#146;s failure to take action within a reasonable period of time regarding a material departure from a provision of the Code that has been made known to an &#147;executive officer&#148; of the Fund. For this purpose, an &#147;executive officer&#148; is a Fund&#146;s President or Chief Executive Officer, Vice President (who is in charge of a principal policymaking function), or any other person who performs similar policymaking functions for the Fund. For the purpose of determining whether an &#147;implicit waiver&#148; has occurred, if a material departure from a provision of the Code is known only by the Covered Officer who has caused the material departure, the material departure will not be considered to have been made known to an executive officer of the Fund.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">G.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Accountability for Adherence to the Code</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The matters covered in this Code are of the utmost importance to the Fund and its shareholders, and are essential to the Fund&#146;s ability to conduct its business in accordance with its stated values. Covered Officers are expected to adhere to these rules&nbsp;in carrying out their duties for the Fund.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund will, if appropriate, take action against any Covered Officer whose actions are found to violate this Code. Sanctions for violations of the Code may include, among other things, a requirement that the violator undergo training related to the violation, a letter of sanction, the imposition of a monetary penalty, and/or suspension or termination of the employment of the violator. Where the Fund has suffered a loss because of violations of this Code or applicable laws, regulations, or rules, it may pursue its remedies against the individuals or entities responsible.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">H.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Recordkeeping</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">General.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund requires accurate recording and reporting of information in order to make responsible business decisions. All of the Fund&#146;s books, records, accounts and financial statements must be maintained in reasonable detail, must appropriately reflect the Fund&#146;s transactions and must conform both to applicable legal requirements and to the Fund&#146;s system of internal controls.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.</font></b><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Code of Ethics Records.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of this Code, any amendments hereto, and any reports or other records created in relation to waivers of or amendments to provisions of this Code shall be kept as records of the Fund for six years from the end of the fiscal year in which such document was created. Such records shall be furnished to the SEC or its staff upon request.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">I.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Amendments to the Code</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Covered Officers and the Funds&#146; Chief Compliance Officer are encouraged to recommend improvements to this Code to the Board, and the Board may amend the Code in its discretion. In connection with any amendment to the Code, the Funds&#146; Chief Compliance Officer shall prepare a brief description of the amendment, in order that this description may be disclosed in accordance with applicable law and regulations.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-autospace:none;text-decoration:underline;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;A: Covered Officers</font></u></p>
<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, President</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura Woodward, Treasurer and Secretary</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CERT
<SEQUENCE>3
<FILENAME>a17-24476_1ex99dcert.htm
<DESCRIPTION>EX-99.CERT
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.CERT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 2: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I, Daniel R. Omstead, certify that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">I have reviewed this report on Form&nbsp;N-CSR of TEKLA HEALTHCARE INVESTORS;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The registrant&#146;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the registrant and have:</font></p>
<p style="margin:0in 0in .0001pt 22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The registrant&#146;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions):</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize, and report financial information; and</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="53%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Daniel R. Omstead</font></p>    </td>   </tr>
<tr>
<td width="47%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:47.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:   Daniel R. Omstead</font></p>    </td>   </tr>
<tr>
<td width="47%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:47.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:   President</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105733\17-24476-1\task8658856\24476-1-mn.htm',USER='105733',CD='Dec  5 03:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 3: CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I, Laura Woodward, certify that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">I have reviewed this report on Form&nbsp;N-CSR of TEKLA HEALTHCARE INVESTORS;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The registrant&#146;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the registrant and have:</font></p>
<p style="margin:0in 0in .0001pt 22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The registrant&#146;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize, and report financial information; and</font></p>
<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="53%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:53.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="41%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Laura Woodward</font></p>    </td>   </tr>
<tr>
<td width="47%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:47.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:   Laura Woodward</font></p>    </td>   </tr>
<tr>
<td width="47%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:47.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:   Treasurer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105733\17-24476-1\task8658856\24476-1-mn.htm',USER='105733',CD='Dec  5 03:42 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.SECTION 19(A)
<SEQUENCE>4
<FILENAME>a17-24476_1ex99dsection19a.htm
<DESCRIPTION>EX-99.SECTION 19(A)
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.Section 19(a)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 4: SECTION&nbsp;19(a) NOTICE TO FUND&#146;S SHAREHOLDERS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:12.0pt;margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">T</font>EKLA HEALTHCARE INVESTORS</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Notification of Sources of Distribution</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Paid Date: June&nbsp;30, 2017</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Amount Per Common Share: $0.50</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets forth the estimated amounts of the current distribution, paid June&nbsp;30, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, return of capital or other capital source. All amounts are expressed per common share.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.88%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Breakdown</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total&nbsp;Cumulative</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage<br>   Breakdown&nbsp;of&nbsp;the<br>   Total&nbsp;Cumulative</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.62%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.88%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Current</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">of&nbsp;Current</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.62%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net   Investment Income</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.3%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.84%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net   Realized ST Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="15%" valign="bottom" style="padding:0in 0in 0in 0in;width:15.3%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.84%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net   Realized LT Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.5000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.3%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.4500</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.84%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Return   of Capital or Other Capital Source</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="15%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.3%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.84%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:1.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TOTAL   (per common share):</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.5000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="15%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.28%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.4500</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.84%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:1.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The table below includes information relating to the Fund&#146;s performance based on its NAV for certain periods.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Average   annual total return at NAV for the period from May&nbsp;31, 2012 through   May&nbsp;31, 2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.12</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annualized   current distribution rate expressed as a percentage of NAV as of May&nbsp;31,   2017</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.29</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative   total return at NAV for the fiscal year, through May&nbsp;31, 2017(2)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.78</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative   fiscal year-to-date distribution rate expressed as a percentage of NAV as of   May&nbsp;31, 2017(1)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.01</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You should not draw any conclusions about the Fund&#146;s investment performance from the amount of this distribution or from the terms of the Fund&#146;s managed distribution plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The composition of this and subsequent distribution may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $355,270,830, of which $313,116,425 represents net unrealized appreciation of portfolio securities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The amounts and sources of distributions reported in this 19(a)&nbsp;Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund&#146;s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form&nbsp;1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)&#160;&#160; The Fund&#146;s current fiscal year began on October&nbsp;1, 2016.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Cumulative total return at NAV is the percentage change in the Fund&#146;s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September&nbsp;30, 2016 through May&nbsp;31, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Healthcare Investors</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CUSIP: 87911J103</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">www.teklacap.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Capital Management LLC</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 Federal Street, 19</font><font size="2" style="font-size:10.0pt;position:relative;top:-3.0pt;">th</font><font size="2" style="font-size:10.0pt;">&#160;</font><font size="2" style="font-size:10.0pt;">Floor</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Boston, Massachusetts 02110</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax: 617-772-8577</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105733\17-24476-1\task8658856\24476-1-mq-01.htm',USER='105733',CD='Dec  5 03:21 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">T</font>EKLA HEALTHCARE INVESTORS</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Notification of Sources of Distribution</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Paid Date: September&nbsp;29, 2017</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Amount Per Common Share: $0.51</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets forth the estimated amounts of the current distribution, paid September&nbsp;29, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, return of capital or other capital source. All amounts are expressed per common share.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.46%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Breakdown</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:17.32%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total&nbsp;Cumulative</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage<br>   Breakdown&nbsp;of&nbsp;the<br>   Total&nbsp;Cumulative</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.46%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Current</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">of&nbsp;Current</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.32%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;"><br>    </font></b><b><font size="1" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.46%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Investment Income</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.74%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.46%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Realized ST Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.74%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.46%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Realized LT Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.5100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.9600</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.74%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.46%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Return of Capital or Other Capital   Source</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="16%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.2%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.74%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.46%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TOTAL (per common share):</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.5100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.18%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.9600</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.7%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.74%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The table below includes information relating to the Fund&#146;s performance based on its NAV for certain periods.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Average annual total return at   NAV for the period from July&nbsp;31, 2012 through July&nbsp;31, 2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.00</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annualized current distribution   rate expressed as a percentage of NAV as of July&nbsp;31, 2017</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.76</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative total return at NAV   for the fiscal year, through July&nbsp;31, 2017(2)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.85</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative fiscal year-to-date distribution   rate expressed as a percentage of NAV as of July&nbsp;31, 2017(1)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.34%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.46</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You should not draw any conclusions about the Fund&#146;s investment performance from the amount of this distribution or from the terms of the Fund&#146;s managed distribution plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The composition of this and subsequent distribution may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $362,411,775, of which $282,136,984 represents net unrealized appreciation of portfolio securities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The amounts and sources of distributions reported in this 19(a)&nbsp;Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund&#146;s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form&nbsp;1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Fund&#146;s current fiscal year began on October&nbsp;1, 2016.</p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cumulative total return at NAV is the percentage change in the Fund&#146;s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September&nbsp;30, 2016 through July&nbsp;31, 2017.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Healthcare Investors</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CUSIP: 87911J103</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">www.teklacap.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Capital Management LLC</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&#160;Floor</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Boston, Massachusetts 02110</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax: 617-772-8577</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105733\17-24476-1\task8658856\24476-1-mq-03.htm',USER='105733',CD='Dec  5 03:22 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.906CERT
<SEQUENCE>5
<FILENAME>a17-24476_1ex99d906cert.htm
<DESCRIPTION>EX-99.906CERT
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.906CERT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EHIBIT 5: CERTIFICATION PUSUANT TO SECTION&nbsp;906 OF THE SARBANES-OXLEY ACT</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:26.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of TEKLA HEALTHCARE INVESTORS, do hereby certify, to such officer&#146;s knowledge, that the report on Form&nbsp;N-CSR of TEKLA HEALTHCARE INVESTORS for the period ended September&nbsp;30, 2017 fully complies with the requirements of Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of 1934, as applicable, and information contained in the Form&nbsp;N-CSR fairly presents, in all material respects, the financial condition and results of operations of TEKLA HEALTHCARE INVESTORS for the stated period.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.78%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated:</font></p>    </td>
<td width="38%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:38.24%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:48.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.78%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="38%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:38.24%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="48%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:48.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.78%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="38%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:38.24%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:48.68%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Laura Woodward</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.78%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.22%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel   R. Omstead</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.3%;">
<p style="margin:0in 0in .0001pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.26%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="40%" valign="top" style="padding:0in 0in 0in 0in;width:40.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura   Woodward</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.78%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.22%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.3%;">
<p style="margin:0in 0in .0001pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.26%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="40%" valign="top" style="padding:0in 0in 0in 0in;width:40.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Treasurer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A signed original of this written statement required by Section&nbsp;906 has been provided to TEKLA HEALTHCARE INVESTORS and will be retained by TEKLA HEALTHCARE INVESTORS and furnished to the SEC or its staff upon request. This statement accompanies this report on Form&nbsp;N-CSR pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-ms.htm',USER='105348',CD='Dec  2 06:46 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>j17244762_aa001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_aa001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!5@&U P$1  (1 0,1 ?_$ :(    & @,!
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M[#OVPS[QO$\\(AG=25>-4"+'&^IM<;Y[S4UI2F/4TW_#5_\ PG4_[VA;S_\
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M^F5@_P"R*]_[:NO?U0]L?^CO)_SG@_ZT]>_X:O\ ^$ZG_>T+>?\ Z4U\9_\
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M_?Z['WDO^F5@_P"R*]_[:NO?U0]L?^CO)_SG@_ZT]>_X:O\ ^$ZG_>T+>?\
MZ4U\9_\ [1/OW^NQ]Y+_ *96#_LBO?\ MJZ]_5#VQ_Z.\G_.>#_K3U[_ (:O
M_P"$ZG_>T+>?_I37QG_^T3[]_KL?>2_Z96#_ +(KW_MJZ]_5#VQ_Z.\G_.>#
M_K3U[_AJ_P#X3J?][0MY_P#I37QG_P#M$^_?Z['WDO\ IE8/^R*]_P"VKKW]
M4/;'_H[R?\YX/^M/7O\ AJ__ (3J?][0MY_^E-?&?_[1/OW^NQ]Y+_IE8/\
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MZ]_5#VQ_Z.\G_.>#_K3U[_AJ_P#X3J?][0MY_P#I37QG_P#M$^_?Z['WDO\
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M -_;IJ*BDVYL_:GR'^.&9W!FZFDH:K)5,&-QE'T++4U<L&/HIIF"*2(XV;Z
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M &D0]#+V_P#^5QL?^:C?]6WZO&_[NZO]]_WK*]P/_P"P=_ZO^CWU('_@Z?\
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M"TEA,0/X-,G#Y(S$_P"7RZ+_ $60H,E$9\=74=? &9#-15,-5$'4D,AD@>1
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_MZS\.__  \]Y_\
MOI]_^XB]^/\ ITF]?\T(_P#M(AZ&7M__ ,KC8_\ -1O^K;]7C?\ =W5_OO\
MO65[@?\ ]@[_ -7_ $>^I _\'3_J_P"4#I&_RK_^X=3^:%_X>?R:_P#@9^B?
M:[W8_P#$DN5?^:%E_P!IMUTQRA_T['=_^:D__5B'K4*]YC]0IU[W[KW7O?NO
M=&$QOQ#^5V3Z$VG\G,9T!OW=_1FZX<R/])O5=">VMK;6R>V<O48#=.#[#_N(
MN6W'UAD-N9JE>GJ'W+C</2S'3+2S5%/+#-)!NU>_W),NZS\O<SF39M^MIWAD
M2X%8=:-I.BX4:=!XAY5B!&1BA(]N_;O?4M(]RVH+>[?+&KJT>'TL*YC)K7R(
M4O0_.M"XTE=19"$5%!5TM;3EF03TE1%4PEUMJ42PNZ:EOR+W'N9K'<+#<[<7
MFVSPW%HW!XG61#]C(2I_(] BXMKBUE,-U&\<PXJZE6'V@@'J5[6=,]>]^Z]U
M[W[KW7O?NO=1I:RD@J*2DFJ8(ZO(3QTM!2/*@JJZJF<1PTM%3:O-5U,TC!4C
MC5G9B  3[*MUWW9=BA^HWJ\M;2#^*:5(A^1=A7\NE=I87U^_A6,,LTGHB,Q_
MXR#U8-T/_*K_ )CWR52EJ^IOAMW7-@JME,6[>R,#2=&;2DI7"D93'YKNW(=?
MKN7% ,#YL-'DR]F$:NRE1#.__>2]KMDU):W,^X7"U&FVB8BO_-27PHR/FC-C
MA7AT-]N]L>:[ZC2Q1VT9\Y7 -/\ 2IK8'Y$#JZ7HW_A*5\HMTBCKOD7\G.E^
MG*-O'/48#J?;.[>\=Q30/8M0S9O<S=+X#;V31&LTL5/GJ9)%]/F4ZO<([_\
M>WWF<-%RSM5O;C@)+B1IF^WPXQ"JGY%Y!YYX=#O;O9VQCHVZW<DA_AC4(/LU
M-K)'Y*>K,\)_(7_DM_#*CQ&>^7';>7WWD:C3+C*KY0?)##=38'*9!20]-@-D
M]8U'3&/W1!/*K1PXZN7./+<1MYI+'W">^^]GNAS"2+S=[J*$_@MR+9:'RK $
M9A_IV:OG7H=;?R+RIMU##91.X\Y*RFOKWE@#]@'5D/2.>^%G1M)+3? _^7WO
M?+U0I]3UWQZ^'V%^/V,W+3^-:9<C1]V?(6E^-W6'8?WL):];3;IR1G"MKD+$
M:HPGGFN96GN7:2=C5F8EF)]234D_;T*DC2)!'$H6,< !0#[ ,=&3'</S"W X
M;:7PQP.V8)F(@'?/R=V?LJL@0&>75E(.C]B?)NEIF:E6- *6HK1]X[1DB!15
M,UU?K-_?7Y]?]XT?#_\ ]+A[H_\ O>OOW7NHY[O^6.W-1WE\(,INH)K0CX\?
M(CJ#?C22Q^<&2 =^R?%)6HY6$1B=S',49R\4;(JR>Z]T1KY'=<?RF/F7EZ+:
M'S;^/&)Z;[=W-5+BL!G_ ) =>;B^,?9^6SU8ZRKM_KKY/;?FVWMSLG,O-1I)
M-BML;VSJ3*B?<0/$X#FNS[YO/+]V+_8[JXM+P?CAD:-J5K0E2-2^JFJG@01T
MDO;"RW&$V]_#'- ?PNH8?:*C!^8R/+JB?YM?\):>T-C4>=WW\#.W)>X\121U
M-?'T%W=/@=M=F>)%DJ&QVQ>W\738+8.ZZR61U@HJ#<&-VX(H8]=3FZF4DMDW
MR-]Z?F';&2SYW@7<+' ,\06.X4>I4:89:#%*1'S+D]19OWM+MMT&GV&0VT_\
M#DM&?D#ET^VKCR"CK5B[ V!O[J7?&X>L>U]C[LZR[)VG/'3[GV#OO!5^VMUX
M.28,U-+68C)10SOCZ^-3)25L/EHJZ&TU--+$RN<SN4N=N6.>-N&Y<M7<=Q#0
M:UX2Q$_AEC-'0\:5&EJ50LM#U"&\;%NNPW/TNZ0M&_D>*L/5&&&'V&HX$ XZ
M27L5]%'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW1P/AU\!OEQ\^=U5>V/BUU%D-Z8[#9),5O#M#<-9_<[I7K
M^L*Q22T^\.QZZEJZ63+4D-1%++AL+39K<8@E29<<T),@A;W$]].2_;]GL'<W
M_,*X^F@(JA])Y<I%\UH\HJ#X6DUZ''+7(.^<QA;@+]/MI_T60'N'_"TP7^W"
M<1JKCK;'^.W_  F\^#WQ:V73]Q_S)._,;VI+A!25>XJ'+;T'QU^+NUZN=[4E
M'DLK)N+#[WW?]M62+%Y\KN#'XO*A0)L-&KM![POYS^\%[B\W%H(;G]V;6:_I
M6A:-B/1YJ^*QIA@K(C?P#AU.&R>W/+6S 2/%]5=C\<U&%?Z*4T#.14,P_BZN
M4Z3[?^/G5^TTV?\  ;X)=J;@ZZ!@G6?H+H#KWXS]49)W1Q39W&[G^0>X?C9M
MKLJ@J YD;+[=;<*SAV=9)7)!A*21Y7,LI+2,222:DDY)).22<DGCT.U544*H
M 4"@ X >@Z'!.S/F]F&:; _$OI/!4:^H0]K_ "_S.VLVZ222"%5HNKOC!W?A
MQ41QQ:JA3D1'&9$$3S^LQTZWUR??'SXB1I7^,?Q)G2-6D:"A^;W;TE;,J LT
M5''7? +'44E5(!:-9JB"(N0'D1;L/=>ZBU/R ^0V&26DWQ\#>W,[221SK6U_
M3G:OQM[#P,-"(!+4R5E'V1VKTCO"OC:GE,8IZ'"U]3--')&D+KX7F]U[JN[O
M#I[^1_WW45#_ "L^,/7'Q_W3D99QD]Z=Y=#=C?!C<5?6^<*U''\CCM_IS%;Q
MD>JE A_A>[<E!)-,5A9I)&!-MJW[?-BE\?9+RZLYJUK#*\1/VE&6OY]([O;[
M#<$\.^@BF3T=%?\ X\#T2SM;_A+C\)^V\&N\?B;\F^VNIZ7/4LE5MF2NK]I_
M)+I[[:0NM/58V.KFVIV)G*=)00SOOB82*M@5:[&8=A^\?[I;)I2>[AO[=?PW
M,2L:?\U(_"E/VL[= O</;+E.^JT<+V\A\XG(_P",MK0?DHZIT[W_ .$R_P#,
MGZJCK<EU9)TC\G\+3ZQ146P=]-UIV/7JC<RU&S^X*;;>P\:K1L"J1[TK9"58
M6%DUS;L'WN-KE"Q\T;3/"WG);2+*#\_#E\(J/EXCG_!T!=Q]G;M:MM5Y&X\E
ME4H?]Z74#_O*]4P=Y_%SY-?&*61/D9\>>Z.D:6)VB_C_ &-UUN7!;(J9T94D
M@Q78[4$W7>>DC9U#?896J UKSZA>;^7_ 'M]L.9-*6>[6\-P?]#N:VS _P -
M9@B,?]([5\CT ]QY%YJVRK3V<CQ#\45)13UHA+ ?Z8#H!H9H:B))H)8YX9%#
M1RPNLD4BGZ,DB%E93_4'W*44T5Q&LT#*\+"H92""/4$5!'V=!-T>-BD@*N.(
M(H1]H/63VYU7KWOW7NO>_=>Z][]U[IQVYAL[O/<^-V/LC;VX]];YS3:,)L78
MNWLUO7?&<DU1IXL)L[:U#EMR9B4O*@T4U+*UV MR/88YBYTY4Y3B\;F/<+6T
M%*A7<>(W^DB%9'^Q%)Z-=MV/=]X?1MEM+-GBJG2/M8T5?S(Z%+OGXX?(7XO[
MHV+M'Y!]3Y;J3<'8.QZWL7"[6W=F=O1;]I-H)G7VYA,[N78N*R.5SNS*3=66
MQ^3AQ\.:7'9&4X>K9J58Q%)*#N1_=S9?<3?KK:^5[>YDVJSAU27<@\-"[,%C
MCCC-9#K =JN(R A[34='6_<G7W+>WQ7>ZR1+=S/185.I@H%69F%%&DZ11=0.
MH9Z!SW+'00Z][]U[JV'^1K_V]9^'?_AY[S_]]/O_ -Q%[\?].DWK_FA'_P!I
M$/0R]O\ _E<;'_FHW_5M^KQO^[NK_??]ZRO<#_\ L'?^K_H]]2!_X.G_ %?\
MH'2-_E7_ /<.I_-"_P##S^37_P #/T3[7>['_B27*O\ S0LO^TVZZ8Y0_P"G
M8[O_ ,U)_P#JQ#UJ%>\Q^H4Z][]U[KWOW7NK/OY8O\UCOK^6)V#FZ[9&,I.T
M>BNQ,C1U_;G0N>RTV%H<OE:2E@QL'8/7NXXZ7(+LGLZCQ5)#235$E+5X[-X^
MGBI*Z$/!05V.QS]Y_8BU]PG/,6P/';<V*@5M6(KE5%%$A )65115EH05 1QI
M"LDE\D>X$O+BC;=Q5I=H+$BF7B)XZ030H3DKC)+*:DAMM_97>_\ (:_FL=8;
M?[U[DZ6Z>V+ENP<KD<')NSY+]84'QY[';>^/RE3C<YLC&_)3&R8/!;LW=196
M _<8_;N]LE5(9(GFC1I(P>?<-YOW*VYRQV<]S8[K!(T;F*1XG5T8JRED9356
M!''CUD6\.W[M:HTT<5Q:2*&76JNI# $&C C(IU$W5_PF6_E9]GX^'-]69_Y"
M]78'+1BJQ==U+WQ2;^Q,M*TQ8/C,MWCMGO)ZRG(3QAS43'2#ZM5V,B;;[\>[
M&U@+#O$\B#RF2&>OVM+&[^7DP/SR>@W=>W_*%V27LHU;^@SQ_P D8#^71?LM
M_P ),_B_(E>-O?+[Y14#N\W\)?/XGI+/"EB,I-,N43%];;5_BDL<%ED: T*R
M/ZE6,>@">/[SGNH@ ::R<CS-NN?MTE?Y4Z*F]J^4F)(2=:^DAQ^T'^=>G/'?
M\)-OB(M7&V:^6/R[JL> _F@PC]!8;(.Q1A%XJ_)=*;DI(D60@N#2.64$ J3J
M%)?O->ZTB:4N+1#ZK;1U_P"-:A_+JR>UO**FIBF8>AE;_)0_SZ5=/_)4_D'_
M !ERPI_D'W%CMRYZEF^WAQ/R)^9F/Z^K3D*:HJ(6@_NGUEN'I6FR]:\JFG:C
MFHJE)7C"^$R:BP.W7WI]T]X4K>;W>*IX^"4MOE_Q'6+\_7SZ.K3D?E*R-8;&
M D?QUE_ZN%^K#^AJKX)?'NF,/\O[X!;JW7FWI?M9-P_'KXI8_J>#<U ^F,UM
M3\F_D+!T5UIV+#H4K++'O3+5>B'059O$C1O=7=W?3&YO99)KAN+.Q=C]K,23
M^WH3Q0PVZ"*!%2,< H '[!0=&=7+?/[L3QG&;2^,_P 8,--&9X<AO?-[[^4_
M8312: ,?F>OMEGX[;"VEF(0'_?H][[LHP61M,@#1LGZ<ZXK\.\SO"9ZKOCY5
M_*+MZ.90QVGMSL*G^-77V.E;3YJ;&XWXN8GJ'?F9PLUF#4>Y]R[E61)&21Y(
M]*+[KW0R=4_&7X[]&55;DNG^D.K>N<WE5MF]S;4V1M_%;NW'(5"O4[GW?!0C
M<VYZZ95'DJ,A5U,\EO4Y]^Z]T./OW7NO>_=>Z][]U[KWOW7NFG/8'!;IPN4V
MWN?"XG<>WLY0U.,S6!SV.H\OA<QC:R)H:O'Y3%Y"&HH<A0U4+E)(I8WC=20P
M(]^Z]T2R;X>9CIY*C+?"?M"NZ!EB5)8>BMV4^6[/^)&4\(LN+QW45=GL9FNC
MZ5X=:PGK?,[6QL-7*:VNQ>696@E]U[HF_P I>GOB?_,/I,-\6?YC'1#?'3Y,
MY"#+XOHCL.DW#BZTYO,?;2UL^3^(?R:BPF)H-^R0K :ROV)N/%XK.5$5')49
M/:LV,2&LF.=@YAWOE?<X]XV"YEM=QC.'0TJ/-6&5=#^)&!5A@@](=PVVQW6U
M:RW&));9N(8?S!X@CR(((\CUHP?S$?Y;WR#_ );'<7^CGMZC_O5U[N::HGZ;
M[\V_B*VAV)VGBH8Y:B3&S1S/61[/[-PE+"S97;D]3/-%&OW5)-5T++4>^C'L
MW[V;=[D6W[JW,1VO-T*5:,&B3J!W2P5SCB\1)9!W LM2N-7.W(MSRQ+]7:EI
M=F=J!C\49/!)*?\ &7P&X$ T!(#[GCJ/NO>_=>Z][]U[K%/-%3Q/-,VB.-=3
M'2S'^@5$0,\CNQ 55!9F( !) ]I+^^L]KLI=QW"5(;&"-GD=S14115F)\@ .
MGK>WGNITMK96>XD8*J@5))-  /GUM#_ 3_A,IW3\@-E;>[;^979>>^,.TMTT
M5+EL%TQLW;F+RO?\V"R$%-54&2WOG-X0UVSNHLW)"[$X.;![CKX4D05IQ]7'
M-0IA#SS]ZK=Y[N2RY"MXH-O4D"XG77+)3\:1$A(U/D)!(Q%"0AJHG?8/:2SC
MA6?F&1Y+DBICC.E%^3/\3'U*E0#4#4,FS[>'_"47X59#;RTNQODG\N]K;II*
M)H:+-[BR_1N\L'75IC@1*W<VVZ'I'9U;D$5HF<Q8W*8<%I6]0 0)&UI]Y+W;
MMKCQIK^&XCK7PY+:W"4]*Q1QO3_;UQQX]">;VQY.ECT);O&U/B660G[>]F6O
M^UI\NM6S^9!_*H^3/\LO=V#I^UFQ'9/3>]\E-A^M_D)L3%9/%[2W#FJ>C:N?
M:>]-LY"JR];U;V!/1P3U-+BY\CE*/(T<$LE#D:MZ>LBI,J_:/W^VOW"N%V#>
M8DL>:"I**&)AN*"K>$6[D< $^$Q8Z1J5WHP6).<?;R[Y<C.X63FXVJN211XZ
MF@UTP5.!K &<%1@FM+WD/U&W7O?NO=>]^Z]UQ=TB1Y972..-&>21V"(B("SN
M[L0JHJBY)X ]TDD2)#+*0L:@DDF@ &223@ #))X=656=@J@EB: #B3Z#K9,_
ME+?R,*+Y#[(H/FK_ # <I)T_\-L?B9]Z[7V#G=P3]<9WN+9^/I3D'[$[&WA/
M5X6LZKZ$FH5:HI98:JBS&X*5?NUJ*#%F";*8*>\OWB;O<Y9>5_;^9H=K4E)K
MQ#22:F"L##,<7K(*/)C052OB3]R3[:PVJ)NO,2![L@%(3E4]#(.#/_1/:OF"
MWP[:G7&Z.P^P-A[:ZJ_E\=4;*^+WQ?VKBHL#M3OOL+K*;";=EV[ Z&*'XO\
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M3G<V,VED86AJNI_D1-B_F5U#F$<H\D&YCW]'G?D!D\:9(P5HJ3L7'4B D+&
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M+5LL3,!XDK=TTI'G)(14@<0HTHM3I5:GK'+?.8]WYBN/J-TE+@?"@PB?Z5>
M^9-6/F3T@/8UZ(^O>_=>Z][]U[KWOW7NO>_=>Z][]U[JV'^1K_V]9^'?_AY[
MS_\ ?3[_ /<1>_'_ $Z3>O\ FA'_ -I$/0R]O_\ E<;'_FHW_5M^KQO^[NK_
M 'W_ 'K*]P/_ .P=_P"K_H]]2!_X.G_5_P H'2-_E7_]PZG\T+_P\_DU_P#
MS]$^UWNQ_P"))<J_\T++_M-NNF.4/^G8[O\ \U)_^K$/6H5[S'ZA3KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NAU^+_>6=^,O?&S.[-L56YL?7X&K
MI8<I5;(W#3[0WI'C$FDTY79^Z:K#;AI,%O#!15E3]E+54%?BZ^DJZW#YBBR.
M RV7Q==!WO9[16_N3LPN]N"1\V6BGP'.!*G$P2'T)J8V/P/YA6?H>\B\Y2<L
M7IAN=3;/,?U%&2AX"11ZC@P_$OJ0O6^!\?/F5\(?F9UGM?LSYA]6] ]DX/\
MB<&UL'\T<GU-M>/9V%W9'!2P8S:7?C9(;DWG\$_D!14M7!&8,UE1LW*M44-5
MMC=%<N5HJ"+FMNFU;CLFX2[5NT,EON,#E7C<:64CU'H>((J&!!!((/63]I=V
MU];I=V;K);2"JLIJ"/\ 5Q'$'!SU:A!\(.F(H5J=K;^^5VW/*T=7C)L!\Y?F
M)5X3'P2Z'6'#;3SG>>=V%!B9*:\<5,N,:DAC?5 D;A'5!THZE?[)OMS_ )_Y
M\P/_ $J#M/\ ^O/OW7NH<WP-Z&R$1@W#G_E!O"FEC1*_';Q^</S2W-M[*NJR
M!Y<EM#*]^U&SI_(\K/XQCU@1M.B- D87W7NEMLCX9?$7K;+G<6P_C!T#M7<[
ML\D^[<1U'L2FWA6S2H\<M1D=VC!-N/)U4L<C*TM152R,IL6(X]^Z]T97W[KW
M7O?NO=>]^Z]U[W[KW3?E<MBL#C:W,YS)X_#8C&T\E7D<KE:VFQV-H*6(:I:F
MMKJR2&EI:>)>6>1E51]3[]U[HJ$G\P+X1?=5E%C_ )5=%[CJ,;42T>4&S.Q-
MN[XBQ-?#))%-C<O4[/K<Y38K*0O$==+4/%4*.2@!!/NO=89_YA'PCHD$^7^4
M'3NW:'4%ER^Z]WT&TL#2D@E37[@W*<5A,>LA&E3/41AG(4$L0#[KW1C]@=E]
M<]K[>I]W=6[_ -D]E;4JV*4NY]@;JP6\=O5+@!BM/FMNU^1QLS!6!LLI-C[]
MU[I;>_=>ZKT^6.RX^H-R9;Y;8/:7]]>O<CL>7K3YQ]118ML]1]I_'2*&O1.T
M:7:'@JX]S=B?'ZCRF0GEHXH)*G<NQZ_,8HPU]=!MZ&E]U[K0P_FY?RQ,C_+^
M[8Q6^>II6WW\'N_JA=Q_''M#"5C[FP6V(\Y0/N&FZ<W%NNEDKJ&LJ:'#EZS:
MN3>HD7<>W$5TEGJZ+(/[S]^[S[R1\PV47(W,LO\ R(+=--M(QS<Q(M=!)XS1
M*.)-9(QJRRNQQW]R.2FVV=]_VM/]UTC5E4?Z$Y/Q >2.3]BMC *@63?\)0_^
MRN?E/_XKEMK_ -^;1>P3][W_ )*.Q?\ -"Z_X]!T>^S7^XU__IXO\$G6]I[P
MXZFOKY)GSQJ:>C^=7S_JZN>*FI:;YV_-J>HJ)Y$B@@@B^3_;$DLTTLA5(XXT
M4EF)  'OJ+['W-O9^SFTW=VZ16L5M,SNQ"JJK/,69F- % !))- ,GK%'GR*2
M;G6\AA4M*TJ!5 J23&@  &22> ZV;OY/G\OC<'P?ZWVQ\[.[^KAN'YP_(=Y.
MJ?Y?OQFW:3C,KM.7>^%KZRM[#W[221/7;,RU=L:@K\]N>J$;Y/9W6V.R$7B;
M*Y&JQ/O##WQ]VY/<;>Q8;6S+RG9.1"#4>,_!KAU\JCMB4Y5*DT9V43?R%R<O
M+-B;B[ .\3@:SQT+Q$8/RXN1@MC(4'K;*^-W1-#\?NMH]JRYVHWOOW<V<RO8
M?<W:.1HTH<UVUW%NW[>HWOV!E*))ZM,53Y"IIHJ3$XJ*5Z/;^ HJ#$46BAH*
M:-()Z'_0]^_=>Z CM+Y2_&?I#*4^"[D^0G2?5>X*VG^ZQ^W.P>T=D[1W)E(3
M&\L9Q&WL[FZ',Y:2=(V\24T$KRD60,>/?NO=!O\ [/Y\-?\ O(7K_P#\[*[_
M .H/?NO=+#8'S$^)_:>X8=F]>?)+H_=N]Y[:-A8GL[9\N_TUU!IHON-BR9>/
M=M)]S*!XO+1IYE9634KJ3[KW1C_?NO=>]^Z]U[W[KW7O?NO=,^>V]@-U8JKP
M.Z,'A]R8/(1^&OPV>QE%F,56Q'ZQ5>.R$%11U,9_U+HP]^Z]T5:K_E__  P:
MJJ\EM_XY=:]:9NOFDJ:[<W2.)FZ$W=6U<BRJ:VKW?TK5;"W-45R+/)HG>K,L
M>MM#+J-_=>ZXK\).LZ)A)@.U?F)@9F\JSRM\X?EOO%:B.602^,TG9?<>^,?2
M^.071Z:&&55]&O1Z??NO=<G^&6U9D:&J[V^8512S*T533I\K.YL:\]/("DT*
MY'#;GQN8H&EC)434E33U,1.J*1'"L/=>Z"7N/XR_ CI[9]5OGY-5.Z-Y;"7*
M4./IL)\I?D5\D?D]M/,[ER*QPXC:VT.I>\^T>U\3NK>&Y):!8J+"8?#5>2RU
M2@2&FGF(4^Z]UKT?S7_YG^!Z1ZRR_P 8.B^OL!\=,1F\+CZ3!_%K:&&PO7?9
M62VWN:CK)Z'??RIP6RX*.#X]].5N#ABJ<=U;!)%V'O=*JGAW*-M8)Z_'9.2?
M;3VQW_W+WD6.VJ8MJC8?47+*3'"O&@X!Y6'P1@U)RQ5 S ,<T<U;=RO9&>Y(
M>[8'PX@>YSZ_)!^)B*#@*L0#IOQQZ#,[,))ZJIJ:VLG$%)2FJK:R9ZFLJFIZ
M"GI*&G:HJ)&;QP110Q@Z8T1 JCJ)RWR[M/*>R6_+^R1B+;;9-*CS)XL[F@U.
M[$L[4RQ)ZQ1W/<KS=[Z3<;YM=S*U2?(>@ \E44"CR '63V>=(.O>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NK8?Y&O\ V]9^'?\ X>>\_P#WT^__ '$7OQ_T
MZ3>O^:$?_:1#T,O;_P#Y7&Q_YJ-_U;?J\;_N[J_WW_>LKW __L'?^K_H]]2!
M_P"#I_U?\H'2-_E7_P#<.I_-"_\ #S^37_P,_1/M=[L?^))<J_\ -"R_[3;K
MICE#_IV.[_\ -2?_ *L0]:A7O,?J%.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[H=OC?\FN]_B+V5_I9^/'8%=L+==7CQ@MU8Z2DIL_L/LS:
M3"I2IV/VQL#*K+MSL':%7#6SH*>LB^YH6G>>@J*.KT5"1E[B^T_*GN39Z-WC
M,6[(M(KJ( 2IYA6KB2.O%'X5.@HQU="KEKF_=^6)JV;:[-C5XFJ4;YCS5OZ0
M^50PQULN?"S^>)T;B*.AQ";JRO\ +KWS.U/_ !7KG*[+W?\ )C^6?NNN0F(?
MW&V1@<QC>\OAK)E7=M-'MRJHMAX3RFKKH<W.C-[P2YW]@/<#DYVF@MSN>T#(
MFM59R!_PR$5E0@98@/&/]^&G4_[#[B<N;TH2206MX?P2D**_T7^!OE4JQ_AZ
MV5>H/YA-1OC:=+O3/](YC??7M1)X:;OWX0[VV]\ZN@\S*J2//!ADZCAH?DG_
M !2A\6FMI9^M(XJ69A#'4U+ GW"3H\;F.0%74D$$4((P00>!'F.ATK!@&4@J
M14$>?0P+_,'^%M'(*;>/R+Z[Z@RC22PKMWY"5U=\;]VM/3J&JJ=-H=]T'7&Z
M'J*+4!/&*0O W$@4\>Z];Z$";Y>?$ZGI9:Z?Y0?'>"A@IWJYJR;NOK:.EAI8
MXS-)4RU#[E6&.GCA4NSDA0HN3;W[KW2#_P"'"_@?*WAQOS)^,>XJSR>(8K:'
M=W76\\VS"+SN4P6T]PYG,21Q0?N2.L!2./U,0.??NO=81\Y>I<J1!L+8/RB[
M/K9F@6A79WQ(^1]'MW)&="5-'V7OCK39O4>F*2T<QEW!$*>0D2E-$A3W7N@7
M[:^>^^NLL/'G-X]+=4_%[$/#]P^<_F!?,SH'XZX]J1P_BK\3!TWD/E549-7\
M,H2GJVQ4KR0M&QB-V6RJSL$0$N30 9))X #S)ZT2%!9C0#JD+Y'?S\.D,!E*
MO%9/Y>]I=WF.FDIY.N/Y<W1.)ZCV E4TK-]EO3Y7_*3.[CW/O/&>,#1F.LJ?
M!3<H/&=,ZM*7+/LK[E<U4>PVN>&U(KXMR/ITIZKXNEG'SC5^@GNG//*^T56X
MNHWF'X(OU&KZ'34*?],1U3UV9_.ZH\UE5RW5WP%^/C9FBR/GQ.__ )K]C=T?
MS$NU,7'' (J?+;3WCW=N/ R=?YN)D5HH:=,C0TZJL066-1[FW9?NC;Q+1^8=
MWMH!YK;Q/,3\M<A@"_;H;[//H"7WO'9)4;;9RR?.1U3\]*B2OV5'0,[D_GQ?
MS9LR]32X3Y@Y?8NVI((:2AVIL_I'XM8['82A@1$AQ^%RDO1%3N>@HZ9$$<.F
MO\L<*JNLD%FD^R^ZK[<V\:B[GW.>4&I)EC0'Y:4A! _VQ/\ 2Z"L_NWS-(Q,
M,=K&AX (Q(_,OD_E3Y=-^U?YZ_\ -SVG51S4_P V=V9RC6H-3/B-V]1_&[<E
M%6N8#"(IZZNZ7_O+34H.E_'29"E76M^-3:GKS[K'MI<*1;R;G U,%)T:A]:2
M0O7YBO#A0YZI#[M<T1D>(MK(*^<;#_CKK_J]>C*=:_SVJK*[OAW5\M_A1TGV
M%NVHEIH\C\B_B%G]\_"SY7P4E.\KBHK.P]A[FJ:S?[JLAB.)?,;9Q%5$[).&
M0R++%/,WW2]WMHVN.4]RBNJ9$5PG@N?D)5+HS'RU+&OJ1T+MK]X+.5A'O%J\
M5?QQG6OVE3I8#["Q^76QS\)?YK&![_KZ/!_&GY&X;Y6U"4$M57_%#Y68_:?Q
MF^?N%@I5^ZJHNL]^8JGP_P =ODQ#B\3&L<=)%28Z."0^7+;SDED94QEYFY-Y
MHY.N_HN9;&>TF)[2Z]C_ /-.1:QR#U*,U///4I[7O>U;U#X^USQS)Y@'N7_3
M*:,O^V ZN)Z5^6/37>6>S.PL#ELQLSN3:N/7*;UZ"[6P&0ZX[OVACON5H#F\
MAU_N-*;(YS9<V1)@I-SX1LKM7*N-6/R57&5<AGHTZ)#W+T[U/\?]B=F=%_(G
M:&%WW_*Z[NEFI:O'9>AK):'X?;HW=GH:JLQ&9K:">*KVK\9*S=54F8V]N.D:
MDEZDS8(-12[?&/GVZ];W%Q:3I=6KO%=1L&1T8JRLIJK*P(*L"*@@@@Y'5)(X
MYHVBF57B8$%2 00<$$'!!'$'CT1?^53_ "P*_P#EG?S'._,#@.S:3M;I#N3X
MN4>Z>E-Q9!PO8=#A,%VGMR#+[?[!2@Q]-MK*UN,?.4GV>9QLB19>"0R/1T<B
M%9)!Y[]R]Z]PK#:X-_5&W+;HY8S.,&=7\/2SK2@D&@ZF4Z7J#I4@U#FP<KV/
M+=Q=R;<2+:Y9&$9_T,KJJ%/$J=6 <BG$^6RS[CCH3=:A'QM_E?\ QFZW^2'R
MH_F>?.K<F)[(QNZ/YBOS.3XF?&K;^$S.Z:G.]D4'S-[EP6TJJKV72T_\9[H[
MIRNY]MU+;;VK0T=7BL9!%_%:IJF>-9<-)&[>Y_,.X\DV'(%NWT_+UG&0ZH3J
MN&,C2 RG^!"W;&.VHUMJ.G0&;3E7;;;?;CF*0>)N,S J2,1 *%H@_B(&6.:&
M@H*UV*/CMT_OS,[VR_RP^1^*I\;WMO;;\^U-A=;+64>9QGQ>Z3K<A1YB'J?$
M9.@K\IA<KV1N^NQM%D^PL]CI32YC+T='04TD^*PF+E>-^A-TF=^_.O;]9-N7
M;_Q?V4WR4SNTER2;S['I]V8SKKXE]3S8CS#,OVS\I<U19;:$4VVY::2/+XC9
MU%O3=.(D4??8FFC)E7W7NM>/Y=?SO/C=MV?)8C=_R [/^=F\H&J(FZ3^#^XM
MP?$SX482L6*>E_A&Z_DU19+(][=U4VG5'5UN$RV>VEF$:\NWZ16>F65N2_9;
MW!YY"W&V69@VMN%Q<DPQ$>JU!DD'SBC<>1(Z".^<\<N;"3'=3^)=C_0XN]_L
M.0JGY,RGJG/)_P ^OYB[8ILKA?BEU7\0_@OM;*2SSO1_'CX_[5R&\*J::1I1
M5[JW?V/!N7;>\<OY#KDK7VQ1/42LSR(SMJ]Y);#]TC9XHU?F?=;F:7S2V1(E
M!] \HF+#YZ$/E0<>HQW#WBO68KM5I$B>1E9G)^>E"@'V:FZ!R?\ G@_S=*G*
M)FIOG=V+_$(Y()4\'5WQHH\6&IPBQ!]MT71M-M>>,A!K22B=)B29 Q)/L:K]
MUWVO$1C(W$N?Q&X&H?LC"_M4]$1]U^:R^K_%@OIX9I_QZO\ /I<4_P#/5_F$
M;@QHP/R"W)T3\Q-JR5C35>Q_E'\7^B-T;)J*1_MO)1_P7K+8_4M4K3"%M<K5
M3L;KP-'J#V[_ '3.3[E#^Y=QW"UFI_H@BN$KZZ0L+?EXG[.C*S]X-ZB;_'K:
MWF2OX=4;?M)<?\9Z-_TO_/?ZHVLL-+NCXL]X_&ZIIE?[;=O\OWY3[CPNT<86
M9U3^ ?"GY ',?%:F:&..(JU<U>+!8%1(4/EB3?/NI\]6 ,FR75C?QC@NIH)3
M_M7!C_;,.AC8>[FP7!"WT5Q;MZT$BC\U(;_C'5X7QW_G;=<=BQ4]%L?YH_$7
MLFJE,%-1=>_.2GWA_+J[HH7_ &?/!FNX,;MGN#X_=O;C9)P\4>T-K8:AD8>'
M4K"25()YBY&YOY3D,?,6W7=J ::V0F(_Z65=43?[5ST/]MW_ &;>%#;;<PS$
M^08:A]J&CC\P.K8,!\QM\SXFGSVY/A_WQ5[4GCBDA[,Z2W-T)\BNM,ND_F,<
M^UXNM^WINZ<[1E(=9F.R*:,*Z G4VD!3HWZ4!^?'QBHM1W7N;LCK!!K(E[L^
M.OR/Z*@D1?/IF@J.X^IMC05%/.:64121LT<S1.(RQ1@/=>Z=L3\]O@OG\A'B
M<%\T?B;FLK,TB0XS$_(SI_(Y"5X:9JR98Z.CWC-4NT5(IE8!25C!8^GGW[KW
M3QGOFK\-MK42Y+<_RU^,NW,<TPIUK\]WSU9B*)J@Q33B!:K(;JIX#,8*>1PN
MK5H1C:RFWNO=(U_GQ\;LC=>N<QV1WN7DD@I:WX[=%]V=[[6JYTT^-#V-U?L#
M<O66,IZM7#055=FJ2CF7U),5Y]^Z]T13Y8?S5QT73-2]B[FZ-^"5/44L%=#_
M +,[N:@[Y^4^5Q3"EJ)Z_K_X/_%?=F[\UF*&OH*I5I\IEMZX]\74S0O78:9-
M=.3/:MEW??;L6&RVMQ=WAX)#&TC4X5(4$@>I.!YGI+=WUGM\)N+Z6.& ?B=@
MH^RI(S\N/6K1\M?YWF2W#N+*5GPWP/9%-V75XROVUD/GG\K:G:.\_D^NW<I&
M\.8P_P =.K=NT"='?$?;^:CLLT^W<;#79" K+44%'E(UKERC]O?NN;SN,J;C
MS_)]%MX(/TT;*T\@XT=P62$'SIKDXK2,T81/S)[KV-LC6W+J^/<Y'BL"(U^:
MJ:,Y]*Z5X&K#'5 U;65^4R.5S68R>5SF=SV4K\YN#<&?RN1SVX=PYW*U,E;E
ML[N'/YBIK<QG<YE:V5YJJLJYYJFIF9GD=F)/O-W9-BV?EO;8]GV*WCM=MB%%
M1!0?,DFI9CQ9F)9CEB3U!-_N%[N=TU[N$C2W3G+,<_8/( >0  'D.H_LVZ1]
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U;#_(U_[>L_#O_P //>?_
M +Z??_N(O?C_ *=)O7_-"/\ [2(>AE[?_P#*XV/_ #4;_JV_5XW_ '=U?[[_
M +UE>X'_ /8._P#5_P!'OJ0/_!T_ZO\ E Z1O\J__N'4_FA?^'G\FO\ X&?H
MGVN]V/\ Q)+E7_FA9?\ :;==,<H?].QW?_FI/_U8AZU"O>8_4*=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TK^O.Q.QNH-R/
MO+I[LGL?I_>$HC6?=O4F_P#=_6&Z*J*%9$CIZS<.Q<U@,O64HCF=?#+,\11V
M4J0Q!!7,GMUR/S>3)S%MEK<W!_T33HEIZ>-&4EI\M=.CS;.9=^V8:=MNIHH_
MX:ZD_P!X;4G\NK-^M?YZ7\V/J^"EH,=\Q=T;RPM'<Q8;M+KSISL,RLWA!:MW
M9F^O#V36CQPZ0KYPJ"S-;423$&Y_=8]MKUB]E)N5F?)8YD=!^4T4CG_>QT,[
M7W:YG@&F=;68>K(5/_&'4?\ &>A$_P"'_?YA24%'24U#\2:"NHJA*E-RT/Q;
MVI'N29XI))(A,\^<J=O1Z&=;-!C8)!XU(8'46#Z_=(Y4\4EMUW$P>0"PAO\
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MYZQZHFZ7=6K^_=>ZI(^/0^/WQRI]Z]Z;@P?8'>?RM[8^7G\QO:70_6=!D6[
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M#3S%3')D^1ICT/3TGO%O)'Z-I;*:>9=OLX,O^KTZ*?V]_-@_F8]ZQU5/V/\
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M_*O_ .X=3^:%_P"'G\FO_@9^B?:[W8_\22Y5_P":%E_VFW73'*'_ $['=_\
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MS;R7RC[E[$MKO$<=Q:21ZX+B,KXD>L K)!**X(H:=T;BFM67'0&V??-YY7W
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M!B.&)!Y#T 11EBHSU"FU[/O/-&X-%9*T]VW<[LV!4Y9W8^9^TGR!/5Z>QO\
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M/O\ ]Q%[\?\ 3I-Z_P":$?\ VD0]#+V__P"5QL?^:C?]6WZO&_[NZO\ ??\
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MGAQ>-SV\:^4SR9%^V7O!RELC1[?SOR_M-Q M%6\@LK5;A1_PU!&JRCA5E*.
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M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U;#_(U_[>L_#O\
M\//>?_OI]_\ N(O?C_ITF]?\T(_^TB'H9>W_ /RN-C_S4;_JV_5XW_=W5_OO
M^]97N!__ &#O_5_T>^I _P#!T_ZO^4#I&_RK_P#N'4_FA?\ AY_)K_X&?HGV
MN]V/_$DN5?\ FA9?]IMUTQRA_P!.QW?_ )J3_P#5B'K4*]YC]0IU[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO="1TUW#V-\>>WNLN^^G\U#M[M+I[>6+WW
ML?*U44]1CAE<:)Z:MPV<I:6IHZJOVKNW UM9ALS2QS0O68?(55.)$\NH CW#
MY)L/<'E2YY:OB$>0!XI*5,4R9CD'RR5<"A:-G4$:J]'O+>^W'+F[Q;I!W!<.
MM::T/Q*?\(\@P4T-.OIP?R[/YH?QR_F(])X?L;96>Q6P.R:&OQ>TNT^C-U[B
MQ:;VZ\[#R%-)-3X6E\IH'WAMG<HIII]O9JC@6'+TD;J8J>MIZZAI.5W-'*V]
M\G;U-L._PF&_A/VJZ_ADC;@Z,,JP^P@,"!EKM.[6.]6*;AMSA[=Q^:GS5AY,
M/,?F*@@]63>P]T9=>]^Z]U7C\AOY6?PK^2>&.'WGU%@,)$D];544>V<'M*HV
M_B:[*M4/F\UA.M=[;:WGU%A=WYQZDM4[AI=O1;A+*K)7(P!]OVUU<V4RW-G)
M)%<*:JZ,58?8RD$?D>FY8HIT,4RJ\1XA@"#]H..J4NTO^$LO0.7GJ:SK7LC/
M[6I$,RT&V]M;DW9M"MJB\[RPUFX-]=N3_+B@EF5&TS08G:V'II"!X$I$ 02K
MLWOM[J[(BQ6^[SS0KY7"QW!/VO*KR?L<=!*]Y Y1OR7DLXT<^<9:/_C*$+_Q
MGHFFY/\ A*OW/%Y)ML]Z[9H:/R52K3UF8'9V?CCF@'\.:*E?K7XYX.N:BK3:
MI+U]'YJ<:XT20"-AU:?>J]RK< 3P[5./5X90>/\ PN=!7RX4^71!-[2<KR9C
M>[C_ -*Z$?\ &HV/\^C4?RX?Y9?SI_E1]N]F=J[!ZXC^4<6_^OL3L3-8W<YZ
MT^/N.QM'B\Y3[EK\OA\EM;O[Y-;LRB+4T\L4,2;=DK:B$0LM*)IGIZ>//<[W
M6W7W1ELI]UMK>VELDE4>$7HPD*'(<L130/,UJ>A'RKRC:<J+.EG+)*DY0G7I
MJ-(8<5 K75Z=7"_\.2=B[#.GOKX4=Q;/I*>&-LQO/8.9BGZKV_4LE1//1Y+L
M3Y5[6^&6.R,U+34[>G$091ZF;TTBU*?N^XLZ%O6F?N'^7MA?EQ\DOD5W%EOD
MC_LM6(^0/RY^3?876:]Y],[-V?LW=N'['^0/8N\MHXO9_:'8_P J>I\;V#G,
MML_+TE2T6V\9F7I*RJ6EE3]J>:/(OE+[Q_,G)O*MIROM>WV+QVB,HDE,K%M3
ML]2J/&!0MY'@/7/4:[Q[9[9O>[S;M=W$ZM,P)5 @ HH7!8-Y#TX]61[&_P"$
MK.\:Q*:?L#O.+(8S(T_FAK>O>R\/L;*T$-;'/)1U,N)W#\7^\<+6U%!&T!FI
MH,O)!4OY5BK40QR^_7_WH?=&\4BW.WVI/G%;DD<.'CR3#]H/$_*GK?VHY4A(
M,@N9A_3DI7_G&J=6-=*_\)F_AOL*IHJ_L7)CLFLI&AJ&EKMJC</\2;5,:C#[
MHVQW+N+N+I#/XAH9%3RT6Q<)7F1#+'- K"&.,.8/=#W!YH1HM[W:\EMW^*-7
M\*)OMBA$<9_-<>70JV[E3ES:2'L+.!)%X,5UN/L=]3#]O5Y/37Q5Z Z"3'R=
M7];X?#9;$X>KVYC-TY2?);KWEC-LUU<N4J=IXC=VZZW-;APFR_XBHFBP=%44
MV&I7 $%+$JJH ?0@Z,'[]U[IISV>P6U<)E]S;GS6)VYMS;^-K<SGMP9[(T>'
MPF$Q&-IY*O(Y7+Y7(34]!C<;04D3RS3S2)%%&I9F !/OW7NM._\ G8_SVL1F
M.MNX/A!\7:'(T6Z-_E]B]C=P)F9*/*;3ZJK:)H=\8.';T5'2Y/9/8?8&M\/3
M4-;.,WBL%+65];28JIGPWW4Y^R?M'?>X>^1[AN$;)R?:R!II""!,5R+>,_B+
M8$I']FA-2'9 0%SUSC;\MV#6ULP;>I5(11G0#CQ&] /P@_$WE0,1IJJJHJHB
MJB(H5$4!555%E55%@JJ!8 ?3WTT5510B ! * #  '  >0'6+))8EF-2>N7NW
M6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZMA_D:_]O6?AW_X>>\__ 'T^_P#W
M$7OQ_P!.DWK_ )H1_P#:1#T,O;__ )7&Q_YJ-_U;?J\;_N[J_P!]_P!ZRO<#
M_P#L'?\ J_Z/?4@?^#I_U?\ *!TC?Y5__<.I_-"_\//Y-?\ P,_1/M=[L?\
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M:6GAARFR1M:KRM<\%1/5538OM+:/4> VYBFAD$-!#FL;\H,SE\NSHS5@VEC
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MZ&7M_P#\KC8_\U&_ZMOU>-_W=U?[[_O65[@?_P!@[_U?]'OJ0/\ P=/^K_E
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M_ITF]?\ -"/_ +2(>AE[?_\ *XV/_-1O^K;]7C?]W=7^^_[UE>X'_P#8._\
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M-K)+G*ND;<>&-7R]]^.3]QY5]Q;^YN(V_=VY7$EU!)^%_&8O(H/\4<C,K+Q
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M'9KK6SBC^XR/8L]'L+8M#5&JJ8WDQV]\5UE-1PA*##9+?F5?R2>Z]T<?>O\
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M>:>H2:/8WGB+D_G:UAO8+:;:[V>.%V>)&EA9VT1S12E3(FAFJZ@Z60MVZ]+
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M(3%4PPU,+155/3SQ KGOD+E_W#V1MDW]#I!U12I02PO2FN-B",C#*0588(J
M0><O\P[CRW?B^VYA4BC(V4=?1AC[0000>!XUVJ/@/_PIBWGLI<#U]\T,'_>/
M;].?M)>QJ.KK:O()!))(*2.ASE<:O)4OV:"GHZ>DWC/7QRZJC)YC?=*JI2'
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M@^-=)D/5NC;N/WEGNX-C;<CI>9MP;%QM-OWMXR4[(\U16;>_TG0Y?(S1P4F
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M&# TJ'4@K0@GG^TW&;EZ:ZVRXF@GMT9V",5#Q@5<-3.%!(((X$&H.-1(
M6 X '  'X'OJ&  *#AUBCU[WOKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_MZS\.__  \]Y_\ OI]_^XB]^/\
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M5?\ ]PZG\T+_ ,//Y-?_  ,_1/M=[L?^))<J_P#-"R_[3;KICE#_ *=CN_\
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M=E@MPB12"2J.6)D=0JLK%^RK$J2%53A03*7)//.S\J[9);36LKWTDA8NNFC
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MNO>_=>Z][]U[KWOW7NO>_=>Z5.S]^=@==9.JS77'8O8W6V8KZ 8O(97K??\
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M_1SV%_SPF\O_ $%\W_\ 4/OW[RV[_E(@_P![7_/U[Z6Y_P!]O_O)_P W7O\
M1SV%_P \)O+_ -!?-_\ U#[]^\MN_P"4B#_>U_S]>^EN?]]O_O)_S=>_T<]A
M?\\)O+_T%\W_ /4/OW[RV[_E(@_WM?\ /U[Z6Y_WV_\ O)_S=>_T<]A?\\)O
M+_T%\W_]0^_?O+;O^4B#_>U_S]>^EN?]]O\ [R?\W7O]'/87_/";R_\ 07S?
M_P!0^_?O+;O^4B#_ 'M?\_7OI;G_ 'V_^\G_ #=>_P!'/87_ #PF\O\ T%\W
M_P#4/OW[RV[_ )2(/][7_/U[Z6Y_WV_^\G_-U[_1SV%_SPF\O_07S?\ ]0^_
M?O+;O^4B#_>U_P _7OI;G_?;_P"\G_-U[_1SV%_SPF\O_07S?_U#[]^\MN_Y
M2(/][7_/U[Z6Y_WV_P#O)_S=>_T<]A?\\)O+_P!!?-__ %#[]^\MN_Y2(/\
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M?]]O_O)_S=>_T<]A?\\)O+_T%\W_ /4/OW[RV[_E(@_WM?\ /U[Z6Y_WV_\
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M_37WO_9!<_\ ;-U[]]>X_P#T9H/^RB+_ *V]>_V;K^?S_P!ZF.FO_2KNF_\
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M_P!ZF.FO_2KNF_\ [</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_ /1F@_[*(O\
MK;U[_9NOY_/_ 'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_ &S=>_?7N/\
M]&:#_LHB_P"MO7O]FZ_G\_\ >ICIK_TJ[IO_ .W#[]_4[[O7_37WO_9!<_\
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M_P#MP^_?U.^[U_TU][_V07/_ &S=>_?7N/\ ]&:#_LHB_P"MO7O]FZ_G\_\
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M_37WO_9!<_\ ;-U[]]>X_P#T9H/^RB+_ *V]>_V;K^?S_P!ZF.FO_2KNF_\
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7_P#*/XBZ?]Q=/]IJT_V7?\7'MXXZ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>j17244762_ba002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0%0 P$1  (1 0,1 ?_$ :(    & @,!
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MO_GEJS_SZ8?_ .J_?NO9Z]_%<W_SRU9_Y],/_P#5?OW7L]>_BN;_ .>6K/\
MSZ8?_P"J_?NO9Z]_%<W_ ,\M6?\ GTP__P!5^_=>SU[^*YO_ )Y:L_\ /IA_
M_JOW[KV>O?Q7-_\ /+5G_GTP_P#]5^_=>SU[^*YO_GEJS_SZ8?\ ^J_?NO9Z
M]_%<W_SRU9_Y],/_ /5?OW7L]>_BN;_YY:L_\^F'_P#JOW[KV>O?Q7-_\\M6
M?^?3#_\ U7[]U[/7OXKF_P#GEJS_ ,^F'_\ JOW[KV>O?Q7-_P#/+5G_ )],
M/_\ 5?OW7L]>_BN;_P">6K/_ #Z8?_ZK]^Z]GKW\5S?_ #RU9_Y],/\ _5?O
MW7L]>_BN;_YY:L_\^F'_ /JOW[KV>O?Q7-_\\M6?^?3#_P#U7[]U[/7OXKF_
M^>6K/_/IA_\ ZK]^Z]GHFV[?D;O7>74_SEFVMM/<W5&8^.F.WQM'9?8;Y;8F
MXFW9V!A.LH]Z+4;>V_-%G_M/X-D,OC:8PY2A9*V2J"T_D(;1KK?4#Y&]T]FT
MM/V!/T%E*'<VY-I[9ZT'6>#V\U/N.GWMV'N/>-!6=E;?S-%0PY!\A-M3IK.X
M++T=*K1ZZ//RUP63[5)Z3W7NHN([([<D[.WIA\5F\AG=BXC?GQ^QG164F:GK
M/]*NTMV[@P5+\E*^LK(,=%'NC_1=AZFNDCEI3&N*\&J:X0^_=>ZL$]^Z]U[W
M[KW1'/E'\WO]E?W?M[:/^RA?./Y$?W@VV-Q_WG^+G0/^EO:&$ODZ_&?P'<.:
M_O9M_P#ANY!]A]P:7Q/_ )+-%)J]=A[KW19/^'=__!8/\W[_ -(K_P#TE>_=
M>Z/%\@>PNW=E[9ZQWWU%M63=U1_?"&LWYU)D,='#O#>O7"[!W?N7<V V/.]7
M318;N#"C#0U>&IZJ5L;E*RF?$U+4HKDRN.]U[H$:?YT;7Q^$Z]J<(B]MP=FU
M6XCL3(T6?P6VMQ;K@RU/VEN/J2DI<%7XC!XBEJM]8S8]'BJ.&MGQ>4J\EDJ=
M::@JF9[>Z]U&KOFU'FYNO=R;=BP> V/A^T-R[1[?7<V<JMIY]9\'\1^Y>^:C
M;0P'9&QMI9;;-/B\EMS%"JK,PVWZZEJZ"NIZFFCCIJA9/=>Z6^VOF91;HB4X
M_9%/]QC]Z8'9VYJ>7=E52O12;K^5^\?B;@J[!4U?M"BRN8^VW3LFIR>5@K*7
M%38RCJ*:*TT\VE?=>Z:/D/W[VAU)OGL7)86+^(;!ZLV'\=NQ=S1C!8:MPV#V
M1O/M3M7 =UY_=:?QJG[#SV0Q'6^P9:S;M+MBFJZLY:!(Y:"O6402^Z]U&/S-
MS%'L[M#<2=?4^8JNK^V-R=5YC%5>Z(L!GZS,S]H[LV!M#*;>P$>$RS9[KNEJ
ML;!'D,]]Q3N8\9G)(*.>?%2TLONO=*#!?+^LK,=/D<IUU3PXG#?W$V?N7=M/
MOS;E/@L5W)V%2]0MMO:%;@LB8=]8K:=?5=O4K-FYL:QAHJ9JP4LU)-2U$_NO
M=)O._*W?_6![VS._MD8?.8O9O9&]MK[:P^W=Z1O4XV?8?POQ/R5EP"UDVQ<7
M'D</N&3;67(R=4XKJ.KRD4#4A@@NGNO=*7.?+S,[8K>Y\+G.JZ--Q='X?L?=
M^XL;CNP14TVY=F]?[*ZE[!,FQ:[([-P\F=WA7;?[BQE/4XV:"DHL;E2L$N1:
M"JHZN?W7NHFT_E'G:*GW?CLY@6W?6[+[*R>*S617*8S!Y1]J[U^9O=GQRZZH
MML8"CPIIMSYK;F.ZVC^YIS+1U60)@CIS55M04/NO=-.,^:FY\S3=8YBAZ3CB
MVOV_68K:VQ=QY'L&JI:2O[*W7U9#VGLW8]6D'7M8*:.KIH,AB,ME8WFH,/G*
M%J-FGE++%[KW0I=V=T;GZI[,ZQQM#CUW#A]Z;9K:2KVN:RAQD9W3D^_OB_TW
MM[*Q;@EQ%974]#BX>^*VJJXM#BJ6BA6-8FUE_=>Z"#+?,'<>4P3/0;?P.RMP
M;$[BZDV-VS1'=DNZ9J>GW+\KL[\>\Y1["Q+;!I,UOW"[AAV#FY:#(&FP=2>!
M##)64E91Q>Z]U.J_FANZFQ?4NZWZ.Q]'L#N7=FT]M;7WG7]T;2KL?0T/8V%V
MWD.NMX[A79.&WM#B=GY_.YPX&>L:=A39N?&PPBKCR<<T7NO=#[T3AN\,0F^/
M],^>I<V]7N:>;:_@.-<4]!]Q7&=Z)L;34VG U-.]+]G'4+#5Q%)5DA3AYO=>
MZ'[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$_P#B
M?_Q\?S#_ /%P-Z_^^KZ;]^Z]T;B"DI:5JEZ:FIZ=ZRH-76/!#'"U55-%% :F
MI:-5,]08*>-"[7;0BB]@+>Z]U(]^Z]U[W[KW7O?NO=-5?G<'BI$ARF9Q6-FD
M3RQQ5^1I*.22/44\B)431LR:E(N!:X]O1V]Q,-4*.ZCT4G_ .J-(B8=@#\S3
MJ!_?+:'_ #U6V_\ S^8S_P"JO;GT-[_OF7_>&_S=:\:'^-?VCH,.VNW.L^M-
MP=8T>[J*DRN]=ZY7<&,ZGQPEV;0YS-;@I,$]3E<'LK*;WSVV,;5[MR^%F=8,
M50UC9;)4RU#PT\M-2UDD"7ATYT"F[/D)\5:/,=NU&=VKMW,;BZ7PN[8=TM/M
MS84VXZBNZZP6X]U97K^BI,SE*3.XS=4NU-V9+,83&YB/%KGL'F*G*8IJS&SU
M-7[]U[I=9/=O0$^!WSO+>W6V#Q57U9D,9T3G<;N+9.T,[N>.?<U-LVKV?U=M
MM=OR[FIL_3[Z?LG"4^*PU!4S+59#*149A2K\D*>Z]TV[RH>ALG@:7"=E[/QO
M1\.R=[8[?&TIMPTG66$JZ67KS-]:]HU79FV:W!Y#=F+Q6R</O-L-3YG(U1HX
M!D*<05@$4U,U1[KW2JJ^R?BSGMYQ5=;N+I_-[ZQ>8QNVX<S41[<RF;QN7QV_
M<GLK&8U,^]//+128GM7&SX1+3JE)N8K072OFBA?W7NL>R.U/BKN&@I,WUQNC
MI_-TE-)#'A*K92[=R,U:-_T&9W333[4AP=/-5YNCWMCJ#)U\<^-2>')I1UTJ
MM)]M5&/W7NF>LWW\3]OXI-R8VEZGR&&W%M/%;,7-;5PNSZ^@W+USD<#7[KHM
MNX.NHHDA[ VFFW6>N&%PS920T]5&Z4;"H37[KW2HVY1?''? QV,Q&S>NZR;<
MF#I]XT^%R/7V,Q]754%5MW$TC3UV,RN"II(<Q2;3W30155),JUU)C<G3":-(
M*J'R>Z]T&O8W>70/46%WMN#)==XT5NR.ZMM=:C%F#IKK^KW+VE4==;5WSM^L
MV[N;MC>_6^PX:JEV/FZ<4=7D\SC:B4TC4U&)7-+'/[KW3UENP^AEF79_]SOM
MJS+Y#?6#VE'MFAV_@LMGMTR[MVSUUVM2=?YW Y[%Y7#[HP.]=[4]%FLE!4X]
MH*N*IG6J84<TT7NO= /\<8_C<G<U/M+J/K"LV]4X_:>#[&&Z,,N%VQ1965L?
MNS:6%I-_;&V?08''19C:F.R>3AC:NII9H9<E3U%1>JK*>8^Z]T.%5W9T!O?<
M.U*+<.T,/E]RYSM#LOI:C3<]'UED<UM^MZ@J-^[CW)FLS!5[FK<KA]CBMZ;K
MJVCF"-,TL%).]/$7C<>Z]TMJ?)_&M\[MT4N,ZQ7=7\>R>,VW VV,'0[BQ^Y<
ME64>\JJEA%9C*6NV[DMRY+&4>4@><TO\4G6DJ8FF9Z>1O=>Z+_M;O?X>;GV]
MMG*/UCMW;."[!QN3SV['W;UAMG!8O:E5GNM-@_(C<L&^:FHI&QV6FJMJ[EQ6
M:RN1QSY3$H**2MJZU(J59S[KW1KLUW5U%M9,PF:W]M?$Q[9CKOXLLM?$L>/@
MP<%?49]P(@RRT^TZ'$551EVBUIAZ6DFFK#!%%(Z^Z]UX=X=0R97/82G[&VG7
M93:N43"[IH\;EZ;*/MC*&I>CGH]QOCVJ8L%)CJM!%6FJ:):&22-:@Q&6(/[K
MW4?=G=NP]B;P;:>]<C'M.G3:^&W,V\=PY# 8C9WDW%O6AZ_P&V17UV:@R3;H
MS>YLG304E.*,Q5$D\<<<K3NL1]U[I/YOY+=1XS"[-SV)W-1[PH=]9SKK#X5M
MJ55#DO%3=F[_ *+KC 9S*O+5TT.*Q<>XJBI219V2J?\ AE>D,,LM%4I%[KW3
MI/\ (?IFGS>.VR^^L>^XLO'5RXG!4]#F:O+Y2*AKMDXZJEQV/I<;-55T<<W9
M>VWU1(P:FW!C*A;P5]+)+[KW0T>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>ZUV?YZ?\V7?WPJVSM/JCXA9/^\/R0V_N#8W?/R4
M&$VOCMZP] _";:.X8:KL;>N__P"+8#<NW-KU'9]:E'MG$154(R=1!DJJHQX2
MJBI)3[KW6Q(CI(BR1LKHZJZ.C!D=& 965E)#*P-P1P1[]U[KE[]U[KWOW7NO
M>_=>Z][]U[HG_P 3_P#CX_F'_P"+@;U_]]7TW[]U[HX'OW7NO>_=>Z][]U[J
M-5U#4M/).M-4U9CT6IZ18WJ)-3JG[:RRPH= ;4;L/2#_ *WOW7NB^]F=(]&=
MS9:@SO:_Q_P78>9Q>.&)QN3W;M';V:K:+&"IGK!04U16UDLD5**JIDDT VUN
M3]3[/MJYFYAV.%K?9[VXMH';4RQNR@M0"I \Z "ORZ0W6W;?>N)+N&.1P* L
MH) XTST&W^R8?#G_ +P_ZW_]%QM+_K_[,_\ 7!YX_P"CM??\YG_S])OW#LO_
M "BP?[P/\W2^[OZ^Z_[9V1)U_P!EX[<-)UOG,95[,S6SJFDV%_=C=5)G6QU/
MC\;60;HH\PU/E\?48^,XFIQTE'D:.=V>GE6325"#%G8NQJQ-2?4GHV% *#@.
MBS9KX<=45&7W5FYNU.^,+5#J7L3IS?;057Q]2:IZL[*H\A+BL7O[*Y3K&MSN
M:R77*93(U.U]PYFKJ-PT_P#%,G]UD*Z+*9)*K5.O5Z-;E-H===A]5'85)MK)
M/LS(28K+8K+[)AVOB9*#=&VMQT.Z]O;ZVW6[<F@PU!NS;F^\)39BDJJ> 1PY
M6E23QG24]^IUZO0=Y;JS:794>8DS&_\ M;>2=B;'WILK(RQ5'3TL&X^L-P4F
MT<'NC:]+!A=I4U#-M^CKL8\OW<$8KJ2LS]:HJE2:FBI_4Z]7H.:SJ;J2FW1A
M,4O:7:#;HW5FJOL;:NW)<OT[&F?K:7Y-+\I_-1O#L>IJWQ,O8[_P]=!D=\*K
MQ1ZZJ-ZL>IUZO4[I;H.@VSMCJ_%[FW1O;*]T]-;'Z6VSDLQMBNZ\KUVM/USU
MKV)L7"T%!C9]H8N.3;^8P_;.Y9HCF<9+72KD Z2@T\+1^IUZO373?#7H_;];
MC<=15G:6!SF:J**KJQ0S]68?-=BQ;6%?+(NZ*>DVO2MO6HQ]%F13C(3Q393%
M8\)34551TSR12^IUZO0P=2]"[;Z@W5DMV8BH[.W)6Y/%XV@EAW;@.GJJ6GJJ
M';FV=L5>7HMQX/9& WQ35&:Q^TZ1JJB&5.'$P9H**!=*KZG7J]*@]?STDO;T
MF*J=W31]W;HI]P[PQV[-J[)W1A\73CKC;75]?C-IXQ!AH5CK]N[/Q[-_'3GZ
M8SQR>2GDBE:(>IUZO2)Q7QHZOP$.UJ7;VW^R,)1; 6M/7%+2U6"JQL"HS.[-
MF;XW+6X"KR\>2R5;5;JW5L>EJ\@<I/D4F,]5&JI%4R1GU.O5Z'C9E#C=B;5P
M.S\!MC="8C;V-I\;1M518^>LJ!"MYJ[(5(KX_N\ED*AGGJ9BH,T\CN1=C[]3
MKU>@'S_QSVAN?:-)L?.57<E9MVG[&[P['GIHY]CX^IR%7W]B>X,+O7;E3D<9
M@Z.OIMNT-%W?FOX:U))392F<4[25LQB.OU.O5Z3\/Q=Q,>0V'E'WWWP:G8>X
ML7NZ*&AVY\<]N8K<VZ<16K)3[CW/@-I]08# 2YY\'JPS5M#2T%4,0[0I(C,9
M/?J=>KTF:+X6;%H=H5FQXMW?(9\'7;+S.QJA96Z?-6<9F_COL;XT5%:M0G7L
M>G*4^Q^OJ&MB;3X!F&EE>)Z9UI$]3KU>E9OGXRT&_>N=S=5Y'LCY)8S:&[-R
M=E;CS%)B)>GA4S_Z5Z'L"/=V!>HRW7>6^[VV^<[&J\O24M2L_P!ED*6C6)EH
MZ<4C>IUZO4JK^,VTZ_<N)W9D,IVYD\MB]W=A;ID7,X#I+/8S*4_9M;L');FV
MO78?.==Y+&0849#K;&S4E51Q4N=I3YD3(>*9T]^IUZO2V[&Z@Q'9.[Z#>.1K
MNVL'58^GZ[ABQ6WX>OUQ$LG6G;NW.YL'5S#-X#.90U%9N3:]-2U@6J2)\<72
M-(IV%0OJ=>KT$.6^'6R<WB]W[=R6ZOD)/M3L3=4&\.P=K+4]64^,W=F*;O+.
M]\QM55E-L>+<."A.X=PS8MOX-78R5\,D2ES6QBN]^IUZO4Z?XG[<J<=UY3S;
MQ[RBS/5V_*#L_:6[<1MSX[[6W%!O^BI<7MZ?=.0_NEU'@<%E,IFNMJ?([0KV
MFH66KVUG\A3R*9C25-)ZG7J]'(_C\W_/.;B_\YJ#_P"N7OU.O5Z]_'YO^><W
M%_YS4'_UR]^IUZO7OX_-_P \YN+_ ,YJ#_ZY>_4Z]7KW\?F_YYS<7_G-0?\
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MQ]M_S$.R<;\@MK?'?XU?Z*/BU\@</L?;76NWNQ9OD[OW =M]PKB]B;?K:C^
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M #U&W?\ S]XW_P"J??J'T/7NO?WOVG_SU&W?_/WC?_JGWZA]#U[KW][]I_\
M/4;=_P#/WC?_ *I]^H?0]>Z]_>_:?_/4;=_\_>-_^J??J'T/7NO?WOVG_P ]
M1MW_ ,_>-_\ JGWZA]#U[KW][]I_\]1MW_S]XW_ZI]^H?0]>Z]_>_:?_ #U&
MW?\ S]XW_P"J??J'T/7NO?WOVG_SU&W?_/WC?_JGWZA]#U[KW][]I_\ /4;=
M_P#/WC?_ *I]^H?0]>Z]_>_:?_/4;=_\_>-_^J??J'T/7NO?WOVG_P ]1MW_
M ,_>-_\ JGWZA]#U[KW][]I_\]1MW_S]XW_ZI]^H?0]>Z]_>_:?_ #U&W?\
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M_,/_ ,7 WK_[ZOIOW[KW1P/?NO=>]^Z]U[W[KW7"22.)#)*Z1HMM3R,J(+D
M79B +DV_U_?NO=1_XA0?\KM)_P"=,/\ T?[]UJHZ]_$*#_E=I/\ SIA_Z/\
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MLKI&SLC$!@+B[\NT;I! +F:WF6 ^94_;G&!3S-*]56>%FT*REOMZ6G\0H/\
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MQ^V^ANO-NX':7CR&6GR&XA48R"KI6J*=$J%<>J>O= 3OW^;ON_KW;LF$W/\
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M3M6XW<!%0\^F"'Y$&HUCYB0"N/M8N=XM+>3P;FYACD'%5J[?80 :'\J]%K[
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MVT5.3IX?X1G*:IR-'$2U/'44LU,9+&1)%!B=98?0?4J=R\7Z05KX=-1] -1
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MR\-V1O'>GR8VOM[!Y>FJ=X5.+WQUQUOLW;*T\LM!$,O6XZ>%FH:/(RTWNO=
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M5S1:H(Z85GNO=-'?'Q?^'N%V3\T^M^K^N\?F>X=I[7H.U*2&@W92;AW3L/\
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M*GW7NC-?'_XQ;3ZL[,^074FUOCYA^JMH]A;TPO?Q[$P/:V&WC7G/=>;[VO\
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M[KW1H.^/X)_LG\G]Y_\ 9A/[K_W+Z^_O-_=[^Y/^G/\ @7FV]_$/[]_Z0_\
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MO\9]^Z]T8;JE>KUW)UL,#+DIC_H-G;H)ZZ#%4^('1S?Z*FW+%M*.GJ*K=S+
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M ,.^S_B>O]O^&>;[S_)_/[]U[H,S_LM/^A/=-O\ 2Y_=C_9>]_?QS^/?Q?\
MT@_Z-OX7L'_9C?+_ '[_ -R']_+_ ,(_OQ]Q_N5_O!]SX?\ <U_$/?NO='8V
MC_"/XWO?[?\ CG]X/XI@/[Q?WAT?<_\ 'F[>_AO\%\/^1_W;\?EO]E_D'\:_
5B?C_ '?/[]U[I>>_=>Z][]U[K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>j17244762_ba003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P"Z P$1  (1 0,1 ?_$ :(    & @,!
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MC\,32M(L$;2 1\V[/<<V>Y<W+.R&-8+-%M49R5BBAL8 CN[#6513&Y)H34T
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MVCN7!9=D=S4RQSSS RZ*AHD^][A<<S<B6NYW,CS;IM^XW"7!)JQ2\TS1RMZ
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HPU%^T'2>-.DUR+0^']7X=?$&C53^T_#IK^+C2F:5\J]"3[+.E/7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>j17244762_ba004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@!T P$1  (1 0,1 ?_$ :(    & @,!
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M[J;%0$FRH3;\VO\ \5]^Z]U,6@<'E2#_ +'_ (W8^]=>Z<(\6Y4G3_AS^?\
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M-]GEJ4-P6L!JX(]TD'=^75XSCJC<038]G0JVF)PR2@']R._%C:X8%N03]?\
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M>]@.6+ &Y!_UC^/?NO=)*7_<;E-14BASLL<+L>%ILV D-'.;*=,>4B1:=O\
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K_F]_3_:O?AU[JSO_ +IN_P#=N=_V6G_Y:G_S(S_W_P#_ /*[[W^+KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>j17244762_ba005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ W@&I P$1  (1 0,1 ?_$ :(    & @,!
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MOP;Y$U4I73(!6E32OI4_;T:-)XUD9:4U1DT^T=:VWO)[H&]*S87_ !_.S/\
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MD4:&-F4ECP)'E\NJI/\ 3UWG_P _H[8_]&+O#_Z\>Y>_J]L'_*#9_P#.&/\
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M^\<+_P#Y7I_^ED/^KHZ%T7_),'_-'_GWK7N]Y']!'I6;"_X_G9G_ (=FW?\
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M53CMP8G*83,0Y."JP;XFI,4]-]@].8)KLIU<^Q?MW)&^[I91W]HL1MY 2M7
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M6_[6V)_]YG">YHY)_P"56L_](W_5Q^@[N/\ N;)]H_P#HLOL5=(NMA'X._\
M9+G6'_DZ_P#OQ-V^\<.??^5LN_\ FU_U9CZ%VU_[@I_MO^/'K7N]Y']!'KWO
MW7NMA'Y4_P#9)>^__#2VO_[NMN^\<.4?^5QM_P#FM)_QU^A=?_\ )/?_ $H_
MPCK7N]Y']!'HPGQ1_P"RB^H__#MIO_<:J]AOF_\ Y5J\_P":)_PCI78?[F1_
MZ;JPG^9I_P >-UC_ .'9F/\ W3I[CCVL_P!S[O\ YHK_ ,>Z-][_ +)/],?\
M'5.7N:^@[U8__+1_YFMOW_Q'K?\ O28/W&/NC_R1[?\ YZ?^?'Z.=E_W(?\
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M_-%?^/=&^]_V2?Z8_P"#JG+W-?0=ZL?_ ):/_,UM^_\ B/6_]Z3!^XQ]T?\
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MCU_]J;V+/]8CVI_Z-7_9S>?]M'1)_KE<Z_\ *;_U1@_ZU=;>WQV[4WYW=_+
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M3U7![D[HFZMW_EB_\6+M_P#[6VSO_</</N&O=7_<BR_TDG^%.A!LGPR?:/\
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M6'O./_*U;A_SUR?\>/1)O8ZZ#77T$?A#_P!N>^L?_%4=Z_\ NDW;[YS\^?\
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M%_\ "9;_ (_GY=_^&IT]_P"[CL'WBA]Z;_<#9O\ FM<_\=AZFSV9_P!RK_\
MYIQ?X7ZK[_GO_P#;RGN#_P -3J/_ -]GMGW(WW?_ /IU]E_S6N/^K[]!3W0_
MY7&X_P":<7_5M>J>/<T]1]UO=_\ "?[_ +=V[<_\2OVA_P"[.A]\_OO%?]/*
ME_YXX/\ CIZR?]JO^513_FO)_A'6DWWQ_P SQ[F_\2MV)_[U^8]YT\O_ /)
ML?\ GCA_ZMKUC?NG_)3N?^:\G_'ST%'LXZ0=?02[O_[<M[G_ /&?>%_]\GB?
M?.?8?^GXQ?\ BQM_VE-UE;N?_3N7_P"E4O\ U9'7S[??1CK%+HUWP._[+C^&
M?_BUWQW_ /?O;/\ 80]P?^5"WO\ Z5%Y_P!H\G1[RO\ \K-MW_/=;_\ 5U.M
M[;^91_S(S:G_ (EC!?\ O'[[]X ^U_\ R7YO^>-_^KD766>]?[BK_P U!_@;
MJD;W._09Z/E_+I_YG_6?^(]W'_[L]O\ N/?<O_E75_YZ4_XZ_1KL_P#N6?\
M2'_".E;_ #+O^9K;"_\ $>K_ .])G/:/VN_Y(]Q_ST_\^)TYO7^Y"?Z3_*>J
MX/<G=$W5N_\ +%_XL7;_ /VMMG?^X>X?<->ZO^Y%E_I)/\*="#9/AD^T?Y>B
M1?,C_LI?M;_M;8G_ -YG">QWR3_RJUG_ *1O^KC]%FX_[FR?:/\  .BR^Q5T
MBZV$?@[_ -DN=8?^3K_[\3=OO'#GW_E;+O\ YM?]68^A=M?^X*?[;_CQZU[O
M>1_01Z][]U[K81^5/_9)>^__  TMK_\ NZV[[QPY1_Y7&W_YK2?\=?H77_\
MR3W_ -*/\(ZU[O>1_01Z,)\4?^RB^H__  [:;_W&JO8;YO\ ^5:O/^:)_P (
MZ5V'^YD?^FZL)_F:?\>-UC_X=F8_]TZ>XX]K/]S[O_FBO_'NC?>_[)/],?\
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MR[Z@OK:+_P"$RW_'\_+O_P -3I[_ -W'8/O%#[TW^X&S?\UKG_CL/4V>S/\
MN5?_ /-.+_"_5??\]_\ [>4]P?\ AJ=1_P#OL]L^Y&^[_P#].OLO^:UQ_P!7
MWZ"GNA_RN-Q_S3B_ZMKU3Q[FGJ/NM[O_ (3_ '_;NW;G_B5^T/\ W9T/OG]]
MXK_IY4O_ #QP?\=/63_M5_RJ*?\ ->3_  CK2;[X_P"9X]S?^)6[$_\ >OS'
MO.GE_P#Y(%C_ ,\</_5M>L;]T_Y*=S_S7D_X^>@H]G'2#KZ"7=__ &Y;W/\
M^,^\+_[Y/$^^<^P_]/QB_P#%C;_M*;K*W<_^G<O_ -*I?^K(Z^?;[Z,=8I=&
MN^!W_9<?PS_\6N^._P#[][9_L(>X/_*A;W_TJ+S_ +1Y.CWE?_E9MN_Y[K?_
M *NIUO;?S*/^9&;4_P#$L8+_ -X_??O 'VO_ .2_-_SQO_U<BZRSWK_<5?\
MFH/\#=4C>YWZ#/1\OY=/_,_ZS_Q'NX__ '9[?]Q[[E_\JZO_ #TI_P =?HUV
M?_<L_P"D/^$=*W^9=_S-;87_ (CU?_>DSGM'[7?\D>X_YZ?^?$Z<WK_<A/\
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M !T].1?VJ_Z8?X>KN?Y@O_9.F2_\.W:W_N3/[@CVX_Y65?\ FC)_@'0FW?\
MW#/^F'5#7O(/H*]''^!?_92^S_\ M4[O_P#>9R?L$^X7_*K3_P"GC_ZN+T8[
M5_N:OV'_  'HPG\SK_B^]0?]JG>/_N9M[V&_:K_<>]_T\?\ @?I7O?Q1_8?\
MG56GN6NB/JTO^6+_ ,7WM_\ [5.SO_<S</N)?=7_ ''LO]/)_@3H\V3XI/L'
M^7JW?W#70AZ][]U[KWOW7NO>_=>Z^;7_ #)/^R^OF!_XL%V9_P"]+7>^G?MC
M_P!.\V7_ *5L'_'!UA[SC_RM6X?\]<G_ !X]$F]CKH-=?01^$/\ VY[ZQ_\
M%4=Z_P#NDW;[YS\^?]/HN_\ I;Q?\>CZRNY:_P"G?P?\\+_\=;KY]WOHQUBC
MTK-A_P#'\[,_\.O;O_NXH_:/</\ <"?_ )HO_P =/2BU_P!RH_\ FHO^$=;W
M7\]__MVMW!_X=?4?_OS-L^^?_P!W_P#Z>A9?\T;C_JP_63WNA_RIUQ_S4B_Z
MN+UH,^^AG6+/5KG\D+_MZ#\8_P#RM'_P/7;/N(O??_IU.Z_]0W_:9;]#KVU_
MY76R_P";W_5B7JUO_A3K_P!R1?\ ERG_ ,P+W$/W5O\ EO?]07_:WT.O>G_E
MF_\ 41_U@ZU2/>7?4%];1?\ PF6_X_GY=_\ AJ=/?^[CL'WBA]Z;_<#9O^:U
MS_QV'J;/9G_<J_\ ^:<7^%^J^_Y[_P#V\I[@_P##4ZC_ /?9[9]R-]W_ /Z=
M?9?\UKC_ *OOT%/=#_E<;C_FG%_U;7JGCW-/4?=;W?\ PG^_[=V[<_\ $K]H
M?^[.A]\_OO%?]/*E_P">.#_CIZR?]JO^513_ )KR?X1UI-]\?\SQ[F_\2MV)
M_P"]?F/>=/+_ /R0+'_GCA_ZMKUC?NG_ "4[G_FO)_Q\]!1[..D'7T$N[_\
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MD^&3[1_EZ)%\R/\ LI?M;_M;8G_WF<)['?)/_*K6?^D;_JX_19N/^YLGVC_
M.BR^Q5TBZV$?@[_V2YUA_P"3K_[\3=OO'#GW_E;+O_FU_P!68^A=M?\ N"G^
MV_X\>M>[WD?T$>O>_=>ZV$?E3_V27OO_ ,-+:_\ [NMN^\<.4?\ E<;?_FM)
M_P =?H77_P#R3W_TH_PCK7N]Y']!'HPGQ1_[*+ZC_P##MIO_ '&JO8;YO_Y5
MJ\_YHG_".E=A_N9'_INK"?YFG_'C=8_^'9F/_=.GN./:S_<^[_YHK_Q[HWWO
M^R3_ $Q_P=4Y>YKZ#O5C_P#+1_YFMOW_ ,1ZW_O28/W&/NC_ ,D>W_YZ?^?'
MZ.=E_P!R'_TG^4=)+^8M_P S_H__ !'NW/\ W9[@]K/;3_E76_YZ7_XZG3>\
M?[EC_2#_  GHAON0NBKJ[G^6O_S(S=?_ (EC._\ O'[$]P1[H?\ )?A_YXT_
MZN2]";9?]Q6_YJ'_  +U4]WU_P SS[H_\2QV+_[V&8]R_P O?\D"Q_YXX?\
MJVO1!=_[E2_\U&_PGH)_9QTQUL([&_[(IQ?_ (KW6_\ O$U?O'"__P"5Z?\
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M^Y?_ "KJ_P#/2G_'7Z-=G_W+/^D/^$=*W^9=_P S6V%_XCU?_>DSGM'[7?\
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MQ_\ #LS'_NG3W''M9_N?=_\ -%?^/=&^]_V2?Z8_X.J<O<U]!WJQ_P#EH_\
M,UM^_P#B/6_]Z3!^XQ]T?^2/;_\ /3_SX_1SLO\ N0_^D_RCI)?S%O\ F?\
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M*]''^!?_ &4OL_\ [5.[_P#WF<G[!/N%_P JM/\ Z>/_ *N+T8[5_N:OV'_
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M]^-E?\]AM;_T(,3_ /5?L;?U@V#_ )3K/_G-'_T%T'?W7N?_ "C3_P#.-_\
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M^Q]N35#PT&/SE152I!"A=RJ$*H)-@/>!WL/<VUI[EV<]U(D4 BN*L[!5%87
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M[CNI/EE75LF0VKVOMWK_ +5[#V[NIICE)J+<6 W5VOM;;_5N,QNY,15[?/\
MHZI]I[=*144*TF7I]U4M?%#)49!\GD/=>ZL>1TD19(V5T=5='1@R.C ,K*RD
MAE8&X(X(]^Z]T7/O_<.]L5E>F\%L+=4.W<OOG>78&V*J"L.+CQU73Q?'ON;<
M6"R&4JJO!YS(XVAP?8.!P<K5--&RJ\BQRQSB58F]U[HOX[([6J=L_'C)[5RU
M=3QR;^QNQ-[8.7=V/W[E]Q9G*=]=>X@[FPNX\KM[:N0[*ZQR'0^"[ R^.R%/
MCJ:=\)58_-/00?:?<X_W7NK#O?NO=$/[P[#W]C^V-W;'QVXI*;K^3;_QXK-Q
M53U4N(@V)19W,?).?=-8N;VOBYMWTM'OG-['V9MW)RJU1+C*'.?<P&C+BI7W
M7NA0ZTK<CO/LK";VH<SOC;6);IO'Y#=W3F;R=)_ =I[HW/E:+!X7#TV%IL.H
MI<YL6LZUW+09,K5I']W4C3'*NDP>Z]T:#W[KW1&:#/[CW/NFIK,CVSN['ILK
MY#=G19.#%9'#8[%474W7%)2;GR='G,/C]N/29;$TE:V,P$\M24JXZ/+F3SM6
ME9F]U[H>NIMSYO/[O^0^+RF<DS>.V=W11[=VIY(L7&,7M^?I7IW<M;B()<91
M48K*?'[SW!EX_)/YJE)%>&25FBLONO=#!D9(HL?72S5_\*ACHZF27*:Z2/\
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M28^*2:=*>EG9*>-W9=",1[KW6.FZ-[,S&^LC@*/YW?,O(Y79V/2+*[I7KO\
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M,\-?ALG687+T%70Y#X+TM=15V,RV/GIIX9HXY8IHF5E!!'OW7NGK_9:>Y_\
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4\,E4].UX8:>23W7NA4]^Z]U__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>j17244762_ba006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ S@&7 P$1  (1 0,1 ?_$ :(    & @,!
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MR?\ /.4G_G]/_P!:??J#UZ]GKW\2W)_SSE)_Y_3_ /6GWZ@]>O9Z]_$MR?\
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MG*3_ ,_I_P#K3[]0>O7L]>_B6Y/^><I/_/Z?_K3[]0>O7L]>_B6Y/^><I/\
MS^G_ .M/OU!Z]>SU[^);D_YYRD_\_I_^M/OU!Z]>SU[^);D_YYRD_P#/Z?\
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MZ][]U[KWOW7N@][;_P"94]G?^(]WI_[S>2]F6S?\EBT_YZ8O^/KTS<?[CO\
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M!FD_^O'OU.O=>_TFR?\ /N.T/_09I/\ Z\>_4Z]U[_2;)_S[CM#_ -!FD_\
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MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ5_Y\W8N\NL/A#B=R;%S<^
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MO[O[D_YZ6D_\]V?_ /LS]^KU[KW]W]R?\]+2?^>[/_\ V9^_5Z]U[^[^Y/\
MGI:3_P ]V?\ _LS]^KU[KW]W]R?\]+2?^>[/_P#V9^_5Z]U[^[^Y/^>EI/\
MSW9__P"S/WZO7NO?W?W)_P ]+2?^>[/_ /V9^_5Z]U[^[^Y/^>EI/_/=G_\
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MV_P'KY7OOK3UA!U[W[KW5@G\JG_MXE\2_P#Q*^/_ /=9E/<<^[G_ $[7>/\
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M_N"FIHO+-A8X8_)-(HU.RJ+W) Y]\\^3O^5NVK_I96W_ %>3K*;?B/W'>_\
M/)-_U;;KYN_OJEUA=U[W[KW5H'\F;<F%VC_,G^-^X=PUG\/P^/\ ],'WE7]M
M5U?A^[Z%[1H:?_)Z&"IJI/)55*+Z4:VJYL 2(B]]_P#IU.Z_]0W_ &F6_0Z]
MM?\ E=;+_F]_U8EZWO?]F/Z8_P">Q/\ Z#F[/_K%[YS]965'7O\ 9C^F/^>Q
M/_H.;L_^L7OW7JCKW^S'],?\]B?_ $'-V?\ UB]^Z]4=>_V8_IC_ )[$_P#H
M.;L_^L7OW7JCKW^S'],?\]B?_0<W9_\ 6+W[KU1U[_9C^F/^>Q/_ *#F[/\
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MXP]M5E8V_!]ASG#_ )5+=*\/W=<_]67Z-MA_Y+EE_P ]</\ U<7KZ1>]QO\
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M )5<#_Z%4O\ ]K?W[M^?7NO6["_Y5<#_ .A5+_\ :W]^[?GU[JK/^=4-Y?\
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M-]!RO8.AHIEP.?5]+ AE,:$W!#<$'%'[TM/H-FK_ +^N?^.P]39[,_[E7_\
MS3B_POUM@6["_P"57 _^A5+_ /:W]X==OSZGOKUNPO\ E5P/_H52_P#VM_?N
MWY]>Z];L+_E5P/\ Z%4O_P!K?W[M^?7NO6["_P"57 _^A5+_ /:W]^[?GU[K
MUNPO^57 _P#H52__ &M_?NWY]>Z];L+_ )5<#_Z%4O\ ]K?W[M^?7NO6["_Y
M5<#_ .A5+_\ :W]^[?GU[KUNPO\ E5P/_H52_P#VM_?NWY]>Z];L+_E5P/\
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M(G5K?_"B/_L@7#_^+!==_P#O-=@>XB^[9_T\-_\ I6S?\?AZ'7NW_P JJO\
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M*5<'1Y19,>V-QLT,BY".L\=6K^4D.."#[Z">V')6P;AR!M5[=1R&XDM06HY
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MX/-\?^U8(O-55,D4$7EGE5%U,-3L .2/<1>^_P#TZG=?^H;_ +3+?H=>VO\
MRNME_P WO^K$O6Y5\_?D$.M/AK\AM^]3=E[9QW8VU>OJW+[3KL7F=OY:OI<G
M3UM#^[3XZ2>J2J9:9I+J8V]-S^+^\'O;;;+'>>>MLVO<HQ+83W(5T/!ETL:8
M^SK(SFR]N=NY<N[ZS;1<QQ$J>-#4>O6EW_P\1_,6_P"\A\A_Z"NU/_K5[SO_
M -9GVT_Z-<7[6_S]8X?ZXW.'_*7_ ,97KW_#Q'\Q;_O(?(?^@KM3_P"M7OW^
MLS[:?]&N+]K?Y^O?ZXW.'_*7_P 97JT+^4%_,A^5G?'S*PVPN_N[X\WUS)U]
MOO+UM#F,=MC T!R>-HJ3^%2RY&*DHWC:.IG]*^0:V('/T]Q'[V>W/)G+7(LF
MZ;'8QP7XN85#@DD*S$$9/GT-_;[G#F'>N8UL=RG\2V,3FFD#( IPZMT_G6;W
MV7F/Y9?R6QV)W?M?*9"H_P!#?V]#CL_B:VLG\/R ZJGE\-+35<L\OB@B9VTJ
M=**2> ?<)>Q'_3UMJ_ZB?^T.XZ'_ +E?\J5>_P#-G_J_%UH*^^C'6*77O?NO
M=;$'_"<3.83 ?*+O.KSN8Q6%I9>@Y*:*IRV0I,;3R5#=A[,E6".:LFAC>9HX
MF8*"6*J3:P/O&?[S_P#RJ.W_ /2R'_5F7J7O9S_DN77_ #R?]9$ZM._X4&[O
MVGGO@=B:/![HV[FJR/OSKVI>DQ.;QN1J4ITV[OR-YV@HZF:584DE12Q&D%@+
M\CW$7W;/^GAO_P!*V;_C\/0Z]V_^557_ )ZX_P#CK]:2/O/7K&?KWOW7NMG7
M_A-;G\%M_>?RVJ,]F\1A()]L=/PP2Y?)T6-CGE&5["<QPO6SPB5U1;D+<@?7
MWBA]Z8']W[,?+QKG_CL/4V>S/^Y5_P#\TXO\+];8?^DKKK_GOME?^A5@O_J_
MWASU/?7O])777_/?;*_]"K!?_5_OW7NO?Z2NNO\ GOME?^A5@O\ ZO\ ?NO=
M>_TE==?\]]LK_P!"K!?_ %?[]U[KW^DKKK_GOME?^A5@O_J_W[KW7O\ 25UU
M_P ]]LK_ -"K!?\ U?[]U[KW^DKKK_GOME?^A5@O_J_W[KW7O])777_/?;*_
M]"K!?_5_OW7N@<[/^6_2/4]9B:/<>[*.K;,4U14TDV"EBS-,%I98XIHI:C'O
M4113H95)0D-I8&UB/8EV/E3=^887GVX(4C8*=1(R17R!Z175_;V;!9S0D5'^
MJO06_P##B/QL_P">CK__ #VU/_7OV>?ZV7-'\,7^]'_H'I-^^[#^(_R_S]>_
MX<1^-G_/1U__ )[:G_KW[]_K9<T?PQ?[T?\ H'KW[[L/XC_+_/T-6V_DYT[N
M?K[)]DT&[<9#@\509_)34U=64U'F)Z7;E-4560>CQ51+'6U5TI9%CT(VMU*B
MY!'L-WO+NY6&[Q['<!?KI60* 32LAHN:>O''2R.\@EMS=(?TE!)_+CT8#V1=
M*NO>_=>Z+)V/\9MG=I=@4._\[B-L8;.[:J,;E=M;IV_@::GWS6[BP+X;)[3R
M.[=RJE+69O [0W'B8JVFP<[5%!/5T5%4R%7ID3W[KW0,]T];X#;.]_Y?NSJJ
MGI-P8_(_.#N3=F:3*T%-/19/<&^OA[\_.Q-Q59QE1]U3PTTNZMP5$\$),@@7
M0H8E WOW7NJIOG5_-&V'\4_E1VET'%UELJ6/8?\ <C3(.HMMY75_>CKG:&\S
M_E[K"T]FW$1^D:;:?Q?WDK[?^RD'-W*-IS"X4M<>+QD93^G-)%P&!\'^7J,N
M8?<2SV+>)MJE$ADBT5HH([D5^/V-T4G_ (?,V/\ \^NV5_Z)+;/_ $?[&7_
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M?6__ #[[9'_H*8'_ .H/?)>IZS?Z^7IOL ;XWD  H&Z]Q !0  !EZP  "P
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M@\WR ZJ@E\-52TD4\7E@E9&TL-2,0>"?>+OL0?\ F*VU?]1/_:'<=3+[E?\
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M '<4?M'N'^X$_P#S1?\ XZ>E%K_N5'_S47_".OJ@^^2W6;_7ROM^?\?SO/\
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M FI5<L$8K_=RX5BAL?S8_P!/8T_X*/9/^C5=?\Y$Z#_^LUN'_*;#_O+==?\
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M;G1:&.(SR!^XHE,< U7F<-MP:(AI/J/'!]^_X*/9/^C5=?\ .1.O?ZS6X?\
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MK=W]N;;W%T1#@*^J2"'+TVQ>K*7(8QG@AB:F\HCJ%65@![KW3=DO^R^]F_\
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MK\HD0KJS&82NW+D9J2GD=HJ:7(5+QJK3REO=>Z*E6_)S.U75,W>VT.OZ3/\
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MVNV5IWSE=5S_ &.,H8JG,9K;T-2F7K%AQ5?0ON#;F0H14TTTU.U9131!R\;
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%=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>j17244762_ba007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba007.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ Q0&J P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ W^/?NO=$%[(^0_;.TLO\A*?!8.'<W^BO*=@Y38F&QU)1
M45;O[+[)Z&^-W8>S_C_35%?)4B;>/;^Y.ULV*&K@5JM(\;HAIW"-;W7NA3V)
MVYV9E.L-Z;FHMBU?:NYMLYG95)MW#8++;4VG5;WH-U]<=4[YS.0HLIG\CBMK
MT%)MS)[]R=/$LLT<CT>)2)FGJRTLWNO=*WH_O*3N[K#;?9F/ZVWEMR+/3;BH
M:C Y7(;'JLAB,IM7=&;VAFJ&>JQ^[)J"K$&7P,X26%VCDCTL#S;WNGSZ]T+'
M\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?Q
MO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\
ME_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7
M_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\
M\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR
M&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;
MB_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+
M_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_
M #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\
M.G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z
M=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IV
MG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?
M_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__
M &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\
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M5FHL+CZC)5T.%WR^1J(Z>G@FG/[<&VBJ/*L#!-;(K,/J.?=OHKA9$CE1T+L
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MVW?_ #NR?_UO]^QU[/7M>[?^5;;O_G=D_P#ZW^_8Z]GKVO=O_*MMW_SNR?\
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MU[M_Y5MN_P#G=D__ *W^_8Z]GKVO=O\ RK;=_P#.[)__ %O]^QU[/7M>[?\
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MA?\ IX'-'_-5O^TF7J;?<O\ Y5?9_P#2#_JTG53O\HG_ +>._%C_ ,/3/?\
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M?)?_ &7^_8^?7NO?;;L_YW>W?_07R7_V7^_8^?7NO?;;L_YW>W?_ $%\E_\
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MJ5"*BO"M>D-QN>VV<GA7=Q!%+2M'D533UHQ!IUEV3W1L#LK*383KOOKHS?\
MF*6E;(56'V3F<+NG*04"2)%)634.#[$R%5#2K+(JF5DT!F )N0/>K_8=\VN$
M7&YV5W;0,VD-+%)&I:A(4%U )H":5K0$^76[;<MNO)#%9W$$L@%2$=6(&!6B
MDFE2!7YCKYO/R>#CY&]ZB1D>0=L[]ULB&-&;^\N1N51I)2H)_!8V_K[Z><H?
M\JIMM.'T$'_5I>L.M]_Y+5W_ ,],G_'SU>A\0$R!_D-_-YTJJ):$;^JO)3M0
M3O5LQRG5 0I6#))#&%;D@P-<<7'U]X^\]T_X(CE[_GEB_P"KEW3^>?LQCCU*
M7+5?]:O=/^:S_P#'8.M;LWL;6!MP2+B_XN+BX_V/O*3J&.MG/^=_'DD^%_\
M+G-=5T-3&VW,G]NM)CZBB>)?[@=<ZA-)-DZ]9V/%BJQVM]#?C%#V%I_K@<T>
MOBM_VDRU_P!7^'J;/<O_ )5?9_\ 2#_JTG54G\I-:I_YB_Q;6CF@@J#O//>.
M6III*N%3_<'=U]=/%543R"W])%]S%[R?].RW?_GG7_J['T N0?\ E<+'_FJ?
M^.-T(G\[E:E/YFOR-6LF@GJA3]-^>:FIY*2GD;_0-U@5,5-+55LD*B,J"#*]
MV!-P"%!1[!_].LV[_3W/_:3+TO\ <W_E=+K_ $L/_5E.CX?\)VX\G)E?FO\
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M\]>'_P#J3W[KV>O?PK-_\]36?^>O#_\ U)[]U[/7OX5F_P#GJ:S_ ,]>'_\
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MB4Q0QQQ1:8G5-*BWHO\ 4GV4>P?_ $ZS;O\ 3W/_ &DR]+O<W_E=+K_2P_\
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M]78NJ;/E#_V4AWO_ .):W]_[TV2]S5RA_P JIMG_ #P0?]6EZCS??^2W>?\
M/3+_ ,?/5[/P^_[<(_.'_P /^H_]VW5'O'WGO_Q(CE[_ )Y(?^KEWU*7+7_3
MJ]T_YKR?\<@ZUK_>4O4,=;07\\K_ +(L_EP_^&UE/_> ZW]XG^PO_3P.:/\
MFJW_ &DR]3;[E_\ *K[/_I!_U:3JIW^43_V\=^+'_AZ9[_W@=W>YC]Y/^G9;
MO_SSK_U=CZ 7(/\ RN%C_P U3_QQNA#_ )X7_;SSY)?\L>F?_?!]6^RCV"_Z
M=9M_^GN?^TF7I=[F_P#*Z77^EA_ZM)T?C_A.=_Q=?FY_XBG8W_6SL/V /O,?
MV&Q?\]DO^"+H3>T/]KN7_/.G^%^M:NI_X$3_ /+:7_H=O>4*?"/LZAQOB/V]
M;0F9_P"X9K:?_AV5/_P8NYO>*,/_ (E//_S27_NUQ]39)_TYB/\ TY_[3'ZU
M=?>6 X]0EU]6SWR*ZSGZ(7\U-\X#8&5Z=RF\NL/C/V!LO(U^Y\5F,G\C-S[=
MV'2[/S$DNU?[H9/;N\]T;9WCCZ>.MRTKTU910XZ>LD>6GK \%'0UTZ>Z]T*_
M9&RMT]N]9=7UFT\CF-A[Z$FS\[C-Q;0W%78O [)ILS04=+O:6IPU<,>-TT$F
MRLAD\=CZ>?&?>K-4QM#)B9B:^D]U[K%L_H?<N,ZQWMLO*]B;CV9E]XY;9F2B
MW#U7EJ6#*;2I]E=<]5[ 7'[6R&Z=LY&BIJ+/KUF]34Q28YQ%'E9X49G J#[K
MW0:_ #;%11_%+K^A?=FZZY\?N;N?'OD*VLQCU^1>A[R[)I6R.1DAQ$$$N1KV
MB\L[I'&C2NQ5%!"C=>O='*_@$W_/1[B_\Z:#_P"MOOU>M4Z]_ )O^>CW%_YT
MT'_UM]^KUZG7OX!-_P ]'N+_ ,Z:#_ZV^_5Z]3KW\ F_YZ/<7_G30?\ UM]^
MKUZG7OX!-_ST>XO_ #IH/_K;[]7KU.O?P";_ )Z/<7_G30?_ %M]^KUZG7OX
M!-_ST>XO_.F@_P#K;[]7KU.O?P";_GH]Q?\ G30?_6WWZO7J=>_@$W_/1[B_
M\Z:#_P"MOOU>O4Z]_ )O^>CW%_YTT'_UM]^KUZG7OX!-_P ]'N+_ ,Z:#_ZV
M^_5Z]3KW\ F_YZ/<7_G30?\ UM]^KUZG7OX!-_ST>XO_ #IH/_K;[]7KU.O?
MP";_ )Z/<7_G30?_ %M]^KUZG7OX!-_ST>XO_.F@_P#K;[]7KU.O?P";_GH]
MQ?\ G30?_6WWZO7J=>_@$W_/1[B_\Z:#_P"MOOU>O4Z]_ )O^>CW%_YTT'_U
MM]^KUZG7OX!-_P ]'N+_ ,Z:#_ZV^_5Z]3KW\ F_YZ/<7_G30?\ UM]^KUZG
M7OX!-_ST>XO_ #IH/_K;[]7KU.O?P";_ )Z/<7_G30?_ %M]^KUZG7OX!-_S
MT>XO_.F@_P#K;[]7KU.O?P";_GH]Q?\ G30?_6WWZO7J=>_@$W_/1[B_\Z:#
M_P"MOOU>O4Z]_ )O^>CW%_YTT'_UM]^KUZG6"IQ"T=//5U>ZLY2TE+#+4U55
M4UV,@IZ:G@1I9IYYI<>L<,,,:EF9B%5023;WX L: 5)Z\: 5/#HKDWS,^%%/
M++3U'SJ^/$$\$CPS0S?([I2*6&6)BDD4L;YU7CDC=2&4@$$6/L7#D#GPBHV3
M=Z?\\=Q_UKZ(SS/RT#0[C8U_YZ(O^@^@_P#E/\R]C="?%/<?RMZSW#0_(S:6
M$R&/QU$FQ>U]K+MS-35=>*"J6EWQM_;.^<8LN/E_SB)3RG5Z3I/M=RER'N',
M/.4/)FZ>-ME](&+>+ WB)2(RK6%VB;N4"E2,,&%1Q3;YS+:[7L$F_P!EX=Y;
MH0!HD&EJN$-'4..TUK@Y%,=4G;:_X4>S;BW'M_;_ /LIVXJ/^.YO%8?[O_9E
MZ"H^U_B=?!1?<^#_ &76#S^#SZM&M-5K:A>_N>IONM^#"\O[]KI4FGT7&@K_
M ,I?4:1^\OB2*G[MIJ('^Y'J?^:'0,?\*-YGJNT/B[5O-52_>=093)C[N2">
MH3^*;CJ)S32U,%+2?<1TGBM'=!I+.0!J/LU^ZYC;-Y7TN8/^.2?YOYGI%[RY
MO+ _\*E_X\G1)/Y(-.U1_,0ZH"U-32E<'O/UTS1JQ\F',7J$L4R-H#ZEN.'
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M;=%>_F/?]EY_+S_Q8;MG_P![;,^Q#[2?].TV7_GB'_'WZ*N>/^5OW#_GH/\
MQU>KIOY-O_;M3^9M_P"&+VI_[X/,>X-^\!_RO?+?^F7_ +2$ZD?VP_Y5K=OL
M/_5INM8>7_.R?\M'_P"AC[RX?XC]O4&K\(^SK9J^<G_;B#X+_P#:^ZU_]Y#>
MGO%CD3_Q(7F#_FA+_P ?M^IGYD_Z=;M?_-1/^.R]4*_$K_LJ;XX?^)SZJ_\
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M]4]>Z]_=?&_\K.XO_0OW9_\ 7OWZIZ]U[^Z^-_Y6=Q?^A?NS_P"O?OU3U[I
MY[=_3>ULE+AMS]IX+;F7ACCEFQ6>[@JL1DHHI@3#)+0Y#=E/51QR@$J2H#6X
M]F-OM.[7<0GM;6XE@-:,D3LIIQH0I&//I++?64#^'--$D@\F=0?V$UZD8/<?
M5&YX<G/M?L6AW/'A:1Z[+?W:[3RN??'4B([M45<6(W-62P1Z4-BP&JUA<^V[
MK;]QL=)O;>:$-PUQLE:<::@*_EU:&[M;BHMY8Y"..E@U/MH3T0NH_FM?RRJ2
MHJ*6H^5U/%44L\U-/$S][DQS02-%*A*X0J2DB$7!(/XX]R)_K+^Z'']T2_\
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M[B>> Q@(Z1A3KD5#4C. U1T2<J^Y5]S#OD.TS6T4<<@>K*S$C2I;SQY=$/\
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MC>]44N0O;._5!>1Y7(&Y<B!JDD9Y'/\ B22?<U\H9Y4VW_G@@_ZM+U'F^_\
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M_P#Y6,[_ )OQ?\?3N?\ 3_7_ (N_^<_VO]?^/OD77K.?I*9'ISJ3,;NR._\
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M #4B_P"TP=2![=_\J9O?^E?_ *L'K6T]Y4]0MUL\?-O_ +<4_#'_ +66 _\
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M/^>"#_JTO4>;[_R6[S_GIE_X^>KV?A]_VX1^</\ X?\ 4?\ NVZH]X^\]_\
MB1'+W_/)#_U<N^I2Y:_Z=7NG_->3_CD'6M?[REZACK:"_GE?]D6?RX?_  VL
MI_[P'6_O$_V%_P"G@<T?\U6_[29>IM]R_P#E5]G_ -(/^K2=5._RB?\ MX[\
M6/\ P],]_P"\#N[W,?O)_P!.RW?_ )YU_P"KL?0"Y!_Y7"Q_YJG_ (XW0A_S
MPO\ MYY\DO\ ECTS_P"^#ZM]E'L%_P!.LV__ $]S_P!I,O2[W-_Y72Z_TL/_
M %:3H_'_  G._P"+K\W/_$4[&_ZV=A^P!]YC^PV+_GLE_P $70F]H?[7<O\
MGG3_  OUK5U/_ B?_EM+_P!#M[RA3X1]G4.-\1^WK:$S/_<,UM/_ ,.RI_\
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MY*&CR'S?W?!6T\=3"OQ]WS*(Y!=1(NZ-BJK<$<@.?]O[=^\KCD&$CC^\HO\
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M^>1O^/I_G/50_P J /\ 9EN_' 4-/V]V#52Z0%4SU6Y\E43LJ* D:M-*Q"J
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M_>NK7[JQ\MG^8FZ%8$WL;JQ'^M[Q2A)_X*:<>7A+_P!VR/J:W'_,&(_].?\
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M@_\ NJE]AK[OO_3L;3_FO<?]76Z-O=#_ )7"?_FG%_QP='1_X3H_\7;YB_\
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MS_>JWW#GW:/^G>S_ /2UF_ZLVW0]]WO^5IC_ .>*/_JY-TH?^$ZW_99V[O\
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MW_:6>M;SK3_F8^P/_#VVK_[O:#WE1>_[AR_\TF_XZ>H7M_[=/]./\(ZV#?\
MA17_ ,S#^)__ (@M?_=Y6>\7_NN_\D[>O^>F#_CLO4Q^\G^Y>W_\TI?\*=$S
M_D<?]O$NJO\ M2;O_P#=8ON1/?W_ *=A??\ -2#_ *OIT%?;'_E<;;_22_\
M5MNBO?S'O^R\_EY_XL-VS_[VV9]B'VD_Z=ILO_/$/^/OT5<\?\K?N'_/0?\
MCJ]73?R;?^W:G\S;_P ,7M3_ -\'F/<&_> _Y7OEO_3+_P!I"=2/[8?\JUNW
MV'_JTW6L/+_G9/\ EH__ $,?>7#_ !'[>H-7X1]G6S5\Y/\ MQ!\%_\ M?=:
M_P#O(;T]XL<B?^)"\P?\T)?^/V_4S\R?].MVO_FHG_'9>J%?B5_V5-\</_$Y
M]5?^]QA/<^\\?\J/O?\ TIK[_M%EZC+ES_E8MN_Y[[;_ *O)U:I_PH6_[+QA
M_P#$2;(_WJO]Q+]VW_IWS_\ 2PE_X['T./=O_E:%_P">5/\ "W2R_P"$Y/\
MV69V'_X@S/?^]1M?VD^\Y_RHEG_TMH_^T>YZ?]GO^5DG_P">)O\ J[%U39\H
M?^RD.]__ !+6_O\ WILE[FKE#_E5-L_YX(/^K2]1YOO_ "6[S_GIE_X^>KV?
MA]_VX1^</_A_U'_NVZH]X^\]_P#B1'+W_/)#_P!7+OJ4N6O^G5[I_P UY/\
MCD'6M?[REZACK:"_GE?]D6?RX?\ PVLI_P"\!UO[Q/\ 87_IX'-'_-5O^TF7
MJ;?<O_E5]G_T@_ZM)U4[_*)_[>._%C_P],]_[P.[O<Q^\G_3LMW_ .>=?^KL
M?0"Y!_Y7"Q_YJG_CC="'_/"_[>>?)+_ECTS_ .^#ZM]E'L%_TZS;_P#3W/\
MVDR]+O<W_E=+K_2P_P#5I.C\?\)SO^+K\W/_ !%.QO\ K9V'[ 'WF/[#8O\
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M7LV"@HZ6B@&TNNB(:2GBIH@3MJ!B1'"B)<LQ/T^I/LG]@/\ IV%E_P U9_\
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M_MD_TP_P];)7_"D7_CZ_B%_XC7>'_NRV][Q8^ZW_ &',/_-:R_P7G4S^\O\
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M;)N-I=78OXW*12*[!1'*"U > ) K\^J^V.P;WM?,+W&XVL\,!MG74Z%14LA
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MUJ*U.0NM:TX:AZ]2O[J[+NVZOMQVVVFG$:3ZM"EM.KP:5IPKI-/L/1*?Y/\
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MVK2UK'W7NBD=6?*G*=E=D[1Z]I=J=;9%<GM[=^8WUGNN^[8.P%ZWRF 3;_\
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M,313M'3YA<@)\959..>HPYIV?)4T?NO=&ZZ9_P!DP_CNYM&C7HQG]]/]-O\
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/HH\51R>Z]U>'[]U[K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>j17244762_ba008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba008.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ Q@&D P$1  (1 0,1 ?_$ :(    & @,!
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M9_YZ,Q_]0>_4Z]4=>_O7A/\ CO6?^>C,?_4'OU.O5'7O[UX3_CO6?^>C,?\
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M^>C,?_4'OU.O5'7O[UX3_CO6?^>C,?\ U![]3KU1U[^]>$_X[UG_ )Z,Q_\
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M ,\OMW_SR8W_ .IO?JGU/7NO?W0VG_SR^W?_ #R8W_ZF]^J?4]>Z]_=#:?\
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M=>_@E'_QVR__ *$&>_\ KE[]7KW7OX)1_P#';+_^A!GO_KE[]7KW7OX)1_\
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M /H09[_ZY>_5Z]U[^"4?_';+_P#H09[_ .N7OU>O=>_@E'_QVR__ *$&>_\
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M /H09[_ZY>_5Z]U[^"4?_';+_P#H09[_ .N7OU>O=>_@E'_QVR__ *$&>_\
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M64E/'704&%&5JY:>70PBF5D ?W+VV_JW>O'S5N5G:V2:=)0F:::J@_I6ZT<
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M-#PZV-_Y>W4_8'1WQ ZBZM[2P']U]][7_O\ ?QW!?Q7"YO['^-]G[UW%C/\
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M]%1_^>%?_KE[]CKW7OL-R?\ /14?_GA7_P"N7OV.O=>^PW)_ST5'_P">%?\
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M;Q:?M_M?OK:_+ZO)K^G&G\^_8ZWT]>]=>Z][]U[KWOW7NB?]K?\ 997Q"_\
M$?\ RH_]P>F??NO=' ]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]TG/[X;1_P">IVY_Y^\9_P#57M5]%>?[YE_WEO\
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M"QJ*  4 'H , =.OW.[/^=)MW_T*,E_]B'MG'SZOU[[G=G_.DV[_ .A1DO\
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MDV[_ .A1DO\ [$/?L?/KW7ON=V?\Z3;O_H49+_[$/?L?/KW7ON=V?\Z3;O\
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M $"NJ_\ [<GOW7NO?[-AN/\ [P\^8'_H%=5__;D]^Z]TL/\ 9A,U_<#^_/\
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<9-L4%:,>*I9ZN*&I>J<2QQ1>Z]U8)[]U[K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>j17244762_ba009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba009.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ S &A P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ V]*CM/OK:W<.Z]@=D9C^[.*W/O2/);2WGB:?9NX>L]B]
M0#8OR'W-@:S[^JV]MS=M#OBHR/56,CW/2;A2HH)(ZLK@:Y]-7+1>Z]T/&Z>Y
M.Q-M=#[2[<H>C-R;RW/D=IX'=.\^M,5N?:6U\ULNFK-FU&YMQ"IK]]Y3;^/K
M)-N9" 8]Z='%7)+*&$>E)"ONO=+CKKLJJ[*Z^V)V-A]G9>CQ&_\ 9NV-ZXND
MR&2P2U]+CMU82ASM#3UJP5\T*U<%-7JL@1W4.#8D<^]XZUGI9?Q7-_\ /+5G
M_GTP_P#]5^_=>SU[^*YO_GEJS_SZ8?\ ^J_?NO9Z]_%<W_SRU9_Y],/_ /5?
MOW7L]>_BN;_YY:L_\^F'_P#JOW[KV>O?Q7-_\\M6?^?3#_\ U7[]U[/7OXKF
M_P#GEJS_ ,^F'_\ JOW[KV>O?Q7-_P#/+5G_ )],/_\ 5?OW7L]>_BN;_P">
M6K/_ #Z8?_ZK]^Z]GKW\5S?_ #RU9_Y],/\ _5?OW7L]>_BN;_YY:L_\^F'_
M /JOW[KV>O?Q7-_\\M6?^?3#_P#U7[]U[/7OXKF_^>6K/_/IA_\ ZK]^Z]GK
MW\5S?_/+5G_GTP__ -5^_=>SU[^*YO\ YY:L_P#/IA__ *K]^Z]GKW\5S?\
MSRU9_P"?3#__ %7[]U[/7OXKF_\ GEJS_P ^F'_^J_?NO9Z]_%<W_P \M6?^
M?3#_ /U7[]U[/7OXKF_^>6K/_/IA_P#ZK]^Z]GKW\5S?_/+5G_GTP_\ ]5^_
M=>SU[^*YO_GEJS_SZ8?_ .J_?NO9Z]_%<W_SRU9_Y],/_P#5?OW7L]>_BN;_
M .>6K/\ SZ8?_P"J_?NO9Z]_%<W_ ,\M6?\ GTP__P!5^_=>SU[^*YO_ )Y:
ML_\ /IA__JOW[KV>O?Q7-_\ /+5G_GTP_P#]5^_=>SU[^*YO_GEJS_SZ8?\
M^J_?NO9Z]_%<W_SRU9_Y],/_ /5?OW7L]>_BN;_YY:L_\^F'_P#JOW[KV>O?
MQ7-_\\M6?^?3#_\ U7[]U[/7OXKF_P#GEJS_ ,^F'_\ JOW[KV>O?Q7-_P#/
M+5G_ )],/_\ 5?OW7L]>_BN;_P">6K/_ #Z8?_ZK]^Z]GKW\5S?_ #RU9_Y]
M,/\ _5?OW7L]>_BN;_YY:L_\^F'_ /JOW[KV>O?Q7-_\\M6?^?3#_P#U7[]U
M[/7OXKF_^>6K/_/IA_\ ZK]^Z]GKW\5S?_/+5G_GTP__ -5^_=>SU[^*YO\
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MHW;_ ,K.W?\ SAR?_P!</?L=>SU[1NW_ )6=N_\ G#D__KA[]CKV>O:-V_\
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MQ.C':/\ DI1?:?\  >MG/1NW_E9V[_YPY/\ ^N'O$['4@9Z]HW;_ ,K.W?\
MSAR?_P!</?L=>SU[1NW_ )6=N_\ G#D__KA[]CKV>O:-V_\ *SMW_P X<G_]
M</?L=>SU[1NW_E9V[_YPY/\ ^N'OV.O9Z]HW;_RL[=_\X<G_ /7#W['7L]>T
M;M_Y6=N_^<.3_P#KA[]CKV>O:-V_\K.W?_.')_\ UP]^QU[/7M&[?^5G;O\
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M )Z_<7_G-M/_ .Q?WZH].O=>_@F2_P">OW%_YS;3_P#L7]^J/3KW7OX)DO\
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MM'_)2B^T_P#'3ULY_P $R7_/7[B_\YMI_P#V+^\3JCTZD#KW\$R7_/7[B_\
M.;:?_P!B_OU1Z=>Z]_!,E_SU^XO_ #FVG_\ 8O[]4>G7NO?P3)?\]?N+_P Y
MMI__ &+^_5'IU[KW\$R7_/7[B_\ .;:?_P!B_OU1Z=>Z +Y4XFOA^-W=\LFY
M\Y5)'UINQGIYZ?;2PS*,54$QRM3;>IZ@(WT.B1&_H1[$?)Y_Y%.WX_XEQ_\
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MK0=!JYW][>X> 1 A&(KJXT_+H.?^'=-Q_P#/C\+_ .AU7?\ V,>S/_6:MO\
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MY]Q5[P?\JU!_SW)_U:FZ/N7/]S7_ .:1_P"/+UL%^\<.AIU2[_-[_P"Y>O\
MRK/_ ,S3W.7LQ_RTO^H?_K/T%N9?] _V_P#S[U2[[G+H+=&V^"7_ &5GTU_V
MNLU_[R6X?8-]P?\ E3K[_FFO_5Q.C+:/^2E%]I_XZ>MH[WB;U('16_F#W=NO
MX_=,5O8NS,?M[)YNFW#@<2E+N>DR5;BC392>6*H=X,5EL+5F=%C&@B<*#]0?
M8MY*V&SYCWQ=LOFD2 Q.U8RH:J@4RRL*>N.B_<[N2RM3/$%+Z@,UIG[".JD&
M_FT]_+4&D;:W1RU2TYJVIFP>]!4+2!_&:HPGLCR"G$GIUVTZN+W]S!_K1<L
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MQZ8-S;*2K2(&'](?Y^HO^D7H?_G\NT__ $=C?_9A[O\ N+??^4*Z_P"<+_\
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M89]K8IB(X8<PD42 GA54*HX  ]X8[\?]WE[_ ,]<W_5QNI*M/]Q8O^::_P"
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M=1[R=]J_^523_FO)_A'0&W[_ )*!_P!(O5?7N1^B;JU3^4U_S.;LC_Q&+_\
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M //)'_QT=1SN/^Y\W_-1O\/1?/8CZ1]7K?RDO^9=]N?^'I@__=')[Q_]Y/\
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MAABC3*U 6.**,*D:*.   ![S Y/_ .56V_\ YY(_^.CJ.=Q_W/F_YJ'_  ]
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MI1_R*6_YY)/^/1]$?,'^X _YJ#_ >M>GWDKT">EEURRKV%L1F8*J[SVNS,Q
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M@ ^5>;PT_P ;.\(8<OC)I9.L]V)'%%7TLDDCMB:@*J(DI9F)^@ O[$?)X/\
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M<,:-8U=1<:E4&Q]R1[5_\K:G_-"3_ .B;?O^2>?].O6N1[R<Z _3UML7W%@
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MM]O&CU$D:L^E2; WL/<1^\.=CM:?\I?_ %C?H0\N?[E2?\T_\HZO<_O?M/\
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M%_\ WJMO>XC]X?\ DAVO_/7_ -8WZ$/+G^Y4G_-/_*.K\/>._0QZI"_FZ?\
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M/+UL%^\<.AIU2[_-[_[EZ_\ *L__ #-/<Y>S'_+2_P"H?_K/T%N9?] _V_\
MS[U2[[G+H+=&V^"7_96?37_:ZS7_ +R6X?8-]P?^5.OO^::_]7$Z,MH_Y*47
MVG_CIZVCO>)O4@=5\_S-?^R6LK_X>NS_ /W+J?<D>U7_ "MJ?\T)/\ Z)=__
M .2>?].O6N#[R<Z _3UMK_CX\!_VNL5_[G0>V+K_ '&D_P":;?X#U:/XU^T=
M;E7O"+J4.B^?+#_LFCO3_P 1CN[_ -U-1[$G)_\ RM.W_P#/7'_QX=(MQ_W
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M;_W5EZ+7-0?'&JI'^XQU?#*-$C6#@&Q! QZYYW"SW7FFZO\ ;W$EI)X>E@"
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M$^\D/]<'D[_E.C_WF3_H#H%_NC<O]]']J_Y^O?9]F?\ >,OS9_\ 2$/F9_\
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M5;5=)3XEZ>:9&Q?QWKHT5)CILQ4_X6]PW[G;YM6^7UK+M4RS1QQ,&(#"A+5
M[@/+H2;':W%K%(MPI4EA3AZ?+JQ[_9X>F/\ GBOE_P#^F]OGU_\ <T^XQZ/.
MJ4OY@/8M=V[WM2;KZYZ(^:&Z-OQ["V_B7R5+\!_FY2Q+D:/(YZ:IIO%DOC]1
M5!:**KC).C2=7!/-IU]N>:^7]EY?:SW.Y6*Y-P[:2KGM*H >U2/(^?05WFPO
M+F\$D"%DT 5J.-3ZGHCWV?9G_>,OS9_](0^9G_VB?8]_UP>3O^4Z/_>9/^@.
MBG]T;E_OH_M7_/T?7^7;V;4=.=U[HW/V7T7\T-JX*NZMS>!I,C5_ ;YNU<<V
M6JMV;)R$%$L>,^/M=.KR4>+G<,4" 1D$W(!CSW+YIV#>]BBM-KN5FN%NU<J%
M<441R@GN4#BP'KGHXV2PN[6[:2="J&,BM1QJI\C\NKF?]GAZ8_YXKY?_ /IO
M;Y]?_<T^X0Z%'57'\RCNJA[K_P!"_P#HNZ8^9F[O[L_Z1?XY]G\ _G'1_P /
M_C/]Q/X9Y/XK\>:#R?=_PJHMX]=O$=5KB\L^UW,&S[%]=^]IUA\7P=%0QKI\
M75\*GAJ''UZ#^^V=S=^%].I;3JKPQ733B?D>JN/L^S/^\9?FS_Z0A\S/_M$^
MY9_UP>3O^4Z/_>9/^@.@_P#NC<O]]']J_P"?HQ_Q&W/N3KSY&=8;SWG\>_FI
M@MLX+*Y2?+9:?X%_-:>&CAGVYF:*%WAHN@JFJ</55*)Z$8W;^ES[#'.?.?+.
MY<LW=C8W:274B*%4*X)(=2<E0. )R>EVV[;?07T<LL9$8)J:CT/SZO\ _P#9
MX>F/^>*^7_\ Z;V^?7_W-/O'3H9=$R^>7R6VAVQ\?LAM#KWJOYC[FW'-NG;-
M?%BZ7^7]\ZZ65Z2AJ9WJIA+D?CG1TP6%6!(+W-^ ?8X]O=TL-GYC6]W*016H
MA<:B"<D"@[03G[.BO>()KFR,4"ZGU T_XOJC[[/LS_O&7YL_^D(?,S_[1/N>
MO]<'D[_E.C_WF3_H#H)_NC<O]]']J_Y^G7!1=C4N;P]54?&CYLQP4V5Q]1/(
M?@?\SB(X8:N&21R%Z(+$(BD\ GVU<<_\H/ Z+>H6*$#MD\P?Z'5DVC<0X)B-
M*CS'^?K9Y_V>'IC_ )XKY?\ _IO;Y]?_ '-/O%+H?= S\BOEYUIO+HGMK:FV
M>NOF'E=P;AV%N3$X;&P_R^OGE%+79&MQTT-+31RU7QN@IXVFE8 %W51^2/9Y
MRU=6]CS!9WETP2VCN$9FR:*&!)Q4X^0Z2WT;RV<D<8J[(0!\Z=:Z_P!GV9_W
MC+\V?_2$/F9_]HGWDM_K@\G?\IT?^\R?] = G]T;E_OH_M7_ #]>^S[,_P"\
M9?FS_P"D(?,S_P"T3[]_K@\G?\IT?^\R?] =>_=&Y?[Z/[5_S];'G1WS#ZNV
MMTIT_MC/]??,+&YW;G5O7^!S6.E_E\_/262@RV(VGB,?DJ*22G^-LT$CTM93
MNA9'9"5N"18^\8]_N(;O?;V[MVU6\MW,ZMG*M(Q4YH<@@YST.+1&CM(HW%'6
M-01\P #T*7^SP],?\\5\O_\ TWM\^O\ [FGV4]*.C0[BVOM[=M N,W+AZ'-4
M"3&=*:NA$J)*]-4T,Y0\.BU>.K9Z6=00M125$T$@:&61&]U[I\1$C18XU5$1
M51$10J(B@*JJJ@!54"P X ]^Z]UR]^Z]T3'/?)_<FV6[&IJ[:&%RK]>X'M;?
M<F8P.5R55MK-[6Z4VKL3+]D;=PE?+CDJ,AN[;^]-^P;8$XC2EDJZ2LGDB@JJ
M.HQ$?NO=2,K\I:^ESV#VCCMES9#<_9FZNY-G=2T%,:F<5>3Z&[$R6Q.QZK=,
MDPQU'24M%A\9)N.@45-.,E3)+CUDCJ%AGJ?=>Z,MU_NO&;ZV5MC>&'RG\9QV
MXL/1Y2#(G#Y#;KS-41ZJB.;;N8_W,[>J*6I#Q24%:36T4B&&<F9')]U[I8>_
M=>Z+3NWNK<^V]_R;'IL#@<NF0KMKX*GS6.KLA4TVQ\_O'=./P^W*'><4E/1K
ME:[*[1DK]PBCI)*1Z9,<E%-*BY&@R$GNO=('"_)_=W8&.H/]'VR=OTF?SN\$
MZFQ-#O3,YRGQ-'VC'T:>^L@V5RV'V_55,VPZ3 03XV.N@I/N:BO5'$*Q/8>Z
M]T.W1VZ.R-Y=?TNX.T\)LW!;EJ\UN2GIZ;8>4W#F=M5^W\9G*[%X#<&/R&YL
M%MW)U%+N7'T:Y"G?[8124E3$Z.ZM?W[KW0O>_=>Z+OW;W5E>G*FAR1V_C]S[
M=AVWV%NO<6+Q>0J?[Z8[:W7O6V\]\9G=\=!]J](N#IMPX+";= ;4LM?NBF9I
MX&ACIZ[W7ND3D?DWDL+NK=FS<EM2EFRG5^6Q4'8M;05.1;&U&,SK=/2X^39_
MW%$E36U5/B.X!63>16)GPDE&$'W\572>Z]T[_&WY+4GR!GW'30[?RFWJG!;3
MZZWC/29C!;CV[4PT_8TV]H:2@Q;;AQU)0]A[7H&V5+]AO?;L]=M'<_DE_A=1
M(*.H/OW7NC3^_=>Z"GM;?&X-C4>V*O 8O"YRHS>[MN;9BP-;D*JFSVX*O.YW
M%T$V,VO2P4LL3U6+VU+E,[5U4KM%1T.%E,T2TSU%?C_=>Z!'"?)[,;HR&R,+
M@MGT?\3[4P?7N\MA/DZ[(4M#!MCLO9/?N_\ ;%'NEXL?-+19R;"= SQUC0AX
MJ"IS<*A*@4A-9[KW4CI#Y68WNK+[+BH,%_!:+L3;^_\ <F$V[E9JBD['VUAM
MC9G;>/QF=WGM62G+T>V^P<5N:#)8ZO5HZ6*GJ<>H>J;)1-#[KW1O/?NO=(_?
MFX)MK;6RNX$R.W\/3XJGDK,CF=S&O?%XJ@ABD>6L:@QJK69>H\@2..DCFIWF
M:2R2:PJ/[KW0$[/^0.Z-P9;"XC.]<KM'-9C/8SKBHVW7YR>KJ]O]L5GQRP?R
M0J,)E\S284TLFV:/"Y&MP\U?!3-)%D,:KK#,M7XZ7W7NFG:?RAJ-QX?K3<-5
ML^/&8W=O6_Q:WSN6FI\E4Y2IP]5\KMR9O9.TL=A:K^&T$.5I]I[NP\4>0DEC
MIVEH*W[E5A:G\%1[KW1O/?NO=0<G+6P8ZNFQL=#+7Q4L\E''DZN6@QS5"1LT
M0KJV"DKIJ:EU#UNL,C*MR%/OW7NBF[=^366R(I&R.U*,4=+F.O:3(97'5-9)
M2;GVUW-\AM]]!]0;\V4IAG@;![II=G0;IGCEJ)T@P^5@6"IJM(J)/=>Z5$/?
M&?;K7&;_ *C96'BGE^1$O1>8Q$.[JV>*@I1\I:CXUP;IQF0?:5.^6J)'6++/
M0RP42H'> 5#:!))[KW1F/?NO=>]^Z]T4/<'R*W=@<QN;!1[1V_G9L-)FY:3/
M8G-9!=M5%9LS8VY=\[ZV)]W58Z.HJMP;>DQ&,Q+Y*-$I!49QI33>?$UV-?W7
MNEPG=5579WL#%1TVU]KX/:75?4_;5'O?=><K8\;#M7LK)=G4=?7;FP[XO$_P
MFHVK1]:S5!IA7F.J$ZH]52V9U]U[H5.O<_G-U[ V/NG<^V:C96Y=R[/VSG]P
M[-JYIJFKVEG,QA:+(Y;;-545%%C9ZBHP-?4R4KN]/ [M$28T)*CW7NEA[]U[
MHM>^^Z]R[+WG4;:CV_@\YCYO[EXZ3)8S(5\TNQ\YV-VWU[U5L"'=U,U)$,E_
M>R+>N0S IZ4TST-+MN>)Y916T]3%[KW7MN=]Y+/[GVYMX;.IX4RVP_D'F\A5
M1Y?+UE91[V^.O:>S^I]T[;H<-0[4JZ[*[?R^:W++/09&'76SP4Z@8_7*H]^Z
M]TK.ANV!W#L6?<=3CZS"9S$;LW=M+<.WLMMS<^S<]AJO 9RKBPKY[9V\Z#';
MFVKD-R[-FQ>;2BJ4E5*7*0O!4UE,\-7/[KW0T>_=>Z+[W?W17]-/BLQ-A:'<
M&VUQ.[]P[AQ6,JZF;?$>U]D;,W/N_=NZ\=C/ E!'A=K'#XNB=II3'6UN?IZ?
MRTM0*2')>Z]TT_Z<]RT5=%A<IL_#ME<?WIM#I;=,U+N&OAHL?/O'KC9W95/E
M\"DVWYGS\>+IMYQ8V199*%9I:>2I4IJ%*ONO=*[J[NO:_:VZ.RL)MG*XG)0;
M!KMO4E\=505TTM'G*&MJ*3+U=13UDL44.6GQ]1]I$(@#20QSF5VG:"E]U[H:
MO?NO=!3V[OC<&P=NP9G;N+PN>R4U=3XW%;9R&0JJ++[SW#73P0879>VO!2RT
M]-DLYJG=\A4LU+BX:9IZB)J45%12^Z]T".5^4>3H-C]L[UH]DT=>FQ^J][=Q
M[:QM7FZ[#_QG:VQ=P;ZV_D<9EJY<%ESCLY60;,@R, ^W"_[EC1,H-!)657NO
M=+;%=T[CJ/DIGNEL_M6':^V(]FU.=V!N3(4.^7K.S*_$IL^?<\V%S+;/I>MJ
M"EVT^Z&I7Q;9N?/59II*V&E-#%/+#[KW1CO?NO=)G>.9DV]MK+9Q<EMW"08J
ME>OR.=W752TNW\%B:;][*YK(M$\!GAQ= DD_A:>D28H$:H@4F5?=>Z+OL7Y$
M;GW35;.H<YURVT<SN/-;>Z[S&V,IDL@,EMCM7+_&JC^2V0Q.1K'P<(&V<+AJ
MA\+-4FE2L_B<1)IPOH]^Z]TT[;^4G]Y\5TIDJO"_W/AWYUW\>NQ]]5IH\KO#
M%;;F^1^6DVGUOL3#UM!38:HK:C-[\I)L;/F)Z:-,?&::>6B,%14U.,]U[HXG
MOW7NHM<];'15DF-IZ6KR*4M0]!2UU9+CZ*IK5B<TM/65]/0Y.>AI9IPJR3)3
M5#Q(2PBD(T'W7NBBX+Y.9;(2+'/MC'U='C=R=>8ZNW#C*FL7$;OVOW%WYF>A
M^K=[;'C9*TG#YR7 5F>G:6>H@7'1T_VL]73UT5?'[KW6'>_<_P @:C9N[MP]
M2; ZAK,ULCL;=_7V1P&_-];Y@BS];C:K"8K946V\CMCKO(RC);MS.76":.KI
MH:>@:5+S2HKR^_=>Z.-#Y?%%Y_'Y_&GF\.KQ>72/)XM?K\>N^F_-OK[]U[K)
M[]U[KWOW7NO>_=>Z][]U[HO^S_BYT9L7!5>V]N[+J!B*_(/D:R'.;OWQNRJJ
M7FQM5AZK'RY/=FY<WE'V_7XNOJ(*G%^;^&U,=3,)8'\LFKW7NEU5=2==UC9:
M2?;%+Y<SDJ/,U4T-5DJ:>FRU!N"HW939+"3TU;#-MRN7=59-DVEQ[4KR9&:2
MI<M-([GW7NEMB<5C<%C,?A</14^-Q6*HZ?'XZ@I(Q%34=%21+#3T\$:\+'%$
M@ _UO?NO=.'OW7N@/H/CCT]C=T[VWK3;8R!W-V%60Y'<^2J]Y[ZR(ER%-FL5
MN.EKL)19#<M5C]I5E'G,%0U,,N(BH7ADHH"A40QA?=>Z6%)U9L''34T^,VY3
MXIZ'#PX3'C$U>1Q46-I:;!KM>DK,9!CZRF@QNX*/;"+C8<K L>3AQZBF2H6$
M!![KW2TQV/H<1CZ'%8NDI\?C<91TV/QU!21)!2T5#10I34E)301A8X:>FIXU
M1$4 *J@#CW[KW4SW[KW0.[AZ"ZGW7V9B^WMQ[7FS.^\/@:C;%%6UVY-URX(X
M&JQ6ZL)48VNV1_'!L?*PRXO>^6A)JL=,]JZ0@ZB"/=>Z?(^I>O(Y,1,=MPU%
M5A,DV7HJ^MK\K7Y*7(M7;?R2U66R=;7U&0S[09#:6(FB6ODJ4ADQ-"4"FCIO
M%[KW3IM+K[9^QA4#:N$AQ0J*'%XGTU-=5FEP6"?(/M_;6,:OJJHXG:NW3EJK
M^&XJE\..QXJ913PQ"1P?=>Z67OW7N@G[(Z0ZT[<R>SLQO_!Y#,UNPJRNKML_
M:[LWAMZCIYLE+BIJ],IC-M9_#XW<E'5-A:=7I\G#64YC5TT:)95?W7NIE1TY
MUI4Q9"&;:E&1DZPUM1*E5DH:J)V7<4;TV.K(:V.KQ&+EBWAF$>BI'AHWCR]<
MC1%:RI$ONO=/&(Z^VIAMSY'>E-BXYMV9+%P;?DS]8345U%MBCJGJZ#:N$4A:
M3 ;;HY2K?9T45/%431K45 FJ=4S>Z]TM/?NO=!_V9U?LKN#:LVRNP,=D,KMN
MHR&+RLM%C=R[GVI4-7X6MBR6+G&6VCF<%F%^RR$$<R**@)Y8T8@E5(]U[K#@
M.I>OMK"C_N]MY<4V/V[2[6H9:7)YE:BEQ5'@\-MF"2"H;(O/'FAM[;N/HGR8
M;^)R4U#3QO.RPQA?=>ZQ[?Z@ZXVM#M"#![9AHXMAX7$[=VJCY#+UO\-PNWJ?
M)T>W,?(:_(539*';5+FJR/&&K,[8Y*N84QB$KZO=>Z$KW[KW2=W=M3!;[VMN
M+9>Z*2:OVWNS"Y+;N?H(,CD\3+78;,4DM!DJ(9+#5F/RE&M71SO&SP3Q2!6-
MF'OW7ND'L[H?JG86*VUA-L;6:EQVTYJRHQ$>0SVYMP5#U%9N7*[R$^;K]Q9G
M*Y#=$V.W9G*O(T#9.6L;&UE0\M(87-_?NO=3O]#77?\ =_\ NM_!\A_ /]('
M^E+^'_WIW;H_OW_?#_2#_'?/_'?NO^/Z_P!S'VNO[/\ B7^4>+R^KW[KW0H>
M_=>Z][]U[HO^V?BYT9M+&9S$8?9=0]!N3,/G<S'F]W[XW1-5Y":AS^,J@E;N
M?<N8K:/'U^,W5E*:IHX)(Z.JI\C51RQ.D\JM[KW3]OOH3JWLH[L.\L'ELB^^
M*'9>,W-)1;UWU@):Z@Z[SE9N;95)3R[=W+B9,3#M_<&0J*V$49I[U-1+(^II
M'+>Z]T(FU=LX396V-N;-VU1MCMN;2P.'VSM_'O5UN0>APF!Q]/BL51M7Y*IK
M,C6M34%)&AFJ)I9Y"NIW9B6/NO=/WOW7N@1I_CIT_3;XWEV.FV*Z7>6_EIQN
M7+U>\-[UZ32T==MO)T-9B,77;DJ,/M?)8[(;.Q4U-58NGHZFFDQU.8G0Q);W
M7NE!7=0;&JSCIJ6CRV!K\'L7<W7.WLIMK<NXL!7[>VONY,9_'8<.^-RD$%-D
MJNIPE#4BN,;UB5=#3S"3R0QLONO=+#;NV\5M>AFH<5%-_E==5Y7(UM94SUV2
MRN5KY!)69+)U]2\E15U4NE474=$$$<<$2QP111I[KW3][]U[H(]S]%=7[R[%
MV_VMN7;U9E-Z[8Q<&&P]7)NG=T&$CQU-592NIX:_9E)GJ?9>:DAK,Q/*LM;C
MZB82>-@UX8?'[KW3@.GNNEH,/C(\!)!28+=&+WGC5I\WN&FG7<N$H*;$X;)5
ME9!EHZS*?PK#T-/1TT-5)-3PT=/# B"&*-%]U[I48S:.W\/N'<^ZL=1209W>
M7\%_O%6-7Y&HCKO[O4,F.Q'CH:FKFQ^/^UHY60_;10^8G5)K8 ^_=>Z4GOW7
MN@G[0Z0ZT[F;;+=C8/(9P;/R%5E,#%2;LWAMJG@K*V*&GJS7TNUL_A*?.4]1
M3P")H*Y:F Q,Z:-,D@;W7NIF3Z=ZWR^'WW@*[;4;8GLRCK,=OBEILGF<><]C
M,C79O*9+%R5&/R-+546+R>2W-DZBIIJ9X8*B;)5;R(S54YD]U[I24>T,/2YX
M[F?^(9#-)CWQ%#5Y3)UV07$XJ7[-JFAQ-+4SO24/W\M!"]7.B?=UKQ1_<2RB
M.()[KW2H]^Z]TA>R.MMG]M;2KMC;\Q]=E-LY*JQ-;64..W#N/:]3)58/*T><
MQ,R9C:F6PF:IVHLMCX)U\=0@+Q+>X%O?NO=-^V^H.NMH08"FV[MQ<;#MC;N+
MVO@@F4S50]!CL+MV#:.,K%EJ\E433[FI=JTR8T9J5GS#4"^!JHQ$J?=>ZCX?
MI7K' 46SL?B]K0P4>PL3B,#M:&;)9JN^QPFW,A39;;&(JY*_)5,N:QNU,K1Q
M5.)AKFJ8\541))2"%U!'NO="E[]U[IEW)M[$[MV[G]J9Z":JP>YL+E-O9JEI
MZZOQ=14XG-4,^-R,$&3Q550Y3'334=2ZK/330U$+$/&Z. P]U[H@M;N[H/HQ
MMU["VMT5V1E\ST=G,;6_PFJW%C<A593&[ABV1NK =AKF]_\ :-1F]T]?KN^L
MH,=055<*J2AW!A)HJ6EC.-\L?NO="ALO<^T,EW5A=B[3V3E(]H9^3Y$]I9/=
M&:S-76Q5_;_3/8G6?4NXAC**7>V5J31T>9WQEH98:S&04BUV+@JJ.^B&8^Z]
MT<3W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U3U_-%W-V3M_/=.IL+<&^,)#58C>;9)=HY
M;/8V.HDBK-NBF:N7#5$*RO&KN(S)<@%K?4^YJ]IK3:[FWO3N,5O(0\6GQ%1J
M8>M-0-/*M.@SS!).CQ>"S@4:NDD>GIT8#^7;N3=-9\;LQG-^Y+=V<R5!OK=D
MLD^;_O!N/<#8VBPV J%IJ&DD3(YO(6/D\%-3QR222,5C1G:Q#7N?!96_,BQV
M"1)!],AI&%"UU/4T6@KPZ6[&\KV1,I8MK/&I/ >O0/XCMOY2;%H.Y<9V'+O;
M +OGMKXJ]H]7[T_T<;NWO'L'JKY0=K; ZE[$^/.'J<IM*+#MV]TIE$KLE%'4
M4.3@I:+<U!>AJEHZV.&.NCGH1]O]I?)6M[*Q>TJ[-9:6KVUA>A\]'MN'J"II
M4WSL;?\ \@^^=B[QWIVQF&Q,Z['W$?C[UOC]R46+HYML-0[I\U-+3UD4T6)3
MW7NGC9N]OE=7;.V-79^3/#=^Y^O?CQN84<O3]1@\0F_=W;LJ\9\BMA[HHY\?
M59+86)Z^VS2TE3A:K(U,-1335\L\G\?CIC1>_=>Z8\AV3\L]C]5[=KMTXO?V
MX>R(,])L_*1;8ZKI-U8G<J]4[@3%;H[+-/LG:^3RNU-N]UXR&ORF+Q<U"9I:
M&*C@I:S'UDA%7[KW2JZ=W)WEB>Q]M;.;9VZ#U;E.R/DID=PY7-X?<> K\!!E
M^[?DAN/9-;)+N39V1I-P;/R6W*';L-!#2Y7 5&)2MHC#!F*.ND&%]U[H_'OW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@%[TJ_E
M!24FW#\:-O\ 0N>KGJ,D-W)WIO#L+:5)34BQT?\ !VVY)L#8^]9JZHEF-0*E
M:E:=8U6,H7+,%$.P)RH[R_UIDW"..B^']+'#(2<ZM?C2Q4'#3IK7-:8Z*]S;
M>E5/W,EJ[5.OQGD0 8IIT(]?.M:>5.J@/C1N[^>S6=\][4?:&Q^C:K8L-772
M;8I^WLH=G=8XNI3.I3XBFZ@W3U1LS<V_=RXF? *Q(S-')JAC26IGIZYI(JF9
MN:+/V 3E_;WVF>_&X$#6;=?$G8:*L;B.XE2%&#_[Z89)"JT8!6/]FN/<YMTN
MEO8K8VM3I\4Z(QW4'A-$C.PT_P 8X4)(:H-F^5W-V9MGLOHS/]C83=L^3_T$
M]JT/8>$Z4QO;F_\ J5.T\MO7X_46U(4AI<-C<;6F""3<!QM?G*6AJ*7'"LFD
M>FA$SK =^+$7LHVPRMM^L^&90JR%*]I=49E#4XA68 \">I-MC<FW0W@076D:
MPA)0-YZ2P!(]"0#\NBY;,[;^8>.V!M?/?W-WIG]S87%X_;D7565ZIWKB*7<D
MJ?!+#]DQY#<F]]\');JCS#?++$3[87)U6:BI8X<A+2U_W-6(<A&DZ?Z%6G[D
M[OBW!U#3P8GL;.;=W-O:CFS5?)T5V!C/M-@9?)UNW:J#?%?ENMMK9C'Y[ 9B
MHIYHUDV[LX0XTI62/D*:&KE/NO=2MQ8CM?L/X.9#=&],AV0_?<W1^>[ Q6/V
M-C=[=2;SVMW#D.F\OBQM;;VW=G5>+WH/X3NS+U<=%1U<M94/*\1=YS'%)[]U
M[J/O+-]N=7;IWTO6.*[$SG6N*VOU#NB*AJ=L]A;QW%D<YVIV=OJB[BW!'NC<
M^$[&WAN7*=8;#Q.$J,?MO$T$\^-BJY ^/K],-''[KW2;S'9WRZQ6;Q]1AL1F
M-[/B*/&8Z#;-)TYG]L;8W[7YGXR]J[SH<AFMR[DQ]%7[>J)^\]M;;QKU JL+
M0X:++2T.3IHZAXY:7W7NAT^,E5GLAD/D!F,S4=D5U#N+N# Y[:N2[+Z\S_6N
M5KMOCX_]'[;K'H-NYW:NT)*;'T^]-M9B+0M(&61&9VD$B32^Z]T:CW[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW01Y#I?9V?W+V
M3N7=-+'N"I[*VOM#8N1BEHZ'&3XW9>R9L_EL+@:'.X>GH=S/]ONK=^6RD<\E
M:TE+4U8-/X3&&;W7NI&VND^L-H;KGWOMW:\>.W+/_>@K6C*YVJIZ-]\Y7'9_
M?,V*Q-;DZG#X:HWQN/$P93-24E/#)ELJIK:LS53R3-[KW0J>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[IKRV#PN>AIJ?.8?%YFGHLA19:C@RV/I,C#297&
M3K4XW)TT59#,D&0Q]2@D@F0"2)P&4@\^_=>Z]%@\+!EZS<$&'Q<.>R%'28ZO
MS<6/I(\O78^@>:6AH:S))"*RIHZ.2ID:*)W9(VD8J 6-_=>Z=/?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]T%_<NY]\[-ZXSVY.MMJT>^-Z8^HV\N(VA5Y?!
MX2;<25VYL-CLKB\+6;GW%L_;4V[*G#5=0,+29',8BAR&7^VI:BOHXIGJ8O=>
MZ*_A_F@9^L<[V"VPMP9J/9.Y,5L3?%'DL+6=4;JQ.^]Q[@.VL?B/]'&YJW=&
M37![:S];2X_-Y>')UE'Y(*^HQG\2BI)$'NO=+B+Y4"KK,#1T'7F0J%S7<&"Z
MQGR$FX:.*@PN+K_C7A?E#F-U9!(L?4Y>IJ,;L:NK*2FQM%2535N2HU1JBGCG
M$L?NO=3J'Y-FODZ]IJ;K_)5V0[-P./[#VOC\+F$S[S=1UDO7%/5;UJ\EB,35
M[>HZ[#3]BI]W2/6BA6/'S/'D91-0_=^Z]TMNYM_[JVGUYB-U;1Q\<&>J.W.E
M=EG#[@FHHJ6IQV^N]]C=7;@@KZS'KG5HHWPNY*F>"HI_--#(L3F-RKP/[KW0
M'[4^6^ZMY;SV9A,/U?AQ@]T[TVWLV>:??=0-QTE17=*=Q]J;CEI,<VT(<+5U
M&-S75@Q-#'+D*>&MBJ#5RSTM_ GNO=-N#^<E-/M[:F<W9U9FMK'>&U>JNSJ4
M4&6K][XW;O4O;F(RV3PVZM\UVTMI9"OVI7;9J\'/1;BDEHI-J8">HH9JW<$5
M#6)5K[KW1CMQ]E5N.SDXBQF4H\!L?;>Y]Z;\'V%+DLQDZ.EK\_M?9&VMMTE-
M6R0UV0WQDL)D,E2FGGDJX$QE/25-/#+DD$?NO=%=R?S/W+UOV71=(]I=>8F+
ML&NAQ:X_(X_>_BPV;RV].O\ ([DZZ:GIO[H/_ MJ[_[8V_G.N\')/4U>2GSV
M(C0PU$E;2FH]U[IVV]\U,AE^X\ST)D^L,7@NSL?G-Q;;H,7/V-/58VOSNWMT
M[9E3$5&2CV#%)393<'1>[*3LC'4M/!6U,FVEJ3-' ]'6&#W7NI70GS47N[>,
MW7LW7E+LW>F(AH:S=6%K-\C+'!4N,&]-O=LTL-5%M.@BS.:Z3[7VE#M7<$=.
M/L8*[+4,HK!'5THG]U[I*S?)CLR/:G:,M-'AZG>^ WQOBH-%-DZ&+![1ZYVM
M\G-V=!;?EP<4NSJ')[KRF?HMB5U3D*>62H%#4(9'K:5:['4@]U[HQ6S?D3AM
MVT?<%?%MS)20]3PP9 4VWZVBW/7[MQE7M*7=E)%M\T?VV'R6>J*>DFA6"AK:
M^@>4)XZZ0F18?=>Z#>?YB4\6*WQDX>L\UDX.O-B[P[/R>0Q6XL/5;=WML39&
MTNOMVYK(].YZ:*D3?^2@_P!("XB2&>'$TE+GL56TM350H*2>K]U[IXV_\B=U
M;[PW8>,PFQZ7;6_-J[RW'U##C:K-5>X9,;V='OS<VU-L561Q<>W,//-M&HV%
MB:'L.ID+Q5L>SLK25*TL@F#>_=>Z2^8^07:6T9OXYDX=D[LV[_LU5!\>*/8^
M VWF<1V1G,5NC/8S;6#S>WLM7;YR&W\SGMG?Q8YS<$;X^@HSMS%Y*L1Z04NA
M_=>Z>.OOEK/O.GZ[FRG6LVVI>QL#T1O''T@W;39F;&;3^0LW:R;*GR+P8.DI
MFW%CHNL0^3HH7DIH?OP(:RH,)\GNO=->#^;&#R]'L?)U/7&[L/A=]9[8.-HM
MS5"5.8VWC:+?E#LBN#9JHVEB-Q9S Y+:<F_*.ASE3D<?1;3Q&65J*KS\,\M*
MM3[KW2D3LSN'</8FVL%MC+;!VYM?L38O=_8>U9]X[&S^X<A0X/K7<71>T-G5
ML\N*[ V2K8G>D._,CGI$GA6K@IJND@+1O!*)/=>Z#+9OSGR6_P#I*+M39'2>
MY-[YW&]48W?.Z=F;=KLN!2[JK^B,3W[2;6V[GZK9_P##-QXO<NV<U1T>$JHR
MN3KZ_*4&K&0TDM564?NO="[MSY,4.^=Q8_:^TL!-G%S.)VSNJGW)M2MK,]CH
M.L^R=R;]VAUIV=0Y&HVQ2;4J\3G\CUSDL@8:C(4^O$"">B;)33&D3W7N@9VY
M\XZFA^/^T^W=T==9S=);89FW(=I5N"QV5KNPMO\ Q3K/E#N."DVWN&OQ5'A=
MKYC!X2JH,;55.1$TE?-3,:<8^9,@?=>Z6VXOEWF]H2;[Q.XNH)EW-U9MGN#>
MN_J3#[ZHJ_ )MCI[;/1._,K)L_.U^WL-D-R9K-;+[]QS4E-58[%4ZY?'UM'+
M4I L%=/[KW2NV_\ *&GW%EL5M>AV)F*K>#;LW!@-RX+%U-9DJ?!87;W?N[/C
M_6;PI<X,#38S(8>/,[+K\M*E4V-EAQ<6D@UDM-2S^Z]TA]F?,'-;UW%TWBH^
MK*?;.-[<Q_4V](:[<>^Z5JS"=:=M]+=_]HXW)9&EP^ R6.CWI@LOT!7T%7C4
MK)<<:2KIZI,D7:6F@]U[I.=;?-;<N\\5OG'575%1'V3B.]-M=?;,VMD:VOV%
M09OK'N3 Q[\Z*[9W#4[FQM=G\3MNLVU45&"SM3CL;EP-V;=S,.-AJZ6!)#[K
MW2WPWRYKLSN+%8U>H,Y186GI^I*;>^4JMTX23*8;<?</:/8G2F%QNS\+0P5E
M)OK![>[)ZXJHLIEGK\53/B*B')XU<C3%M/NO=8]I?+K([LV?MS=\/4F0QL>X
M<7\?<P,/6[QQ;Y;'4'RAW33[4ZIJ*I*7%STM13X^JKZ>;<LU/+-3XV(5*8Z3
M,5%++![]U[J%MOYH4V=V+UAOBKZ];#1]E;JZMV9_ *C=\%1N+;.Y=Z;TZKZT
MW[@<OB(< N0DRW4/8_:L6$RYCB-!3Y+$5]+6U>/J_L:>N]U[I/=?]^=^[K[%
MSFR\7BMJ[GQ^V-W4%!D'7:-?2Y)MJ?[-K\F^E]UYG*;I7?F+P&#FV]UATM29
M.BC7$5+Y#)QU%.%)JH!![KW2TVG\NJC<NV<)NVHZGS6)QN3V3\>^RJK''=&$
MR.XJ+9'R6W/7[3V)54V/HH3CLMN+!5^%KILYC(:WR1T\,:XR3*U4Z4OOW7NG
MJ/Y3P5>#V%FL1L'*9YNV>OZ_N#JW%8')OF,CN_J_%T&R\A6UKMC<+58[ ;P\
M78&)CBHZVHBP1EK$\F:BB666/W7ND_2?-3:51O'#[.GVCN3&56:[ Q^S*:NR
M.)W@M%!C\]N3 ;6V=NJHJ*+9-;25&U^P<CGE_@&Y*.6KV%D98_L?[R1Y:6#'
M2>Z]T]0]F=P[CWSLK$;;RVP=M;?[.ZY[L[/VXV\-C9_<-=B<#L'<_2.VNOY:
MF3&=@;'=:7=V"[!J<Y7T]53QUU!+5Q41*&DD,ONO=(;H;YI9;N[%]2Y2'J.3
M 8_LG*;5VA/F*K>E-+04^]-R_%*@^5,4FWJ2+ R9+-[#EP-<,?392I3'5=0X
M^X%"(FCU^Z]T[P?+^3<NU</DMH[ RD66W3UGB=YT'\0EI<NNTIMT=#9SN[";
MIW1@*>NP59D>HZ&3%1[;JLQ2UL$\VYZF+'QTZ*YJX_=>Z8:WYJY':>U\ON/=
M?5F2RV,VAA<MC<]F=M9G"X^JW'V/M_XGX3Y;56.VGM#+Y*KCQVT<WL>;)4E-
M69'.+54N4H4@E@D@F6M'NO=+RM^4]?BJG?FWLGUE,-\]:8WM[<>ZMOT&],5-
MB*G;?4NV^G]ZSOMK=.5QN$I*[<6Y]J=[;>DI*7(P8F@@K/O8*FOACIHZFI]U
M[I$57S@CQW6'9_965ZT;&?Z*9NR<;N/;%;N^2CSZY_K\]C[BI<2F+KMHT><>
M;>'5&P:?=E#!#0SY*+$[CQ=34T<./>LR%'[KW2CW3\K,GLWL'=>UL]LV%<1M
MWLZMZWQM9AZX95\[/4=9=);VP&0SF0R4VVX-APOE>XXX*R4TV7H*6@HJBJJ*
MJE2$>;W7NO;J^7=;M7=59LVJZDRTV5VOELQ#OK(C=N&CVY1X#;V8^/\ 29G,
M;)KA1RY;>%=38;Y&X:N2CK*#"([460IC4)40PK4>Z]T\;M^2.3V14]A9G([7
M;+;8Q'6/?7:>T(8JX8>KR&V/C;/UUAMV?<K/C:]I*[>NXM\5SXJJ24T4F*QU
M'*(U-5)+[]U[I19;Y!Y!315>UMAQ[EP6:[8R_2V%S<N\*#$Q1[XVUNO-;)W'
M_>2A&+R5?AL'1[CV]6P034L>2JIQ2N\E- K0F;W7N@*W+\M.UMT])5_9/3_6
M-5C\MB,3USV/FH:W![:[9FP_3^_>K7[.7-5&TJ[O'XUQY#=6,CM05M!0;AJV
MIY 9:09,,(A[KW2VWEW!W;4[ZWSLS;-?LOJ3 P=9T_;'6G:O:/3F8[-VONG:
M^U:^C';9DVQL+Y&;(W.G]VL=N_;BTYRC;;KY:BKJ3#05D-.SCW7NHFT>_P#N
M+;\.W:'N#;6)SVX*3>V-ZEWQ0]6]=[LHJRKWM4?&2+Y'5NY=IX*3?78M1!@8
M*R<;53%R5=>16(:]\LD6JE3W7NL.T/E)NS<ODGAVW&U'MC>&P-H;MCKMN;AQ
M5;F<IV)\L>S_ (OUG]VCD9L94[?Q?7M;UT^89ZZ@K*G*8^HCCE3'2AY/?NO=
M8>R?E1N[JK_9A\E/M;$[QQ>RMY;NV[UM&<__  %9,GM+X4X+Y0+@\Z]+M_*R
M+@<M)A<TCY5&J:J":LI8DHY85>2+W7NGS?\ \N:[8&5[*HJOJV;(475L.]_X
M[6T^\Z.*?(5?7?2/77?>Y%P=%)@F6>AJMH[]:DQLM3-2RU&5HO'40T=-,*N/
MW7NCI>_=>Z][]U[KWOW7NO>_=>Z2^\O[E_W=K/\ 2%_=?^Z?W&*_B']\OX3_
M '=^Z_B]#_!/O/XW_N-^X_CWVWVNOU?=^+Q_N:/?NO=)>G_T+?WAVI]K_HO_
M +U_P>C_ +C?;_W4_O#_  #Q9G[#^ZGC_P!R7\'\/\0\/V?[.G[C3QY/?NO=
M(O9O^RI_Q#;G^C[_ &7O^*_QR/\ NC_<W_1Q_$/[R_W)F\/]W/X)_E/\<_T<
M>33]K_E'\$U6_P EO[]U[J'3?[*'Y.NOM/\ 9;_+_?#_ (Q)]M_HQ\G]_OM:
M;_F77B]7]\/LO#_Q;/\ +?%H_LZ??NO="1EO]$/]V=O_ ,=_T;_W-_O1@/[K
M?Q;^[']V?[Z?WAC_ +K_ -W_ +S_ '%?WH_O7I^P^V_RO^(V\/[UO?NO=!GC
M_P#95-.'_N9_H#_C7DQ_]QO[G?Z)OX[_ !OR[V_NQ_<OR?Y%_'/XG_>#^&V_
M;^Y_B%N/N_?NO=(OX[?[*-_H,Z3_ -&G^B_^X_\ =?KO^X/\<_T<_P!Y/NO[
MG[0_NE_%OX5_DO\ I _N[_!_)XO\KOX/^;?OW7NA8I/]!?AWC_#/[O\ VG^F
MC;7]\OX1][]C_II_CFSOX'][_#O\D_C'][?X7]QH_P F_C/D^Z_RS[KW[KW0
MD9+^Y?W]5_&/[K_Q3_?F?>_Q+^$_?_\ 'RUG^CS[K[K_ "C_ (_#[C^"Z_\
MEY>3[;]_5[]U[KW^_+_BW_,+_P <_O1_U:?XM_?3^Y?_ )V?WH_T=_\ 57_!
M?^F;W[KW3/7_ .BO^'Y+^*?Z/_X5_!^QOXQ]_P#W<_A_\ _C$7^ES^)?<?Y-
M_!_X_P"/^\?E_9^\T_>_N6]^Z]T$^?\ ]DX_A^SO[T_[+/\ PK^\&^O]'_\
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MW_NL3_I6\GC_ -PG\+_BOV7]X_M_\B^Y\/W//B]^Z]U,_P"<3?XQLK_LG?\
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M(7^UT>OP>_=>Z5F_?]E]_C6!_P!*'^AO^\7]V\W_ '8_O[_<G^-?W0^[P?\
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>_:_:^-?M_MO#^S]OX;:-'ITVMQ[]U[J1[]U[K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>j17244762_ba010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba010.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ B@#: P$1  (1 0,1 ?_$ :(    & @,!
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ML<+QW$MUH8F1WJOANU*,Q R!GCU3E+?MRW6]DAO7#1K%J%%49U >0'D>C8]
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M]9RPUBQ_4M)V6G]!^]3_ +T7'Y=;YJM_"W$3#X94!_,=I_D!^WH+OD97G._
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M>([1Z[V)V3@+_P $W_L_;F\L4K.))(J'<F(I,O303,%3_**>.K$<@*J5=2"
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M>_=>Z][]U[KWOW7NB_?*GI3'?(?X]]K=15]/#-4[LVEDH]O2S+&10;PQL?\
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M,2_"L\@'V!R.@*]B#I!U[W[KW6U?_(@R$\OQC[5Q;A/MZ'O;*5L#6?R^3);
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MN[!P>66L$V/BIJ^@RYHL914V9DI8/=>Z.![]U[KWOW7NO>_=>Z][]U[JC_\
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M&-AH<#2QT6%I$HJ<08FCBH6Q<=-CH_&5HX5QK&GTQZ1X24_22/?NO=<<!M[
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M^(R9R/[H[_R85M ?JMDKF!R>VO$Q/DQGSI0H34E:FO0<WKEFQW@&4_I7M/C
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+O?NO=>]^Z]U__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>j17244762_ba011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba011.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ N0#D P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ W^/?NO=>]^Z]U[W[KW7O?NO=)[=&[=K[(PU5N+>.XL+M
M? T0O59?/Y*DQ6/A)#,D;55;+#$9I-!T("7<\*">/:FTL[N_G%M9122W#<%1
M2Q/Y"N/4\!U226.%-<K!4'F30=5Z=F?S2?C]LZ2HH=DT.Y^T<E"Y1:C$TB[?
MVV[(&#@YG.+'D7 < !X<?/$PN0Q%M4D;5[3<QWH$E^T5I$?)CK?_ 'E.W]K@
M_+HDN.8;*+$0:1OE@?M.?Y="MM7Y3Y??FT=N;NP>W\3B:7<F%H,LM)5U%7EY
MZ"2LIDDGHFJXCBHJB6AJ"T1?PJKE"=(O;V47?*4.WWLME<2.[Q2%:@!0:'!I
MW4J,TKY\>E<5^T\2RH  P!]:?+RZ)'\I_G3W_P!28WLBLVE7;6IWV_MC%9C"
M"MVY3UR0U%9DL-2SF=99]4\>FJF558\7!OQ['G*/M_RYO,MJEXLQ$DK*U'(J
M K$4QC@.B7>-XO;*WEDA*AE4$5%?,#_/U6)@_P"=S\SL5.)<C2=.[FBUEFIL
MSL?*TT90QLGC#[=W7@IE"LVL'43K47NMU,KW'L-R/,M(VO8CZK*I_P"/QN/E
M_LYZ!D?/&](:L(7'S4_\^L.C:=;?S\'\L%-V_P#'U?"='W.;ZVW:?+';A_!M
M?<]%HEU W&K,):UN;W -W3[NXH7V7<N[R6>/_#)&<?\ .,]&]MS_ )I>6^/5
M&_Y]8?\ /W5JW0?\QGXC_(J:BQ6S>T:';N[JXQQP;&[%B79>YIJF8D146._B
M,S8+<-<^DGPXNNKI !<@#W$7,7MESERRK37UHTMDO&6']6, >;:1K0?.1%'0
MLV_F3:-R(2"4+,?POVM]@K@GY*3T>/V >CWKWOW7NO>_=>Z][]U[KWOW7NJ3
MOYM7S0^0/Q1W%TEC^D]TXS;E+O7"[XK-PID-K[>W":JHPE=MF#'-$^;Q]:]*
M(H\E,"(RH?4+WL/<[>SG(W+G.%M?R[["\KP21!*2.E P<M\)%?A''H$<W;WN
M&TR0+8N%#JQ-5!X%:<0?4](O^5-\YODC\J>X>R-F]S;QQF=P>W^L9=QXF'&[
M2VQ@)Z7,?WHV_BEJC48C%TLDX2CR$H$<FN.Y!*D@>UWN_P @<L<H[):WNQPO
M'<2W6AB9'>J^&[4HS$#(&>/3'*6_;ENM[)#>N&C6+4**HSJ \@/(]"/MKYP=
MF[8W'UE29S<Z]QX??^V<]DJ"EV;F.K<IG\ON#9?8V6VU)M6&';VR-M#";VWO
M19;%4^,P$T,XSKQ5DU#E*%\55T]?CWT/NAOW;\ZLMM#L?$XK(GJNNZW_ -$<
MG8&2WMM3<O\ >#;F3S^Y-\]5;4Q6UZ3>69R>S<1MG_1)B-XY#<.Z:K(4YCJ=
MJI2Y:1<-$U3%2^Z]U/[!^7>X:SI;O/-;>SW5^Q-V]=]-[YW?C*JK["VY79K<
M:?Z/M][EZ[[2Z]I:2EWIL_,[#SV4VS1T\8%9E(WJGS%*:A*C  9?W7NN%5\[
M<O1[Q["VJFVNM,O'U!OSI?9N]:C&]EO'G]P-V_WMO?I.--G[6GP3TM+E,$N(
MQ64>*ORH26:IGH"T86*N?W7NF;>7S7W+CZWK#,T5+MN:@J:/"[RR>$VIO"@R
M.(W93;O^/'R?W_6]:9JOR>TY-S87*=39[J3"U^4R5%3+528[)1RMBE8K12>Z
M]TKLE\VJZB[-GZB@H>K9]SU>^MH;*Z_RTG82+A>WZ?<M;UK1[EW)M""FIZR3
M$+U;!V#/+74%942OG*W#RXW&U#5#U$E![KW0U=&=Y[P[%ZMR?9.[]D5&.K,)
M]MMC.;'VCB<OF,]C^T=I@;>[FVKB:JKFCHMWXO9G9<%=@Z;(4@BAGEQ54['2
M!;W7NF'Y ]K;KV[7[5Q>.CR6W\#EM@[IWK74U%FL?MOLO<^6Q53MJ@I-C]=_
M>8/=N.RN_L13;@DKH, T4#Y_*1T5(M8M$N1BG]U[KOKJ#M';FSNR\:G?>ZN^
M-XYS-;@;I5NV:WH78>>EQ>S3MS9^X)),CU#T5MK"4^U8^Q:^5*G*-M?<-314
M-52/'35,TT-'+[KW0!8/Y$]]X?";9R^_:ZAI\3E<3L>EW7FY*?95!'M:1:W8
M6PZK><&30G9F,P/9W9N"WHN.R.5R'\'K<'6XK(X85+T59CJKW7NK!O[^XS_1
MM_I0_A.Z/X-_<?\ O[_ _P"[N1_OI_#/X#_>'^$_W3\?\6_O1]K^S_#M'W'W
M?[-M?'OW7NEQ[]U[KWOW7NO>_=>Z#7<O85+C6DHL0L==6K=9*AB31TS V(&D
M@U,JVY (4'\DW7V:VFV/*!)-58_3S/\ FZ9>8+A<GJFK^9%L3/[IQ&W.WEKL
MAD%VZR[=W'1//,]#1X_(U+/B,M34(9:.B\62F:FG=$#2FH@!X3W-WMC?VUI-
M+LVE5\7O0TR2H[E)XGM&H5.-+>O06WZ!Y%6Z!)TX/V'@?VX_,=5 >YGZ"_5P
M7PLW+_&^EZ?%22%I]I9_,8;2S!I!2U4D>>IG_P!5XM66DC2_T\1 X ]PMSS:
M^!OAF [9HU;\QV'_ (Z"?MZ%6T2:[32>*L1_E_R]%V_F!P>+;/8TED'W76.%
MG.D6)T[SI::\AL-3VI_KSZ;>Q-[<-6[M1Z7;#_JD3_EZ+>9!_B<W_-(?\>'6
MOO[R/ZBWKWOW7NO>_=>ZLM^)?\TCY%?&2HQNW\OEJGM_JFG:GIYMB[TR=5/D
M,1CXF"M'LO=<RUF2V^T</IBIY5J\<@'%,I.H19SC[2\L\U*]S"@LMX-2)8E
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MAQT"2*E!63,&UZ*0ZV> "!O=#EG;MJA/,=JR1!Y KQ5 U,WXHQBK'BZCRJ^
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MX^FAO)-BJAY:J)5=J:652E-'D_[<>\YOIH]BYP95N6(6.YPJL?)9AA58G D
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M=21F6JK\CD*B.DH:*FB7U25%54S*B*.2S >SN::*WA:>=@L**68G@% J2?D
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MVKO'MKN3K_%5'Q][6VSM3$8&#?\ 7]QT6<Z!FQE5N[^[F8%/TQV!BSW5)O\
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4O>_=>Z][]U[KWOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>j17244762_ba012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244762_ba012.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ CP'* P$1  (1 0,1 ?_$ :(    & @,!
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%
M_E[?]D"_![_Q4#XT_P#OF-E>_=>Z-_[]U[KWOW7NJ38/G1\C>NMP=H=C;SV_
M!OGX_;#^6O9GQFW'E,G5==['QVUJG-]N=']:=$9:GW+35%/D\5B<)5]@9>;=
MV3SM'_#8\72QRQ3I4QK#6>Z]U/[^_F,]\8G;OR'V]USTOL?9.ZNG.IOCQV37
M[QW!W1AM[O18OY)?(;Y'] [7FVS@ME]?;OV3N/*XU_CI499EJ<XD--#FZ>.I
M@:JHZN@?W7NE/O3^9KE.JNNH<Q)T[ENP<O'D._MJ8Y<YV/B\#N.?/?'7Y'[9
M^.6X\KVC3[?ZBHZ'8.W]UY;<<>2QE=0XJLUQ5%!!+1P25RF+W7NHN]/YG_8^
MR-W]F;$R/QIV35[BZL[&[8ZBSS4/R'SK86NW]U#\$>KOGCG/X/7S_'>"NFVA
MDME]@U&"I*^:C@K3E,?'))0)!5,U+[KW3;COYOFW]SSU<&QNJ-N;L,NX/A=M
M_!3T?<X6CJJWYA?+3)?$5J/.5-'UEDEQF5Z:WK%1U&X(J 9> /43T GCKJ22
M)_=>Z4VW_P":]M[.];=F[^_T.U=/E.ENE<OW+OSKR/?L4^]]UTFV>S?D'U3N
M7 = 8J?9M$_<%70;E^/%>89IOX"LJ9;'QRI3U$DD$7NO=6!=#=OUO=&U\INF
M?;VW<-C8<S24NV\KM'M'9/;6U]Z[=K]J[;W)0;PP&Y=DU<T$6*KY<[+!!#60
MTM5+%3+5"/P5$+-[KW0X>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZX
M21QRQO%*B212(T<D<BAXY(W!5T=&!5T=38@\$>_=>Z(O\Y=U47QM^'78>ZNO
M^MNH,EA=G?W?D_T;;SV#%ENM\K09C=^)HLE1S[6PF3VU20SRODWJ(Y;R(M0
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M3%08RMA[]U[IXVGUAUKL&MR61V+UYL;9>0S-#A\9F*_:>TL!MRMRN-V\M8N
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M-#B:07H:G"4E<48-$]= LA32-'LZ_P!;3GS_ *-=U^P?Y^DG]8-E_P"4B/\
MG_FZ-1\<^U_CQO[:\NWOCYOW![WPFSM%+DY<7D,CE:R*KK":J6LS.2RD8KLE
ME,E-,TT]1*\DLTCEF8D^R'>>6]]Y>:-=[MI;9I02FL :M-*TH3PJ/V]++2_L
M[X,;219 M*T\J\.A%W#VQL3:^2W-ALSF3297:&U\3O/.TD]%74T-+MO.Y+)8
M;$Y3^+UE/38)J6HRF(J8I)/NA'1B%I*EH8@9 2=+.I$?9VS)-ZX[KS^(UD>[
M<MA\AGL9128+/KC<CC<1!@JG*R8_<XQC;4R$V.@W-0-+#!722J*E3IM<CW7N
ME][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB%]A;\[-6N[Z.+
MW'4U^/ZS^0G6JT^U*7==!L/<V0ZUR?176^3K=F=?UV/V)N6MW5NG<G96;JY,
M3BZPT[9O*>3&?Q2CAL(O=>Z6W2?86XMV=L;[&;Q%;6IEI]UU6*R,=;DI<7L;
M96VLWAL5UI1"@JJ6+&T\?<^SLG%NJGJ:66>>HJ5KH*ED6CIJ:G]U[HWWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[HH'\O;_L@7X/?^*@?&G_ -\QLKW[KW1O
M_?NO=>]^Z]U[W[KW7O?NO=!+V7UC4=AYWJC*IN$86CZYWKGMT9.CCH<F]?N&
M@S_5G8?6-1BL7GL1N3;V0VCD((=_M619&+[J6-Z4*D:LXEC]U[H&MF?%_,[(
MVKL;96+[!P[;=V+WGG>X<?!-LS<556/C=P]A=D;VK-EPUF4[0R?V24=#O2AH
M*2L5&BA;'33O22&M6*D]U[HW_OW7N@[P?:^P-R5>"H<-GQ656Y:W?6-PL1Q>
M9I?O:_K3/5FV-[T9DK,=3Q4U1@LYCYX&69HS/XF>'R1C7[]U[I1[<W7@-VP9
M*IV_7_Q"'#YS+;;R3?:UE(U+F\)4FDR=$\5=3TTK&GF'$BJT4JD/&S(0Q]U[
MI0^_=>Z][]U[KWOW7NO>_=>Z][]U[HM7>.\,QM7?72<=%NM=M8#*Y+LV/>KU
MN2HL3@(\)0=3;OR6)R^XLK5T=8,)C\9NZEQX2L8>*.:5$99&=4/NO=%]V/O7
MNQQTOB4FW//-%E,S!NT9^?-5]143O\D8]KU]+%E)X9UW1BZ'JC&YZ>@^\EFK
M8,72P5U2L4P\Z^Z]T?#<FZL/MJ-?XL]2B3TE54J::*1W\%-58VAF(>-T='$V
M7AM8@V)(/'M1;6TMW)X4--=*YQU5G""K<.B_T2_'O'TE-CX-N5,N.HZ'/X^D
MQE>,WE,92P;KJZZNW/-3X[)Y.KHH<CN*?)U(KJM8Q5U<=1)'+(T;LI7_ +CO
M_1?V]-^/'\^A3V)N/K]+8#9U%)CTJ:MYFA%'+$LU4]'-('FGFDEED\./Q8@B
M#,5AIX8H(PL4<:*GN=MN;2/Q9@NDFF#7JRRHYH./6MYW)_..^6VP^U>P=F83
M'=0OB-L;KS&%QK5VS<W/6&CH*N2" U,T>[H$EF**-3!%!/X'O*+E_P!E>3MS
MV&QW*Y:\^HN+.&5M,B@:I(U=J#PS05)H*G'GU'%[S;NMO>301B+0DKJ*J:T5
MB!7N]!T&G_#W7S+_ .=9TM_Z ^=_^S3V;_ZP_)'\5]_SE3_K5TE_KGN_I#_O
M)_Z"ZMG^97SY[D^./QP^-_;.S-O];YO<W;F&I:W<]/N[#;DK,133R;>P.5<X
M:EP6[MO5-*K5.4D%I9Y[(%'U!)AGDGV_V7F;G/=.7KZ2YCL;)9C&8V0.=%PD
M2AB\;@C2Q)HH-:&M,$5[OO=WM^TVU]"L;32E0VH&F4+&@# \1ZG'57G_  ^M
M\M_^?=_'/_T$>S/_ +;ON7/]8#DW_E)W/_G)!_VS]!C^NVZ_[[M_]Y?_ *V=
M6._RU_YB_=OS&[0WOLGLW:W5F"Q6VMFQ[BH:C8F$W;C,A+6OE:>A,57+N#>^
MYZ:2E\,I.E(HWU6]5N/<9^Z'MGL/).SP;AM4UW)-+<^&1*T;+30S5 2*,UJ!
MQ)%/+H0\N\P7N[W3P7*Q*BQZAI# UJ!YLWKUJ^]K?\S*WS_X=&8_]S)?>4?+
M/_*L[9_TKK7_ *L1]1UN'_)0N/\ FO)_Q]ND30_\#:/_ *BJ?_K:GL_B_M%_
MTP_P](F^$_9UOY?''_LGGH;_ ,0QU=_[P^#]\UK_ /W.F_YJO_QX]3[#_8I_
MI1_@Z&?VDZ=ZPU$AAIYY5 )BAED /T)1&8 VYL2/>QDTZ]U3]G_YC/:.(SV;
MQ,.Q]@RPXO,9/'0RR)N(22145;/31/)IS87R-'$"U@!?Z ?3W-D7MAM,D2R&
MXN:LH/X/,?Z7H.-O,X8C0G'Y_P"?J#1?S(^U*NLI*5MB]?HM354].7";C)43
M2I&6 .;L2H:_MY/:S9RP!N+FA/\ 0_Z ZJ=[N*? G\_\_5@%9VSN>;9FQ=ST
MR8ZCJMT[)V-N:LIDIFFIJ>LW-BLED*V"F\\CRBGBD@18]3,P5>223[BG;-OM
M[IY5FJ0AH,T]?\W1]+(RJ"//I+?Z9M[?\=\=_P">^/\ Z/\ 9M^X[#T;]O3'
MCR?+I00;[W!N?:F\:3*R4KPR; [*J&$%,L+>3&8W;<=*0RDV 7-3ZA_:N/Z>
MRJ^LH+.ZA$-:,PK4U\QTZDC.C:O(?Y^M%;<__'R;A_[7F6_]SZCWT/B_LU_T
MH_P=02WQ'[>L6WO^+_@_^UQC/_<V#VYU4\.KSOYT/_'O?$O_ ,1E3?\ N#1^
M\;?N^?#NW_-2'_K)T/>=_P#B+_I7_P"?>J&O>2/0"ZV1/Y#]1!2;9[\JJJ:*
MFIJ;)8>HJ*BHD2&"G@AQ\4DTTTTC+'%%%&I9F8@* 23;WC#]X8%KK:E7)*3_
M .&+J0^1C2.Y)X53_ W5FG<6R>H.WLKVE7U_R#Z]PR;_ .EJ?J7$Q4.YJ>EK
M=JY"G/8\3;LERF"[)V[5YU'H^R*J$XP_:0,(P9))+@+ '[EWG_E$N?\ G$__
M $#T-OJ[3_?L?^]#_/TI]H5&(Q':6-W/D?DMTIN'9N)V:-C;7V33X^BIMST"
MWPT=#5#>E=V_GJ&:MJ9:&7[XTV"I*C)M+ LLOCI((QH[+O %3:7-/^:3_P#0
M/7OJ[7_?L?\ O0_S]'#5E=5=&#(P#*RD,K*PNK*PN""#P?9;THZ[]^Z]U[W[
MKW1?]X]_8S9V5WMBZK:^8JSLK</3& J*F&KQL<.1;N;=N#VCCJ^E5YS+'2X&
MLSBM4K(JRR"-A&I!#>_=>ZS4'?.)K_D#E_C\N R-+F\1M2JW7)E*VI@ION\;
M3T^SYX<MCL4\?FKMK9*HW:^/ILC%*VK+87)TTD,0IXI:CW7NE!WKN[/;$ZIW
M=NW;,U'3YO"P8R>CEKZ/[^E"S9S&4E6KTOGI];R451(J,6M&Y#E6"Z3[KW18
M]U=Y;LBF[-V]MWLO:>4R$.^^HNN*6:IEP>WZS9&X]X;U&UM\24_V=-N&?&;7
M@1XL3BZC)T^4R5/N@532I-1?:(WNO=#EE.Z:3#?%C-?(7 X'+U-%@^B<SV]B
M-L;KK9*?-U4&&V)5[OHL)N#(B3+RP9"I6E6"IGU5+*[,WK(Y,-HL1N>ZVNVL
MVA;BXCBU4KI\1U6M*BM*UI45]>F+J8V]M)< 5*(S4]=()I_+JBJ3^?;NF1XF
ME^,>UY&IY3+ S]E9%VAF\<D!EB+;*)CD,,SIJ%CI<CZ$^\DO^!XLO^CI+_S@
M7_K;T OZ\R_\HR_[V?\ H'H2.HOYW6Z>S^UNM.MY_CUM_#P[_P!^[1V9-EHN
MQ<C6RXR+<V>H,-)7QTC[1IDJI*1*PR+&9$#E;%A>_LLWOV(M-IV6\W9=RD=K
M6TFF"F%0&,4;2::^(:5TTK0TK6G3]ISG+<W<5L;=0))42NLFFI@M?A\J]7V;
MLW?M[9&*I\UN>N?'8RJW!M/:T%2E!D<B6SN^=TX?9>UZ-H,725M1$F2W+GZ2
MF,S(M/3B7R3/'"CR+CAT/>DID.Y.OL;M_=FYY\GF)\1L?-[AV[N4XO9N],UD
MZ++[5H:G)9VEIL#A]O5V>RZ4=!223+-14U1!.@!B=[K?W7NA%Q]?196@HLGC
M:F&MQ^1I*>NH:RG<2055'5Q)/35,,@X>*:&0,I_(/OW7NI?OW7NO>_=>Z][]
MU[HA_P --];?ZU_EL_#3>FZ*B2FPN(^('Q:CGDB6/4]5E>JNOL-BZ<S5,U-C
MZ&.KRN0AB>JK)Z:@HT<SU4\%-'+,GNO=&"QO>&.S&<ZMQ^.V+OZ?;W;6,%;M
M_?KP;0I-L8W(?W=W5NEMOYW'UN\:;?<.23$[2E;STN%K,67J:8+5D2W7W7NA
MN]^Z]T7?%=\R93O+>728VI#35FV\!NC.8O,S;@E67,1;5PO2>4J9ZO"MM]),
M7ALG5]TQ4='6PU%>DU1AJ]2B/%H]^Z]T)/4^^?\ 2AU9UKV7_"_X'_I$V!LW
M?/\ !?O?XE_!_P"]NW<=G_X7_$?M*#^(?P_^(>+S^"#RZ-7C2^D>Z]UIB_S,
M/^RY_D+_ .'/@_\ WB=L>\\?:W_E0-L_YHM_U<?J&.8O^2W<?Z<?\='1%?8_
MZ)>MT_\ E._]N_\ H'_@G:'_ +^?L7W@I[M?]/#W+_FI'_U9BZF3EG_DAV_^
ME;_C[=#3M3X\[MVC7[+R5#V/MVIJ-F[D^1^Y(5JNN<F8:ZH[UWGN+>F%IY4A
M[(BD@AV16;@,-40[-F8X@8_X<S<1UT>]"YU=U_7]>TF]*:OS]'GSNGL?=V^*
M.2DP<V#_ (5C]RU4-12X.I2;.9S^*5F-2+3)6J:5*DFXIH;6/NO=+O+YO"[?
MHFR6?R^+P>.22*)Z_+Y"DQM$DL[B.&-JJMEA@62:1@J@M=F-AS[]U[J-#NC;
M-1E(,)!N+!3YFJHH\E38B'+X^3*5&.FC::&O@H$J&JY:*6)2RRJAC902#;W[
MKW3[[]U[KWOW7NO>_=>ZIT['^?G;V W7N?:<.TNJ\AB*&KEQXCRN!W/5O54K
M0IKCK$7>4--.)!(0P\84CBWN:=K]N=DOMLM[V66Z$LT$;D!HZ LH8TK$32IQ
M4D_/H.S[M<QS/&JII5B.!\C3UZ2,/\Q[NRFABIZ?9_4=/3T\4<,$$.W]VQ0P
MPQ($BBBB3?*I'%&B@*H   L/:[_6OV#_ ']>?[W'_P!:NF_WU=?PQ_L/_071
M_<AN_);]ZPV)O#,04--D\]M#.UE9!C8JB&ACE&[-F0:::*JJ:RH2/1$.&E<W
MOS[C**SBV_F&XLH2QBB=U!:A) -!6@ K]@'1SXC2VJ2-34P!Q]G03^Q#TQT+
M/3W_ !]-'_U%G_W1;B]DF_?[AC_FH/\  >G[?^T_+K3(^3'_ &4%W'_XD+<O
M_NQF]YN\G?\ *H[5_P!*VV_ZLIU#.Z?\E.Y_YZ)/^/GH#O8CZ0];!7\TK_LB
M+X/?^&W1?^\7L_WC7[3?]/0Y@_YIW/\ VF1=#_F7_E7;+_31_P#5INM?7WDI
MT .KR/Y$W_90';'_ (B^#_WHJ+W OW@?^59L_P#GN'_5J3H:<D?\E"7_ )H_
M\_+U3OVM_P S*WS_ .'1F/\ W,E]R_RS_P JSMG_ $KK7_JQ'T%]P_Y*%Q_S
M7D_X^W2)H?\ @;1_]15/_P!;4]G\7]HO^F'^'I$WPG[.M_+XX_\ 9//0W_B&
M.KO_ 'A\'[YK7_\ N=-_S5?_ (\>I]A_L4_TH_P=#/[2=.]1:[_@%5_]0M1_
MUJ?WL<1]O7NM7;>W_'Y[N_\ #GS_ /[M:OWEO;?[CQ_Z1?\  .@(_P 9^T]-
M.'_XN^+_ .UC0_\ N3%[4Q_&OVCJAX'J\9O^93=/?^(FZC_]YK,>\:-D_M9_
M]-_E/0SF^!?LZ1WL0])NA$VO_P >[NW_ ,1SVU_[@[$]AW>/]R[?_3#_ (\.
ME$/P/]G^?K2(W/\ \?)N'_M>9;_W/J/?02+^S7_2C_!U!C?$?MZQ;>_XO^#_
M .UQC/\ W-@]N=5/#J\[^=#_ ,>]\2__ !&5-_[@T?O&W[OGP[M_S4A_ZR=#
MWG?_ (B_Z5_^?>J&O>2/0"ZOQ_E)?]DV_-W_ ,1]NG_W@LE[QN]]/^2WL7^G
M?_JY#T/N3?\ <2\^P?\ '6ZH8KO^!M9_U%5'_6U_>2/0!Z5?6O\ S,;8'_A[
M;5_]WM![37O^X<O_ #2;_CIZ<B_M5_TP_P /7T%]O_\ %APG_:HQO_N%#[YL
MGCU/@X=._O76^FK.YO%;9P>9W)G:Q,?A-OXK(YO,5\B2R1T.*Q-)-7Y"L>."
M.6>1*:DIW<JBLY"V )X]WBC>:188A61V  ]230#]O6F(4%FX =$8W1VG\/-U
MY/=N2RO<-4D^\,EUKE<I!2TN6B@IZ[J?/46YMJ/0K)M":6-5S>,IYJE97E6;
MQ!+*C.K"?^I/-(Q]&_\ O2?]!=(_WC9?[\'[#_FZ=]I=E_#NF[1_OUA.PURG
M8>Y:JHQM/55_][ZV27*;JQ^Q-JY*2F6IQ"QP39W%=<[=I)59OM8UQ44D:122
MU4L]).3>9HHVEDM'$:J23J3  J3\7IUL;A9L0 XJ?D?\W0Z=D]AXK&9.IV9F
M=GX_=6*J\#ALO4PY2HIY*"K3(Y+-PQTM1BZO$U]/,M++@%E#,3=G'I4H"Q=M
M^U_71-)XFBC4^&OD#ZCIZ27PS2E>D'!V;M*E&1%-U5MRG&7DFERP@;&0C*2U
M"&.HDR(CVZOWLD\;%7,FHL#8W'M?_5W_ (=_QC_H;IOZG^C_ #_V.FGY![S&
M\_AY\J:P8P8L4W0/=]&(16?>!A%U=FY0X84E($!%3;3I-M/UYX5;)8?0<V;6
MFO7JOK<\*?Z,GS/3%])XFVW!I3]%_P#CIZT8&^I_US_O?OH$>/4']#_\3_\
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M?]7'ZB?F+_DMW'^G'_'1T17V/^B7K8#W9_VX;Z[_ /#GKO\ X)G=OO&_;/\
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M@3=?[E2?\U&_PGH,_9QTQU>IMC_F0O57_ABY[_WLMH^\=;G_ )6Z\_YK2_\
M'NA;%_N#'_I1_@Z2/LVZ;Z%GI[_CZ:/_ *BS_P"Z+<7LDW[_ '#'_-0?X#T_
M;_VGY=:9'R8_[*"[C_\ $A;E_P#=C-[S=Y._Y5':O^E;;?\ 5E.H9W3_ )*=
MS_ST2?\ 'ST!WL1](>M@K^:5_P!D1?![_P -NB_]XO9_O&OVF_Z>AS!_S3N?
M^TR+H?\ ,O\ RKME_IH_^K3=:^OO)3H =7D?R)O^R@.V/_$7P?\ O147N!?O
M _\ *LV?_/</^K4G0TY(_P"2A+_S1_Y^7JG?M;_F96^?_#HS'_N9+[E_EG_E
M6=L_Z5UK_P!6(^@ON'_)0N/^:\G_ !]ND30_\#:/_J*I_P#K:GL_B_M%_P!,
M/\/2)OA/V=;^7QQ_[)YZ&_\ $,=7?^\/@_?-:_\ ]SIO^:K_ /'CU/L/]BG^
ME'^#H9_:3IWJ+7?\ JO_ *A:C_K4_O8XC[>O=:NV]O\ C\]W?^'/G_\ W:U?
MO+>V_P!QX_\ 2+_@'0$?XS]IZ:</_P 7?%_]K&A_]R8O:F/XU^T=4/ ]7C-_
MS*;I[_Q$W4?_ +S68]XT;)_:S_Z;_*>AG-\"_9TCO8AZ3=")M?\ X]W=O_B.
M>VO_ '!V)[#N\?[EV_\ IA_QX=*(?@?[/\_6D1N?_CY-P_\ :\RW_N?4>^@D
M7]FO^E'^#J#&^(_;UBV]_P 7_!_]KC&?^YL'MSJIX=7G?SH?^/>^)?\ XC*F
M_P#<&C]XV_=\^'=O^:D/_63H>\[_ /$7_2O_ ,^]4->\D>@%U?C_ "DO^R;?
MF[_XC[=/_O!9+WC=[Z?\EO8O].__ %<AZ'W)O^XEY]@_XZW5#%=_P-K/^HJH
M_P"MK^\D>@#TJ^M?^9C; _\ #VVK_P"[V@]IKW_<.7_FDW_'3TY%_:K_ *8?
MX>OH+[?_ .+#A/\ M48W_P!PH??-D\>I\'#IW]ZZWT#_ ,AO^9 ]X_\ B'^S
M/_>+S?LPVG_DJ6W_ #T1_P#'QTU/_8/_ *0_X.M:F;_/2_\ +1_^AC[RP/$_
M;T!^EOU;_P S-ZY_\/O:'_O08_V@W/\ Y)MQ_P T)/\ CIZ<A_M5_P!,/\/5
MW7<O_,P!_P"&)M#_ -W6^_>/?+_^XS_\U/\ (.A=<?$/LZ##V?=)NGCLG_LB
M[Y9_^(-[U_\ ?49'VCM/^5OVG_GMM_\ J^O5;K_DF7/_ #1?_CAZTF6^I_US
M_O?O/(\>H4Z'_P")_P#V5%\<O_$Y]4_^]S@_8;YR_P"5/W?_ *5=W_VCR=+]
MJ_Y*EK_STQ?\?7JQ#^>%_P!E>[<_\0OM+_WH]X^XU]A/^5,E_P">^3_JW%T?
M\Z?\E9?^:"_\>;JF_P!S;T$>MCK^6IO;<_6W\K[Y<;_V5D_X+NW9V\.U-Q;<
MRWV6/R/\.S&+ZEZ\JJ"L^PRU)7XRK\%1&&\<\,L36LRD<>\9?=.QM=T]V=EV
MZ^379SVULCK4KJ5KJX!%5(85'F"#Z'J0N7)I+?EJ[GA-)4D<@X-"(XZ8-1^W
MJM[_ (=H_F!_\_\ O_85]*?_ &M_<G?ZSOMS_P!&[_LXNO\ K=T'?ZT[]_O_
M /XQ'_T!T8/XG_S,/FWV7\E^B^OM[=U_QK:&\>SMI;>W)B/]''4F-_B.'R>6
MIZ:NH_O\3L*@R='YX'*^2":*5;W5@>?8<YP]K>1-KY6W#<K"Q\.]@M)'1O&N
M&TLJD@T:4J:'R((]1TOVOF/>;G<8()IM43RJ"-""H)SD*#^SK;']X?=2EUJ:
M[6_YE-\;/_%/_AK_ / K=/\ O(_D+_E4[3_F[_U>DZ".Z?[G/_M?^.CIP]C#
MI!U=5\<?^R,=O_\ :XSG_O;U'N"N9_\ E>9?^::_]6AT)K'_ ))R_:?\)ZQ^
M]]7Z7?5__,Q=H_\ 49E__>5W![*]Y_Y)TG^U_P"/#IV'^T'^KRZU7_YF'_9<
M_P A?_#GP?\ [Q.V/>77M;_RH&V?\T6_ZN/U$_,7_);N/]./^.CHBOL?]$O6
MP'NS_MPWUW_X<]=_\$SNWWC?MG_B05W_ *1O^T6/H>W'_*D1?:/^KC=:_GO)
M#H!=6D_R=/\ LN78/_AL]A?^\3G/<0^^'_*AR?\ /3#_ ,>/0IY0_P"2RO\
MS3;_  =%N^>7_98?R"_\2#D/_<6C]BWV]_Y4?:_^>*/_ ([T5[Y_R6+G_FLW
M^'HH_L8]%76[_P#RU_\ LAWX^?\ AL9K_P![/<OO ?W*_P"5[W3_ )ZF_P
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M_2C_  =#/[2=.]1:[_@%5_\ 4+4?]:G]['$?;U[K5VWM_P ?GN[_ ,.?/_\
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M\1]NG_W@LE[QN]]/^2WL7^G?_JY#T/N3?]Q+S[!_QUNJ&*[_ (&UG_454?\
M6U_>2/0!Z5?6O_,QM@?^'MM7_P!WM![37O\ N'+_ ,TF_P".GIR+^U7_ $P_
MP]?07V__ ,6'"?\ :HQO_N%#[YLGCU/@X=._O76^@?\ D-_S('O'_P 0_P!F
M?^\7F_9AM/\ R5+;_GHC_P"/CIJ?^P?_ $A_P=:U,W^>E_Y:/_T,?>6!XG[>
M@/TM^K?^9F]<_P#A][0_]Z#'^T&Y_P#)-N/^:$G_ !T].0_VJ_Z8?X>KNNY?
M^9@#_P ,3:'_ +NM]^\>^7_]QG_YJ?Y!T+KCXA]G08>S[I-T\=D_]D7?+/\
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M"1Z=!>XVZ\>=W5*J7)&5X$GY](6^^O\ O'SY?_\ I%?RW_\ M*^S'^OO*?\
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M9]D?+^.>FQU#!,G_  WQ\]VT2PTT4<B:D^-3(VEU(N"0?Q[PC/'J7APZ<?\
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M<1HO@7(U/)"Z(M6A"BK$"I( XD@9Z5[?RUO4%_!/+#2))XV)UQF@5P2:!JX
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M)U7N_:VSL1OG<553YO>OQW^/W779U5F5ZSWOMK%Y3=N=Z7^+F>@R6U*W 3M
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/>]^Z]U[W[KW7O?NO=?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
